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Colorectal cancer (CRC) is the third most common malignancy worldwide and the second 
leading cause of cancer-related death. The global burden of CRC is rising, particularly in 
younger populations. This increase has been attributed to lifestyle factors, chiefly diet, and 
their effects on the colonic microbiome. Several species of bacteria have been identified in 
high abundance from the gastrointestinal tract of CRC patients, and have been shown to exert 
direct and indirect pro-tumorigenic effects both in vivo and in vitro. However, what is unclear 
is whether these bacteria promote CRC development and progression across the entire 
adenoma-carcinoma sequence, or whether the interactions of bacteria with benign tumours 
differ from those with malignant ones. 
 Three CRC-associated species of bacteria, Bacteroides fragilis, Enterococcus faecalis 
and Fusobacterium nucleatum, in addition to the probiotic species Escherichia coli Nissle 
1917, were investigated using the gentamicin protection assay to determine how they interact 
with the benign colorectal adenoma tumour cell line RG/C2, and the malignant 
adenocarcinoma line HCT116. All bacterial species were found to attach to and invade both 
cell lines. However, attachment was found to be higher in RG/C2 cells, in contrast to invasion 
which was higher in HCT116 cells. All species could also persist within tumour cells, and this 
bacterial infection promoted significant increases in cell yield whilst reducing apoptosis. 
There was evidence that B. fragilis and F. nucleatum may promote a Warburg-like metabolic 
effect in HCT116 cells, by upregulating glycolysis. In both wound healing and transwell filter 
migration assays, E. coli Nissle and F. nucleatum were able to promote both individual and 
collective cell migration in HCT116 cells; however, no bacterial species influenced migration 
in benign RG/C2 cells. Furthermore, F. nucleatum also promoted HCT116 invasion, 
suggesting that this species may be a driver of late-stage disease. 
 This thesis demonstrates that in a 2D model, there are differential bacterial 
interactions with colorectal tumour cells representing different CRC stages. It highlights that 
specific species are able to promote migration and invasion in malignant cells in vitro, but 
cannot confer this phenotype to benign cells. Despite this, all species investigated may 
promote tumour progression by increasing cell yield through the inhibition of apoptosis, 
possibly facilitating the accumulation of further genetic damage. In conclusion, this research 
demonstrates that colonisation of tumours by these species may contribute to poorer patient 
prognosis by accelerating CRC progression, and that these effects should be investigated in a 
more complex model of CRC. This thesis highlights the need to incorporate our knowledge of 
microbial contribution to CRC development and progression into future treatment and 






This PhD would not have been possible without the support of my supervisory team, 
namely Dr. David Qualtrough and Dr. Robin Thorn. Thank you both for your advice 
and guidance, and for all the team meetings that devolved into football chat. I would 
also like to extend my gratitude to Dr. Arwa Flemban, whose kindness and support 
was vital during the beginning of my project. Thank you also to Professor Ann 
Williams at the University of Bristol for providing me with the benign cell line used 
throughout this project.  
 I would like to extend my gratitude to the brilliant technical team at UWE who 
have personally helped me and generally kept the labs running throughout my time 
here. I would particularly like to thank Barbara Rees for her help with looking after 
cells, and for making the Microbiology lab such an easy place to work in. I would also 
like to thank Dave Corry for his help with the confocal microscopy. 
 Thanks to all the friends I’ve made along the way. For the lunchtime 
crosswords and the Friday afternoon fried chicken. For the Christmas parties and all 
the baked goods. And, perhaps most importantly for putting up with my complaining 
throughout the past four years! I couldn’t imagine doing this again without such a great 
group of people to muddle through all the ups and downs with.  
 Thank you to all my family who’ve supported me on this journey, particularly 
Mum and Dad who’ve always pushed me to be the best version of myself. Thank you 
to the all the Burts who’ve (perhaps involuntarily) adopted me over the past four years. 
Finally, and most importantly, thank you to the wonderful Ashley Marie. Your 
contribution to my life and this thesis cannot be described in words, expect for to say 
that without you I would never have applied for this PhD, and I certainly wouldn’t 





Table of Contents  
 
Author’s Declaration .............................................................................................................. i 
Abstract ................................................................................................................................... ii 
Acknowledgements ............................................................................................................... iii 
Table of Contents .................................................................................................................. iv 
List of Figures ...................................................................................................................... viii 
List of Tables ......................................................................................................................... xi 
List of abbreviations ............................................................................................................ xii 
Chapter 1: Introduction ........................................................................................................ 1 
1.1 Structure and function of the human colon ................................................................. 1 
1.2 Colonic crypts are the drivers of colonic homeostasis ................................................. 2 
1.3 The Gut Microbiome ..................................................................................................... 5 
1.3.1 The biogeography of the colonic microbiome ........................................................ 5 
1.3.2 The composition of the colonic microbiome is key to its function and gut 
homeostasis ...................................................................................................................... 7 
1.3.3 Immune system development occurs alongside microbiome maturation ............... 9 
1.3.4 Functions of the gut microbiome .......................................................................... 12 
1.3.5 Perturbance of the microbiome has significant effects on health .......................... 14 
1.4 Colorectal cancer ........................................................................................................ 18 
1.4.1 Epidemiology of colorectal cancer ....................................................................... 18 
1.4.2 The Multistep Nature of Cancer ............................................................................ 19 
1.4.3 The unique tumour microenvironment of CRC governs disease progression....... 26 
1.5 The link between the microbiome and cancer ........................................................... 31 
1.5.1 Colorectal cancer patients exhibit distinct microbiota populations ...................... 31 
1.5.2 Bacteroides fragilis ............................................................................................... 33 
1.5.3 Escherichia coli .................................................................................................... 34 
1.5.4 Enterococcus faecalis ........................................................................................... 36 
1.5.5 Fusobacterium nucleatum ..................................................................................... 38 
1.6 Models of bacterial contribution to colorectal cancer ............................................... 40 
1.6.1 The alpha-bug hypothesis ..................................................................................... 41 
1.6.2 The Driver-Passenger model ................................................................................. 43 
1.7 The two-way relationship between the adenoma-carcinoma sequence and the 




1.8 Aims and Objectives .................................................................................................... 49 
1.8.1 Aims ...................................................................................................................... 49 
1.8.2 Objectives ............................................................................................................. 49 
Chapter 2: Materials and Methods .................................................................................... 51 
2.1 Culture of colorectal cell lines .................................................................................... 51 
2.1.1 Standard tissue culture procedure ......................................................................... 52 
2.1.2 Cell line cryopreservation ..................................................................................... 53 
2.1.3 Cell enumeration ................................................................................................... 53 
2.2 Bacterial culture .......................................................................................................... 54 
2.2.1 Bacterial culture media and culture conditions ..................................................... 54 
2.2.2 Agar culture .......................................................................................................... 55 
2.2.3 Planktonic culture ................................................................................................. 55 
2.2.4 Bacterial enumeration ........................................................................................... 55 
2.3 Quantification of bacterial adhesion and invasion into tumour cells ....................... 57 
2.3.1 Gentamicin protection assay ................................................................................. 57 
2.3.2 Determining intracellular bacterial persistence ..................................................... 58 
2.4 Imaging of colorectal tumour cells and their interactions with bacteria .................. 60 
2.4.1 Phase contrast microscopy .................................................................................... 60 
2.4.2 Scanning electron microscopy .............................................................................. 60 
2.4.3 Confocal laser scanning microscopy ..................................................................... 60 
2.5 Crystal violet biofilm formation assays ...................................................................... 62 
2.6 Monitoring cell yield and viability in infected tumour cells ...................................... 63 
2.6.1 MTS assay ............................................................................................................. 63 
2.6.2 The effect of bacterial infection on tumour cell yield ........................................... 63 
2.7 Cell cycle analysis ....................................................................................................... 64 
2.7.1 Flow cytometry sample preparation and staining ................................................. 64 
2.8 Metabolic analysis ....................................................................................................... 65 
2.8.1 Seahorse general assay procedure ......................................................................... 65 
2.8.2 Optimisation of seeding density and carbonyl cyanide-4 (trifluoromethoxy) 
phenylhydrazone (FCCP) concentration ........................................................................ 66 
2.8.3 Crystal violet normalisation .................................................................................. 67 
2.8.4 Measuring the impact of bacterial invasion on cellular metabolism ..................... 67 
2.9 Analysis of volatile metabolites released by tumour cells .......................................... 68 
2.10 In vitro migration and invasion assays .................................................................... 69 
2.10.1 Wound scratch assay ........................................................................................... 69 
2.10.2 Transwell filter migration assay .......................................................................... 69 
vi 
 
2.10.3 Transwell filter invasion assay ............................................................................ 70 
2.11 Luciferase reporter assays ........................................................................................ 72 
2.11.1 Bacterial transformation ...................................................................................... 72 
2.11.2 Plasmid purification from transformed E. coli .................................................... 73 
2.11.3 Tumour cell transfection ..................................................................................... 73 
2.11.4 Dual-Luciferase® Reporter assay ....................................................................... 74 
2.12 Western blots ............................................................................................................. 75 
2.12.1 Preparation of protein lysates .............................................................................. 75 
2.12.2 Estimation of protein concentrations .................................................................. 75 
2.12.3 SDS-PAGE ......................................................................................................... 76 
2.12.4 Wet transfer and antibody probing ...................................................................... 76 
2.13 Quantitative PCR Microarrays ................................................................................. 80 
2.13.1 RNA extraction and cDNA production ............................................................... 80 
2.13.2 RT² Profiler PCR Arrays ..................................................................................... 81 
2.14 Statistical analysis .................................................................................................... 83 
Chapter 3: Quantifying the interactions between gut bacteria and colorectal tumour 
cells ........................................................................................................................................ 84 
3.1. Introduction ................................................................................................................ 84 
3.2. Aims ............................................................................................................................ 85 
3.3 Objectives ..................................................................................................................... 86 
3.4 Results ......................................................................................................................... 87 
3.4.1. Benign and malignant colorectal tumour cells display distinct morphologies in 
vitro ................................................................................................................................ 87 
3.4.2. Co-culture with bacteria does not impact tumour cell viability ........................... 91 
3.4.3. Bacterial attachment to colorectal tumour cell monolayers is dependent upon 
tumour cell type ............................................................................................................. 93 
3.4.4 Imaging the attachment of bacteria to HCT116 cells ............................................ 96 
3.4.5. RG/C2 and HCT116 colorectal tumour cells are readily invaded by gut bacteria
 ....................................................................................................................................... 99 
3.4.6 Intracellular bacteria persist within colorectal tumour cells ............................... 106 
3.4.7. Gastrointestinal mucin has the potential to promote biofilm formation in vitro 109 
3.5 Discussion.................................................................................................................. 111 
Chapter 4: Bacterial infection increases tumour cell yield and induces metabolic 
changes in colorectal tumour cells .................................................................................... 121 
4.1. Introduction .............................................................................................................. 121 
4.2. Aim ............................................................................................................................ 123 




4.4 Results ....................................................................................................................... 125 
4.4.1 Bacteria significantly increase cell yield in RG/C2 and HCT116 tumour cells .. 125 
4.4.2 RG/C2 cells infected with colonic bacteria display lower rates of apoptosis ..... 127 
4.4.3 The relative impact of bacterial infection on tumour cell yield and apoptosis is 
consistent across RG/C2 and HCT116 cells ................................................................ 130 
4.4.4 Bacterial infection does not promote proliferation in tumour cells in vitro ........ 133 
4.4.5 Benign RG/C2 cells display a metabolic profile distinct from malignant 
adenocarcinoma cell lines ............................................................................................ 136 
4.4.6 F. nucleatum increases glycolytic capacity in infected HCT116 cells................ 142 
4.4.7 Discrimination between adenoma and adenocarcinoma cells using volatile product 
ion peak detection ........................................................................................................ 145 
4.4.8 Identification of intracellular bacteria using SIFT-MS ....................................... 149 
4.5 Discussion.................................................................................................................. 155 
Chapter 5: Gut bacteria influence tumour cell motility in a tumour stage-dependent 
manner ................................................................................................................................ 168 
5.1 Introduction ............................................................................................................... 168 
5.2 Aims ........................................................................................................................... 170 
5.3 Objectives ................................................................................................................... 170 
5.4 Results ....................................................................................................................... 171 
5.4.1 E. coli Nissle and F. nucleatum promote migration in HCT116 cells ................ 171 
5.4.2 Wound healing in HCT116 cells is increased by E. coli Nissle and F. nucleatum 
infection ....................................................................................................................... 174 
5.4.3 F. nucleatum promotes invasion in HCT116 cells .............................................. 178 
5.4.4 Promotion of migration and invasion of HCT116 cells by F. nucleatum is not 
accompanied by a change in catenin-related transcription .......................................... 180 
5.4.5 Regulation of cell motility genes upon infection of HCT116 cells with F. 
nucleatum .................................................................................................................... 184 
5.4.6 Regulation of EMT-associated genes upon infection of HCT116 cells by F. 
nucleatum ..................................................................................................................... 190 
5.5 Discussion.................................................................................................................. 195 
Chapter 6: Final Discussion and Future Work ............................................................... 207 
Chapter 7: Appendix ......................................................................................................... 218 




List of Figures   
 
Figure 1.1: The structure and regulation of the colonic crypt………….…………………4 
Figure 1.2: Spatial organisation of the colonic microbiota……………….……………….6 
Figure 1.3: Microbiota changes during colonic dysbiosis………………………..……….16 
Figure 1.4: The multistep nature of cancer………………………………..………………20 
Figure 1.5: Anatomical distribution of colorectal tumours……………..………………..27 
Figure 1.6: A comparison of the ‘Alpha-bug’ and ‘Driver Passenger’ models of bacterial 
contribution to colorectal cancer………………………….………...…………….43 
Figure 2.1: Method of tumour cell infection……………………………….……………...56 
Figure 2.2: Transwell filter migration assay design……………………………..………..68 
Figure 2.3: RT2 Profiler PCR array format……………………………………..………...79 
Figure 3.1: A comparison of the monolayer forming capabilities of colorectal 
adenocarcinoma and adenoma cell lines…………………………………………86 
Figure 3.2: Confocal laser scanning micrographs of colorectal tumour cells…..……….87 
Figure 3.3: Viability of RG/C2 and HCT116 monolayers after bacterial co-culture…....89 
Figure 3.4: Attachment of bacteria to colorectal tumour cell monolayers…………..…..92 
Figure 3.5: Scanning electron micrographs of HCT116 cells after co-culture with various 
species of gut bacteria……………………………………………………...………95 
Figure 3.6: Invasion of gut bacteria in RG/C2 and HCT116 tumour cell monolayers….98 
Figure 3.7: Confocal microscopy images of B. fragilis infection…………………..……...99 
Figure 3.8: Confocal microscopy images of E. coli Nissle infection………………...…...100 
Figure 3.9: Confocal microscopy images of E. faecalis infection………………………..101 
Figure 3.10: Confocal microscopy images of F. nucleatum infection…………………...102 
Figure 3.11: Persistence of bacterial within colorectal tumour cell monolayers….......105 
Figure 3.12: The effect of mucin on bacterial biofilm formation………………………107 
Figure 4.1: Bacterial invasion results in increased tumour cell yield in adenoma and 
adenocarcinoma cells…………………………………………………………….123 
Figure 4.2: Floating cell counts in RG/C2 and HCT116 cultures 96 hours post-
infection…………………………………………………………………………...126 
Figure 4.3: Comparison of the fold change in cell yield and floating cell proportion 
between RG/C2 and HCT116 cells infected with bacteria……………………...129 
Figure 4.4: Cell cycle analysis of infected RG/C2 cells………………………………….131 




Figure 4.6: Seeding density optimisation for Seahorse assays using colorectal tumour cell 
lines………………………………………………………………………………..136 
Figure 4.7: Rates of oxidative phosphorylation and glycolysis in colorectal tumour              
cells………………………………………………………………………………..137 
Figure 4.8. Energy phenotypes of colorectal tumour cells……….…………...………...138 
Figure 4.9. Rates of oxidative phosphorylation and glycolysis in HCT116 cells after 
bacterial infection………………………………………………………………...140 
Figure 4.10: The effect of bacterial infection on HCT116 energy phenotype………….141 
Figure 4.11: Dendrogram of volatile product ion peaks detected from cell culture 
headspace after hierarchical cluster analysis…………………………………...144 
Figure 4.12: Principle component analysis of volatile product ion peaks detected from 
colorectal tumour cell cultures…………………………………………………..145 
Figure 4.13: Dendrogram of volatile product ion peaks detected from the headspace 
above infected RG/C2 hierarchical cluster analysis……………………………148 
Figure 4.14: Principle component analysis of volatile product ion peaks detected from 
the headspace above infected RG/C2 cells……………………………………...149 
Figure 4.15: Dendrogram of volatile product ion peaks detected from the headspace 
above infected HCT116 cells……………………………….…………………….150 
Figure 4.16: Principle component analysis of volatile product ion peaks detected from 
the headspace above infected RG/C2 cells…………………………….………...151 
Figure 5.1: Migration of RG/C2 cells after bacterial infection………………………….169 
Figure 5.2: Migration of HCT116 cells after bacterial infection………………………..170 
Figure 5.3: Wound healing in RG/C2 cells after bacterial infection……………………173 
Figure 5.4: Wound healing in HCT116 cells after bacterial infection………………….174 
Figure 5.5: Invasion of HCT116 cells after bacterial infection………………………….176 
Figure 5.6: Analysis of protein expression in RG/C2 and HCT116 cells after F. nucleatum 
infection…………………………………………………………………………...179 
Figure 5.7: TOPFLASH luciferase activity in RG/C2 and HCT116 cells after bacterial 
infection…………………………………………………………………………...180 
Figure 5.8: Impact of F. nucleatum infection on cell motility gene expression in HCT116 
cells………………………………………………………………………………..183 
Figure 5.9: Comparison of regulation of cell motility genes by F. nucleatum in RG/C2 
and HCT116 cells…………………………………………………………………186 
Figure 5.10: Impact of F. nucleatum infection on EMT gene expression in HCT116 
cells………………………………………………………………………………..188 




Supplementary Figure 1: Survival of bacteria in serum-free DMEM under standard 
culture conditions………………………………………………………………...215 
Supplementary Figure 2: Efficacy of gentamicin and metronidazole against target 
bacterial species…………………………………………………………………..216 
Supplementary Figure 3: Saponin does not impact bacterial viability………………..217 
Supplementary Figure 4:  Impact of F. nucleatum infection on Cell Motility gene 
expression in RG/C2 cells………………………………………………………...220 






List of Tables 
 
Table 1.1. The abundance and characteristics of colorectal cancer consensus molecular   
subtypes……………………………………………………………………………………..23 
Table 2.1: Colorectal tumour cell lines used throughout this study………………………...48 
Table 2.2. Bacterial strains used throughout this study……………………………………...51 
Table 2.3: Plasmids used for the TOPFLASH assay………………………………………….69 
Table 2.4: A list of buffers used for Western blotting………………………………………...74 
Table 2.5: Gel compositions used for Western blots……………………………………………….75 
Table 2.6: List of primary antibodies used to probe PVDF membranes from proteins of 
interest…………………………………………………………………………………........75   
Table 2.7: Secondary antibodies used for protein visualisation and densitometry using the Li-Cor 
gel imager……………………………………………………………………...……………76 
Table 5.1: Literature review of cell motility genes modified by infection of HCT116 cells with        
F.nucleatum………………………………………………………………………….…….184 
Table 5.2: Literature review of EMT genes modified by infection of HCT116 cells with                       
F. nucleatum……………………………………………………………………………….189 
Supplementary Table 1: Complete list of target genes in Qiagen Cell Motility PCR 
Microarrays………………………………………………………………………………..218 
Supplementary Table 2: Complete list of target genes in Qiagen EMT PCR Microarrays….....219 
Supplementary Table 3: Product ion array for colorectal tumour cell cultures…………………222 
Supplementary Table 4: Product ion array for bacteria-infected RG/C2 cells………………….224 













ACF   Aberrant crypt foci 
APC   Adenomatous polyposis coli 
APS   Ammonium persulphate  
ATP   Adenosine triphosphate  
BFT   Bacteroides fragilis toxin 
BHI   Brain heart infusion  
BMP   Bone morphogenic protein 
CFSE   Carboxyfluorescein  
cfu   Colony forming units 
CIMP   CpG island hypermethylation 
CIS   Chromosomal instability 
CMS   Consensus molecular subtype 
CRC   Colorectal cancer 
CRT   Catenin-related transcription 
CSC   Colonic stem cell 
DAPI   4′,6-diamidino-2-phenylindole 
DMSO   Dimethyl sulphoxide 
ECAR   Extracellular acidification rate  
ECM   Extracellular matrix 
EcN   Escherichia coli Nissle 1917   
EGF   Epidermal growth factor 
EGFR   Epidermal growth factor receptor 
EMT   Epithelial mesenchymal transition 
EPEC   Enteropathogenic Escherichia coli 
ETBF   Enterotoxigenic Bacteroides fragilis 
FAP   Familial adenomatous polyposis 
FBS   Foetal bovine serum 
FCCP   Carbonyl cyanide-p-trifluoromethoxyphenylhydrazone 
FIT   Faecal immunochemical test 
FOBT   Faecal occult blood test 
GALT   Gut-associated lymphoid tissue  




HCA   Hierarchical cluster analysis 
HDACi  Histone deacetylase inhibitor  
HIF-1α   Hypoxia-inducible factor 1 alpha 
HNPCC  Hereditary non-polyposis colorectal cancer  
IBD   Inflammatory bowel disease  
IgA   Immunoglobulin A 
LC/MS   Liquid chromatography mass spectrometry  
Lgr5   Leucine-rich-repeat containing G-protein coupled receptor 5 
LPS   Lipopolysaccharide 
MHCII  Major histocompatibility complex class II 
Min   Multiple intestinal neoplasia  
MOI   Multiplicity of infection 
NADPH  Reduced Nicotinamide adenine dinucleotide phosphate  
OCR   Oxygen consumption rate 
PAGE   Polyacrylamide gel electrophoresis  
PBS   Phosphate buffered saline 
PCA   Principal component analysis 
PCR   Polymerase chain reaction 
PDK1   Pyruvate dehydrogenase kinase 1 
PDX   Patient-derived xenograft 
pks   Polyketide synthesis 
PRR   Pattern recognition receptor 
PVDF   Polyvinylidene difluoride 
REG4   Regenerating family member 4 
ROS   Reactive oxygen species  
SASP   Senescence-associated secretory phenotype 
SCFA   Short-chain fatty acid 
SCNA   Somatic copy number variations  
SDS   Sodium dodecyl sulphate 
SFB   Segmented filamentous bacteria  
SIFT-MS  Selected ion flow tube mass spectrometry 
SOC   Super Optimal broth with Catabolite repression 
SPME   Solid-phase microextraction 
TEMED  Tetramethylethylenediamine 
xiv 
 
TME   Tumour microenvironment  
VEGF   Vascular endothelial growth factor  
UWE   University of the West of England 
 
Chapter 1 - Introduction 
1 
 
Chapter 1: Introduction 
1.1 Structure and function of the human colon 
The colon, or large intestine, is the distal portion of the bowel, and can be anatomically 
divided into four sections: the ascending colon, the transverse colon, the descending 
colon and the sigmoid colon, which is continuous with the rectum (Ellis and 
Mahadevan, 2014). The colon performs two primary functions: (1) the recovery of 
water and electrolytes from its luminal contents and (2) it facilitates the formation of 
stool, which is transported along the length of the colon to the rectum where it is 
excreted. Movement of colonic material is facilitated by peristalsis, coordinated 
contractions of the circular and longitudinal layers of the colonic muscle wall (Spencer 
et al., 2016). The majority of colonic functions are performed by the highly specialised 
epithelial layer. For example, colonocytes actively absorb Na+ ions from the lumen 
using glucose-dependent transporters; this maintains an osmotic gradient between the 
lumen and the epithelium, allowing continuous water absorption (Fordtran and 
Dietschy, 1966). 
 The colonic mucosa is composed of the epithelium and underlying lamina 
propria. It is the most luminal part of the bowel wall and is in direct contact with the 
luminal contents. Beneath this is the submucosa, followed by the muscularis propria  
and the adventitia (Levine and Haggitt, 1989). The epithelial layer is composed of 
polarised absorptive colonocytes and mucus-secreting goblet cells, which form a 
single-cell thick columnar epithelium. Cellular turnover at the mucosal surface is high, 
with the entire epithelial lining being renewed approximately every 4-5 days (Barker 
et al., 2007). Unlike the small intestine, where the epithelium is arranged into millions 
of finger-like villi, the colon epithelial surface is mostly flat, with the exception of the 
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colonic crypts. These crypts are glandular invaginations of the epithelium, and are 
essential for cell renewal and colonic homeostasis (Clevers, 2013).  
1.2 Colonic crypts are the drivers of colonic homeostasis 
Cells at the colonic surface undergo apoptosis and are continuously sloughed off into 
the lumen (Blander, 2016). This prevents the accumulation of damaged cells, and the 
colonocytes are then replaced by new cells which emerge from the approximately 10 
million crypts that are distributed along the length of the colon (Stamp et al., 2018). 
Cells produced at the base of the crypt migrate upwards towards the colonic surface, 
in a conveyor belt-like fashion. To facilitate this constant cell renewal, each colonic 
crypt harbours a resident stem cell population (Barker, 2014). These stem cells 
undergo asymmetrical cell division to give rise to transit-amplifying progenitor cells, 
which migrate up the crypt, rapidly dividing, and undergo differentiation into several 
lineages before reaching the mucosal surface (Barker, 2014). Colonocytes are the 
primary cell lineage produced, in addition to mucus-secreting goblet cells, endocrine 
cells, microfold cells and tuft cells which also comprise the epithelium.  
 The colonic stem cells (CSC) are key to colon homeostasis and are found at 
the base of the crypt between the +1 and +3 positions (Figure 1.1). The maintenance 
of the stem cell niche is reliant upon concentration gradients of numerous signalling 
molecules, including Wnt and bone morphogenic protein (BMP), along the length of 
the crypt (Reya and Clevers, 2005). Thus, CSCs can be identified by the presence of 
the Wnt target, the leucine-rich-repeat containing G-protein coupled receptor 5 (Lgr5; 
Barker et al., 2007). Wnt ligands are produced and secreted by specialised 
mesenchymal cells, which reside in the crypt base and surrounding tissue. Deep crypt 
secretory cells, characterised by the expression of regenerating family member 4 
(REG4), are interspersed between CSCs and express Wnt ligands, in addition to 
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epidermal growth factor, Notch ligands and antimicrobial peptides (Sasaki et al., 
2016). Wnt ligands from the surrounding stroma are also essential, with GLI-
expressing mesenchymal cells also required for the maintenance of the stem cell niche 
(Degirmenci et al., 2018).  
Wnt signalling regulates numerous genes, influencing differentiation, 
stemness and proliferation, having been extensively reviewed by Clevers and Nusse 
(2012). Altered Wnt signalling dramatically impacts colonic homeostasis, with 
subsequent damaging effects on gut health. In mouse models, inhibition of 
downstream Wnt effector proteins, including T-cell factor 4, leads to a complete loss 
of the CSC population; this prevents crypt formation and severely compromises the 
mucosa (Korinek et al., 1998). Where colonic stem cells are lost from the mature 
mucosa through injury, the differentiated epithelium is able to recover this population 
and restore crypt function, as reviewed by de Sousa and de Sauvage, 2019. 
Remarkably, several cell lineages have been demonstrated to display plasticity and, 
after ablation of the stem cell population, express Lgr5 and migrate towards the crypt 
base. These include transit-amplifying progenitor cells and secretory cells. Aberrant 
increases in Wnt signalling within the stem cell population are also relevant to colonic 
disease, and are a driver for many forms of cancer, with 93% of colon cancers 
displaying mutations which lead to upregulated Wnt signalling (Muzny et al., 2012).  
The integrity of the stem cell population is therefore vital to colonic 
homeostasis; however, the mucosa faces numerous challenges. These include large 
fluctuations in pH, mechanical abrasion from the luminal contents and virulence from 
ingested pathogens. In addition, the mucosa is in constant contact with the gut 
microbiome, the community of bacteria, fungi, archaea, viruses and protozoa which 
colonise the gastrointestinal tract (Peterson et al., 2009). 




Figure 1.1: The structure and regulation of the colonic crypt. The stem cells, identified by the presence of 
Lgr5, at the base of the crypt are maintained through signalling by surrounding crypt cells and mesenchymal 
cells in the lamina propria. They asymmetrically divide into transit amplifying progenitor cells which migrate 
upwards and differentiate into one of the several cell lineages present in the colon. Increasing gradients of 
BMP and decreasing gradients of Wnt promote differentiation. At the mucosal surface, colonocytes undergo 
apoptosis and are sloughed into the lumen (Barker, 2014).  
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1.3 The Gut Microbiome 
Microorganisms colonise numerous body sites, including the skin, oral cavity, vagina, 
and gastrointestinal tract. The gut microbiome refers to the consortia of 
microorganisms found within the gastrointestinal tract, which can form commensal 
and symbiotic relationships with the host (Hooper and Gordon, 2001). The colon 
harbours the largest bacterial load of the gastrointestinal tract, and more bacteria than 
all other body sites combined. Its approximately 1014 bacteria dwarf the combined 
bacterial population of the rest of the body, which is estimated to be >1012 (Sender, 
Fuchs and Milo, 2016). Therefore, maintaining homeostasis in the colon is dependent 
on physical, chemical, and immune-regulatory processes which control interactions 
between the microbiome and the host. 
1.3.1 The biogeography of the colonic microbiome 
The colon provides a wide range of ingested and host-derived substrates for 
microorganisms, which foster the development of highly specialised niches. Many 
bacterial constituents of the gut microbiome are present only transiently within the 
colonic lumen; however, the colonic mucosa provides a habitat for many species to 
form permanent associations with the host (Figure 1.2; Derrien and van Hylckama 
Vlieg, 2015). Bacterial distribution along the length of the colon is influenced by 
gradients of pH and nutrient availability, whereas increasing oxygen concentration and 
the abundance of immune effectors and other secretions at the mucosal surface control 
bacterial colonisation across the mucosa-lumen axis (Donaldson, Lee and Mazmanian, 
2015) 




Maintaining proper spatial organisation of the colonic microbiota is essential 
for homeostasis. Goblet cells within the colonic crypts secrete mucus, comprising of 
heavily glycosylated high-molecular weight mucin proteins (Pelaseyed et al., 2014). 
This mucus both protects the epithelium from bacteria whilst also providing a substrate 
for bacterial colonisation and metabolism (Rodríguez-Piñeiro et al., 2013). In the 
Figure 1.2: Spatial organisation of the colonic microbiota. The vast majority of bacteria (blue) are present 
in the outer mucus layer, which has a greater pore size and is loosely attached to the mucosa. Mucin-degrading 
species are able to penetrate the inner mucus layer and benefit from its abundant incorporated nutrients. In 
addition to increasing mucus density, a gradient of increasing oxygen concentration, antimicrobial peptides, 
and IgA controls bacterial growth in the inner mucus layer. A select few species, including B. fragilis and A. 
muciniphilia are able to access and colonise the colonic crypts (Donaldson, Lee and Mazmanian, 2015). 
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colon, the major mucus component is the gel-forming mucin protein Muc2 (Audie et 
al., 1993). Mucin proteins are heavily glycosylated and form a net-like mesh, which 
has a relatively small pore size of 20-200 nm at the mucosal surface and acts to 
physically exclude bacteria (Johansson et al., 2008). As the mucus travels towards the 
lumen, action by host and microbial proteases increases this pore size, exposing the 
abundant mucin-bound carbohydrates (e.g. O-linked oligosaccharides) and proteins 
present in the mucus and provides a potential growth substrate for microorganisms 
(Kaoutari et al., 2013). This constant efflux of mucin from the mucosal surface 
protects the underlying epithelium, and specifically the intestinal crypt epithelium, 
from direct contact with bacteria (Round et al., 2012). However, a select few 
microorganisms, including Bacteroides fragilis, are able to invade the mucus layer and 
reside on the mucosal surface through immune modulation and utilisation of host-
derived substrates (Figure 1.2; Round et al., 2011). Privileged sites such as the colonic 
crypts also display a distinct microbiome dominated by Firmicutes, with 
Actinobacteria, Bacteroidetes and Alphaproteobacteria also present (Saffarian et al., 
2019). The availability of mucin-derived substrates is one of several mechanisms 
through which the composition of the microbiome is regulated by the host, which also 
include secretion of bile acids, antimicrobial peptides and Immunoglobulin A (IgA) 
antibodies (Staley et al., 2017; Peterson et al., 2007).  
1.3.2 The composition of the colonic microbiome is key to its function and 
gut homeostasis 
Current estimates place the number of bacterial species present in the colon at >1000, 
with the combined colonic microbiome encoding 100 times the number of genes 
present in the human genome (Bäckhed et al., 2015). The Human Microbiome Project 
revealed that there is significant variation in gut microbiota composition between 
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individuals, both in the species present and their relative abundance (The Human 
Microbiome Consortium, 2012). This poses a challenge to microbiome research, as 
the apparent lack of a ‘healthy’ reference microbiota composition means that it is 
difficult to study how the microbiota shifts during disease (McBurney et al., 2019).  
Recent studies focussing on microbial ecological succession have provided 
some indication of the factors which regulate microbiome composition, with initial 
colonisation occurring at birth. Depending upon the mode of delivery, neonates are 
exposed either to the maternal vaginal microbiota, or non-maternal environmental 
bacteria (Neu and Rushing, 2011). The placenta, despite previously being thought to 
be sterile, is now known to be colonised by microorganisms, and harbours a microbiota 
similar to that of the oral cavity (Aagaard et al., 2014). These microorganisms are not 
thought to be conferred to the infant, although this is hotly contested (Perez-Muñoz et 
al., 2017). After birth, the composition of a child’s microbiota fluctuates dramatically 
during the first year of life (Bäckhed et al., 2015). Many factors, including chance 
environmental encounters and early exposure to antibiotics exert significant influence 
over colonic microbiome composition; however, the most impactful factor is breast 
feeding (Stewart et al., 2018). 
 Human breast milk contains approximately 103 bacteria per millilitre, and 
these bacteria directly populate the infant gut (Fernández et al., 2013). The 
oligosaccharides present in breast milk provide the primary source of bacterial 
substrate in early life, promoting a gut microbiota dominated by Bifidobacteria 
(Turroni et al., 2019). Formula-fed infants display increased microbiome diversity, 
and this has been associated with an increased occurrence of adverse outcomes, 
including diarrhoea (Ho et al., 2018). This is in contrast to the adult microbiome where 
a lack of diversity is associated with disease (Shanahan, 2013). Microbiota 
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composition remains relatively stable in healthy infants until they are weaned, where 
the introduction of the diverse substrates found in solid foods promotes the 
establishment of a more complex microbiota (Bäckhed et al., 2015). Thus, an 
individual’s ‘normal’ microbiota composition is largely dependent on these formative 
years (Bokulich et al., 2016). The adult gut microbiota is far more stable, with 60% of 
species persisting for longer than 5 years (Faith et al., 2013) and is dominated by 
Bacteroides and Firmicutes, with other notable phyla including Actinobacteria and 
Proteobacteria (Lloyd-Price, Abu-Ali and Huttenhower, 2016).The impact of breast 
feeding demonstrates how diet modulates microbiota composition, and this remains 
true in adults, with consistent dietary patterns shaping the microbiome over time 
(David et al., 2014). Host genetics are also known to play a significant role. Studies 
comparing the composition of the microbiota in monozygotic and dizygotic twins have 
demonstrated that the microbiotas of monozygotic twins display much greater 
concordance (Goodrich et al., 2014).  
1.3.3 Immune system development occurs alongside microbiome 
maturation 
The stability of the microbiota composition is critical to gut homeostasis, and 
throughout the establishment of the microbiota in infants, the immune system develops 
in parallel (Martin et al., 2010). This has been demonstrated in mouse models whereby 
germ-free animals display improper development of myeloid and T-cell populations 
(Williams et al., 2006). During the maturation of the immune system, tolerance to 
commensal microorganisms is gained.  
 The gut-associated lymphoid tissue (GALT) is the largest immune system in 
the human body, and the gut microbiota provides a constant source of stimulation 
(Arrazuria et al., 2018). Specialised epithelial cells within the mucosa, the microfold 
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cells, constantly collect and transfer antigens from the colonic lumen to the underlying 
GALT, which are then disseminated throughout the systemic circulation via dendritic 
cells (Martin et al., 2010). This process is critical to the development of tolerance to 
ingested compounds, including food proteins, and the numerous microbial antigens 
acquired from food-borne microorganisms and the microbiota. Toll-like receptors on 
the surface of epithelial cells act as pattern recognition receptors (PRRs), and bind 
microbe-associated molecular patterns, which may be present on the bacterial surface 
or secreted into the environment (Chu and Mazmanian, 2013).  
Tolerance to commensal microorganisms is developed during early life, and is 
aided by the presence of specific bacteria (e.g. B. fragilis) within the microbiome 
which suppress inflammation, and trigger the differentiation and migration of T-cell 
populations (Mazmanian et al., 2005). Although the contribution of the microbiome 
to immune development is not yet fully understood, relationships between 
microorganisms and immune cell populations have been established. Segmented 
filamentous bacteria (SFB) are key to the maturation of Th17 cells in rodents (Ivanov 
et al., 2009), and SFB populations have recently been discovered in the human gut, 
suggesting a similar role (Jonsson et al., 2020). Presentation of antigens from SFB and 
other bacteria such as B. fragilis promotes the secretion of anti-inflammatory IL-10 by 
regulatory T cells (Round and Mazmanian, 2010). The development of this tolerance 
therefore permits mutualism between the host and a range of bacterial species, which 
as previously mentioned vary greatly between individuals according to genetic and 
environmental factors.  
The development of this tolerance to commensal microorganisms is essential 
to gut health, and impacts all aspects of gut homeostasis, beginning at the stem cell 
level. It was recently demonstrated that the presence of bacterial antigens in the stem 
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cell compartment initiates a feedback loop whereby antigen-presenting Lgr5+ CSCs 
show enriched expression of major histocompatibility complex class II (MHCII) 
protein, allowing them to interact with T regulatory cells (Biton et al., 2018). During 
infection, Th1 and Th2 cells stimulate CSC differentiation, at the expense of self-
renewal, in order to facilitate barrier repair. After this immune response Treg cell 
numbers are increased, which inhibits CSC differentiation and allows stem cell 
numbers to be replenished (Tanoue, Atarashi and Honda, 2016). Where this complex 
tripartite relationship between intestinal stem cells, inflammation and microorganisms 
is disturbed, there is a significant impact on gastrointestinal health. For example, the 
presence of immunogenic microbial products at the mucosal surface leads to the 
production of IL-23 by resident myeloid cells (Grivennikov et al., 2012). This 
facilitates an IL-17 immune response, which has been linked to numerous forms of 
cancer including colorectal, as reviewed by Zhao et al., (2020). 
It is clear the homeostasis between the microbiome and mucosa is reliant upon 
stringent immune mechanisms and the recognition of commonly encountered 
microbial antigens. This however seems at odds with the significant variation in 
microbiota composition observed between individuals. Remarkably, functions carried 
out by microbiomes of differing composition are able to be conserved due to the 
presence of a ‘core microbiota phenotype’ (Turnbaugh et al., 2009). Despite 
significant variation in microbiome compositions between individuals, the functional 
phenotype remains largely consistent. This core microbiota phenotype is the result of 
the conservation of bacterial genes  across species, which allows the microbiota to 
perform the functions essential for gut homeostasis in an average individual 
(Turnbaugh and Gordon, 2009; Zeevi et al., 2019). Many of these functions are 
concerned with the metabolism of ingested compounds. 
Chapter 1 – Introduction  
12 
 
1.3.4 Functions of the gut microbiome 
The majority of dietary carbohydrates, proteins and fats are absorbed in the jejunum 
of the small intestine (Kiela and Ghishan, 2016). Non-digestible compounds, 
including resistant starch, reach the colon intact and are metabolised by resident 
gut microbes (Flint et al., 2012). The contribution of microbial products to nutrient 
and energy homeostasis is substantial. Germ-free mice, lacking a gut microbiome, 
become underweight compared to wild-type individuals fed the same diet (Bäckhed et 
al., 2004). However, reconstitution with a conventional microbiota results in a 
significant increase in body mass, even where food is restricted (Bäckhed et al., 2004). 
In addition, the wealth of enzymes encoded by the colon microbiome allows for the 
metabolism and synthesis of products that would be otherwise unavailable to the 
host.  The colon microbiota contributes to protein catabolism via two major 
mechanisms.  Direct proteolysis by bacteria converts ingested proteins into amino 
acids, which are either incorporated into bacterial cells as they proliferate or absorbed 
by the colonic epithelium (Yao, Muir and Gibson, 2016). Microbes also ferment 
proteinaceous compounds, producing harmful gaseous derivatives (Macfarlane, 
Cummings and Allison, 1986). These products, which include ammonia, hydrogen 
sulphide (H2S), phenols, indols and N-nitroso compounds, exert genotoxic effects, 
linking the consumption of high quantities of protein to DNA damage (Hughes, Magee 
and Bingham, 2000).   
It is estimated that bacterial carbohydrate fermentation in the colon accounts 
for 10% of an individual’s total energy requirements (McNeil, 1984). The most 
abundant products of fermentation in the colon are short-chain fatty acids (SCFAs), 
namely butyrate, propionate and acetate (Bird et al., 2010). Between 90-95% of 
SCFAs produced in the colonic lumen are absorbed by colonocytes, and they exert 
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multiple effects on gut and systemic health. Acetate and propionate are primarily 
transported and metabolised outside of the colon, in peripheral tissues and the liver, 
respectively (Wong et al., 2006). However, butyrate is metabolised by the colonic 
mucosa, with colonocytes generating approximately 70% of their adenosine 
triphosphate (ATP) through butyrate metabolism (Roediger, 1980). Furthermore, 
butyrate is also essential for gut homeostasis, and impacts a myriad of gut functions 
including proliferation, apoptosis, motility and differentiation by regulating gene 
expression as a histone deacetylase inhibitor (HDACi; Hamer et al., 2008).  
Ingested dietary compounds constitute the major source of substrate for the gut 
microbiota, and as discussed, the resulting metabolites have a significant impact on 
host health. However, the interaction between endogenous host products and the 
microbiota is also significant. Bile acids are secreted from the gall bladder into the 
lumen of the small intestine, where they aid in the digestion and absorption of 
lipids (Lefebvre et al., 2009). Although 95% of bile acids are reabsorbed in the distal 
ileum, the remaining 5% enters the colon, where they exert a selection pressure on the 
colon microbiota. Bile acid antimicrobial activity has been documented against many 
constituents of the microbiota, including Lactobacilli, and Bifodobacteria species, 
through the induction of membrane damage and disruption of transmembrane 
electrical potential, which is important for essential cellular functions including ATP 
synthesis (Kurdi et al., 2006). Many microbiota constituents possess bile salt 
hydrolases, which reduce bile acid toxicity by cleaving their conjugated amino 
acids (Song et al., 2019). These free amino acids are incorporated into bacterial cells, 
whereas the deconjugated bile acids are reabsorbed through the mucosa. However, 
some of these deconjugated bile acids are targeted for further modification and 
transformation into secondary bile acids by bacteria possessing 7α-dehydroxylating 
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enzymes (Staley et al., 2017). Secondary bile acids, including lithocholic acid 
and ursodeoxycholic acid, are produced via these mechanisms and are thought to 
cause DNA damage in the mucosa, although the precise mechanism remains 
unclear (Bernstein et al., 2009). 
 Finally, competitive exclusion of pathogens is another important role carried 
out by the colonic microbiota. Depending on dietary composition, the average 
individual will ingest approximately 106-109 bacteria each day (Lang, Eisen and 
Zivkovic, 2014). Many of these food-borne bacteria are potential gastrointestinal 
pathogens, including Salmonella, Shigella, and Campylobacter species, as well as 
Enteropathogenic Escherichia coli (EPEC; Hara-Kudo et al., 2013). The colonic 
microbiome is able to suppress these pathogens through secretion of metabolites. For 
example, butyrate has been shown to directly downregulate the transcription of 
virulence factors in several Salmonella enterica serovars (Gantois et al., 2006). In 
addition, the fierce competition for both space and resources in the intestinal 
microbiota also excludes these pathogens. Loss of this competitive exclusion through 
disruption of the microbiome (e.g. through antibiotic use) is associated with 
colonisation by pathogens such as Clostridium difficile, resulting in persistent 
diarrheal disease (Mullish and Williams, 2018). Therefore, in addition to the direct 
beneficial effects of metabolite production, the microbiota indirectly protects and 
maintains gut homeostasis and limits the possibility for infection. 
1.3.5 Perturbance of the microbiome has significant effects on health 
It is evident that the gut microbiome is critical to the development and maintenance of 
homeostasis in the colon, and that the composition of the microbiota is finely balanced 
within each individual. Alterations to this balance, such as those caused by diet, 
antibiotic use, or infection, can have significant effects on both gut and systemic 
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health. Shifts in the relative abundance of species from those normally present in an 
individual, or shifts in the metatranscriptome of established species, can lead to 
colonic dysbiosis (Petersen and Round, 2014). Dysbiosis is characterised by the loss 
of beneficial microorganisms, colonisation by and outgrowth of potential pathogens, 
and a reduction in species diversity; these shifts may occur independently or together, 
altering the relative abundance of species present in the microbiome (Figure 1.3; David 
et al., 2014). These changes compound one another over prolonged time periods, as 
changes in species abundance lead to altered metabolite levels and immune responses 
which further modulate microbiota composition. Furthermore, the proximity between 
bacteria in the mucus layer fosters nutritional relationships and dependencies between 
species  (Flint et al., 2007). Solubilisation of mucin-bound compounds and production 
of SCFAs are but two mechanisms through which bacteria in the colon cross-feed with 
other species (Schroeder, 2019).  
Due to the interdependence of microorganisms in the colon, small shifts in 
relative metabolite levels or intestinal immunity can compound to cause drastic 
changes in the microbiota composition, potentially leading to the loss of entire species 
and altering the phenotypes of other organisms (Sonnenburg et al., 2016). 
Conservation of bacterial genes across a wide range of species facilitates species-level 
variation amongst individuals without altering the microbiome phenotype. However, 
there are non-redundant genes and relationships present between an individual and 
specific species within their microbiome (Qin et al., 2010). For example, a recent 
metabolic analysis of the microbiome has revealed that at least 434 metabolic 
pathways are present in a single species, and 91.6% of these pathways were present in 
all individuals tested (Visconti et al., 2019). Thus, altered abundance of microbiota 
species may predispose altered levels of bacterial antigens, abnormal concentrations 
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of bacterial metabolites, outgrowth and loss of microbiome residents, and colonisation 
of the colon by alien species. This results in dysbiosis, which is associated with chronic 
low-grade inflammation (Petersen and Round, 2014). Both the environmental changes 
observed in dysbiosis and the action of specific bacterial species, which may be altered 
in this environment, have been linked to numerous diseases. These include obesity, 
inflammatory bowel disease (IBD) and Type 2 diabetes (Aron-Wisnewsky et al., 
2019; Tomasello et al., 2014) . Recently, the role of the gut microbiome in colorectal 
cancer (CRC) has gained increased attention.  
  





Figure 1.3: Microbiota changes during colonic dysbiosis. In healthy individuals, the colonic microbiome is 
composed of a diverse range of species which perform functions beneficial to host health. Dietary and lifestyle 
factors alter the colonic microenvironment leading to disrupted microbial growth. These alterations in 
microbiota composition lead to chronic inflammation. Expansion of pathobionts causes direct virulence against 
the mucosa. Reduced diversity and loss of beneficial microbes leads to the loss of non-redundant influences 
on host health and microbiota stability, leading to further divergence from homeostasis. These dysbiotic 
changes may occur separately or concurrently, having profound effects on host health. Reproduced with 
permissions from Petersen and Round (2014). 
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1.4 Colorectal cancer  
1.4.1 Epidemiology of colorectal cancer 
Colorectal cancer (CRC) is the third most common malignancy worldwide, accounting 
for 11% of all cancer cases, and is the second leading cause of cancer-related death 
(Sung et al. 2021). CRC incidence correlates positively with human development 
factors, and is therefore predicted to rise globally, with the largest increases expected 
in developing low/middle income countries (Arnold et al., 2017). CRC prognosis is 
highly dependent on tumour stage at diagnosis. In the UK, >90% of individuals 
diagnosed with CRC at stage I will experience disease-free survival over 5 years. 
However, 55% of cases are diagnosed at stage III or IV, with the 5-year survival rate 
of these individuals being 65% and <10%, respectively (Cancer Research UK, 2021). 
The low survival rate of late-stage CRC patients can be attributed to a paucity of 
effective treatment options, difficulty in detecting metastases and disease recurrence. 
In addition, the formation of secondary tumours, particularly in the lymph and liver 
nodes, is common in CRC, further complicating treatment (Ganesh and Massagué, 
2021). Therefore, improving early detection and our understanding of disease 
progression is a major obstacle to improving CRC survival.  
 CRC is one of the few cancers routinely screened for in many countries 
(Navarro et al., 2017). In the UK, routine faecal screening is currently offered from 
age 60 onwards. As expected, the majority of CRC cases in the UK are diagnosed in 
individuals aged over 50, a trend which is reflected worldwide (Cancer Research UK, 
2021). However, global incidence of CRC in individuals under the age of 50 is 
increasing, with a rise of 47% between 1975-2015 (Rawla, Sunkara and Barsouk, 
2019). In populations that are not offered cancer screening, the burden of diagnosis 
often falls upon the patient’s ability to detect and report symptoms, with common signs 
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of CRC including rectal bleeding and abdominal pain (Del Giudice et al., 2014). This 
is problematic, as a systematic review of CRC symptomology found that many of the 
symptoms reported in published guidelines are not consistently present in CRC 
patients (Adelstein et al., 2011). Of these symptoms, rectal bleeding and weight loss 
are not indicative of precancerous polyps, meaning that the appearance of detectable 
symptoms often corresponds to advanced disease (Adelstein et al., 2011). Therefore, 
there is a clear need to develop our understanding of both the factors contributing to 
the global rise in CRC incidence, and how these factors can be used to inform current 
methods of cancer detection and diagnosis. As the development of CRC normally 
occurs over several decades, ample opportunity is present for intervention if our 
understanding of CRC progression is improved. 
 An estimated 30% of CRC cases can be attributed to hereditary factors (Kwak 
and Chung, 2007). Of these cases, 5-10% are caused by known inherited conditions, 
including familial adenomatous polyposis (FAP) and hereditary non-polyposis 
colorectal cancer (HNPCC). Although the primary genetic defects predisposing these 
conditions have been identified, the remaining hereditary cases remain poorly 
understood. Nevertheless, the overwhelming majority of cases (>70%) are sporadic in 
nature (Sung et al., 2021). For sporadic CRC to develop, successive accumulation of 
pro-oncogenic mutations in a single colon cell or its progeny, often occurring over 
several decades, is required (Fearon and Vogelstein, 1990).  The increase in CRC 
incidence in younger populations suggests that modifiable factors are accelerating this 
process, with diet and the microbiome being heavily implicated. 
1.4.2 The Multistep Nature of Cancer  
The development and progression of sporadic CRC has been well described by the 
Multistep Nature of Cancer model (Fearon and Vogelstein, 1990). This model states 
Chapter 1 – Introduction  
20 
 
that 3-7 ‘hits’ – mutations to key oncogenes or tumour suppressor genes – are required 
for cancer to develop (Figure 1.4). Many of these early mutations have been well-
defined in colorectal tumorigenesis, and correspond to morphological and histological 
changes (Vogelstein and Kinzler, 1993). Early mutations cause the epithelium to 
become hyperproliferative, with subsequent mutations leading to the development of 
small adenomas, which increase in size and accumulate driver mutations before 
developing into carcinoma in situ and eventually culminating in an invasive, 
metastatic tumour (Vogelstein and Kinzler, 1993). A mutation leading to upregulated 
Wnt signalling is the most common event initiating CRC development, and is found 
in 93% of colorectal tumours (The Cancer Genome Atlas Network, 2012). The most 
common of these mutations is an inactivation of the adenomatous polyposis coli (APC) 
tumour suppressor gene, which is seen in >80% of sporadic cases (Fearnhead, Britton 
and Bodmer, 2001). This loss of APC leads to the inactivation of the β-catenin 
destruction complex, allowing cytosolic β-catenin to translocate to the nucleus 
resulting in the stimulation of Wnt target genes (Munemitsu et al., 1995). 
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Loss of APC has been associated with chromosomal instability (CIS), whereby 
alterations to the number and structure of chromosomes occur in tumour cells due to 
the reduced binding of microtubules which impairs their stability (Pino and Chung, 
2010). CIS is the most common form of genomic instability seen in CRC, and accounts 
for the majority of sporadic cases (Lengauer, Kinzler and Vogelstein, 1997). Genomic 
instability, characterised by a high frequency of mutations and genome altering events, 
drives cancer formation as the baseline mutation rate in normal cells is insufficient to 
drive tumorigenesis (Loeb, Loeb and Anderson, 2003). The literature is currently 
conflicted as to whether CIS is a prerequisite to tumorigenesis, or whether the initial 
oncogenic mutations occur at a normal mutation rate, and are then selected for due to 
the growth advantages that they confer (Sieber, Heinimann and Tomlinson, 2003). 
Other mechanisms of genomic instability are also present in CRC, including 
microsatellite instability and CpG island hypermethylation (CIMP; Li and Martin, 
2016). 
 Early CRC diagnosis was primarily based upon characteristics such as CIS, 
microsatellite instability, and the presence of key mutations such as BRAF and KRAS. 
However, over the past decade there has been a push for the categorisation of CRCs 
into more comprehensive subtypes (Cancer Genome Atlas Network, 2012; Budinska 
et al., 2013). In 2015, a global consortium of CRC researchers and clinicians used 
gene expression-based algorithms to devise four new CRC subtypes dubbed the 
‘consensus molecular subtypes’ (CMS), with the aim of providing a classification 
system with greater biological interpretability (Guinney et al., 2015). The prognostic 
value of these classifications in predicting disease outcome has since been confirmed, 
and their main features are summarised in Table 1.1 (Mooi et al., 2018).  




During the development of CRC, the hyperproliferative epithelium gives rise to 
increasing numbers of aberrant crypt foci (ACF). These ACF were first discovered in 
the murine colon, where methylene blue staining and histological examination 
revealed the presence of larger, thicker crypts which stained darker than adjacent 
normal crypts (Bird, 1987). ACF were then demonstrated to be inducible by 
administering carcinogenic compounds to rats, and after their discovery in human 
CRC patients were designated as CRC precursors (Tudek, Bird and Bruce, 1989; 
Pretlow et al., 1991). The number of ACF present in the colon increases at each stage 
along the adenoma-carcinoma sequence; however, ACF are also found in non-CRC 
populations. An analysis of tissue samples collected from colonoscopy patients found 
that <5 ACF were present in individuals under the age of 38, which gradually increased 
to >10 ACF in individuals aged 77 (Kowalczyk et al., 2018). Interestingly, the 
researchers also found that consumption of a low-fibre diet was associated with 
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increased prevalence of ACF. Accumulation of genetic damage in ACF leads to the 
formation of benign adenomas or polyps, which in most sporadic cases protrude from 
the epithelium into the colonic lumen. Colorectal adenomas mostly display a 
tubulovillous morphology, although purely tubular and villous morphologies are also 
present, with varying levels of dysplasia (Calderwood, Lasser and Roy, 2016). Like 
ACF, colorectal adenomas are also present in the general population, with 25% of men 
and 15% of women undergoing a colonoscopy displaying detectable polyps (Corley 
et al., 2013). However, these adenomas only progress to CRC in 10% of cases. The 
presence of supposed cancer precursors in the healthy population is perhaps not 
surprising given the high basal levels of proliferation found in the colon. As described 
by Vogelstein and Kinzler, the adenoma-carcinoma sequence normally occurs over 
several decades, and therefore it appears that non-genomic factors may control the 
emergence of ACF and the speed at which ACF progress to adenomas, and 
subsequently adenocarcinomas (Vogelstein and Kinzler, 1993).  
 In adenomas, normal cellular migration is reversed, with a reduction in 
migration towards the colonic lumen and an increase in migration towards the crypt 
base leading to an aberrant accumulation of cells (Moss et al., 1996). Colorectal 
adenocarcinomas arise from continued, uncontrolled cell division and increasing 
dysplasia in adenomas (Fearon and Vogelstein, 1990). The tumour suppressor gene 
TP53 is the most commonly mutated gene across all human cancers (Kandoth et al., 
2013). The loss of TP53 inhibits apoptosis in tumour cells and is thought to be a major 
driver towards malignant transformation in CRC (reviewed by Nakayama and 
Oshima, 2019). In addition to apoptosis resistance, it is well established that 
neovascularisation is essential to cancer progression. Early studies of tumour 
xenografts in mice demonstrated that tumours struggled to reach a size greater than 2-
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3mm in diameter in poorly vascularised regions, and subsequent studies found that 
apoptosis can be triggered in large tumours by suppressing angiogenesis 
(Muthakkaruppan, Kubai and Auerbach, 1982; Holmgren, O’reilly and Folkman, 
1995). Therefore, increased signalling through pro-angiogenic molecules including 
vascular endothelial growth factor (VEGF) expression is important for  tumour 
progression, and has been suggested as a hallmark of malignancy (Hanahan and 
Weinberg, 2011). Indeed, VEGF-1 is upregulated in 50% of all CRC cases, with 
minimal expression in colorectal adenomas or healthy tissue (Bendardaf et al., 2008). 
In addition to TP53 and VEGF, mutations in multiple other genes have been linked to 
malignant transformation in CRC including Bcl-2, TGF-β and MUC-1. However, 
TP53 is also frequently mutated in adenomas. Furthermore, Mamlouk and colleagues 
revealed that mutation of malignancy-associated genes, including TP53, is present in 
paired adenomas and carcinomas which display wildly differently morphologies and 
levels of dysplasia (Mamlouk et al., 2020). In a study by Wolff et al. of 2,204 gene 
mutations present in 18 CRC patients, only 52 genes were mutated in colorectal 
carcinomas but were not found to be mutated in adenomas, further undermining 
genomic alterations as the sole drivers of tumour progression in CRC (Wolff et al., 
2018).  
Clearly the acquisition of these key driver mutations, and the speed in which 
successive mutations occur, are significant determining factors as to whether cancer 
develops, and so factors influencing these genetic changes are of great importance. 
Many individuals will harbour benign colorectal tumours asymptomatically and will 
never go on to develop CRC. In patients who develop carcinoma in situ but are 
diagnosed at the earliest stage, 5-year survival rates are greater than 90% (Cancer 
Research UK, 2021). However, prognosis for patients at advanced stages rapidly 
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worsens, which can be primarily attributed to the presence of metastases and the 
difficulty in diagnosing and treating them. Metastasis is responsible for 90% of all 
cancer-related deaths, and approximately 20% of CRC patients present with 
synchronous metastases upon diagnosis (van der Geest et al., 2015). However, no 
specific mutations have been identified as being drivers of invasion and metastasis. 
This has led to the hypothesis that late-stage disease is primarily driven by the tumour 
microenvironment (TME).  
1.4.3 The unique tumour microenvironment of CRC governs disease 
progression 
Throughout the progression of the adenoma-carcinoma sequence, the tumour 
microenvironment becomes progressively perturbed. For example, inflammatory and 
immune cells infiltrate tumours, and the resulting inflammatory signals have been 
implicated in epithelial-mesenchymal transition (EMT) which facilitates metastatic 
spread (Bates, Deleo and Mercurio, 2004). The architecture of the vasculature, 
extracellular matrix and lymphatic system are also greatly modified, physically 
interacting with the tumour and facilitating the provision of nutrients and the 
dissemination of invasive cancer cells (Ogino et al., 2018). Alterations to the 
microenvironment are common to almost all tumours, and in CRC these alterations 
also impact the gut microbiota, which in turn predisposes further changes to the 
microenvironment in a feedback loop (Li et al., 2020). This two-way interaction 
between the TME and the microbiota is present throughout the adenoma-carcinoma 
sequence, and the metagenome-wide associated study performed by Feng et al. (2015) 
confirmed that as CRC develops, compositional and functional changes to the 
microbiota occur in parallel.  
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 The degree to which the development of cancer influences the composition of 
the microbiota and vice versa is not well understood, and therefore requires further 
study. What is clear is that many of the factors known to modulate microbiota 
composition have also been linked to CRC risk. Diet has emerged as the greatest CRC 
risk factor, with a ‘Western diet’ being extensively linked to an increased risk of CRC 
development (Terry et al., 2001; Mehta et al., 2017; Wu et al., 2004). This diet is 
characterised by a high intake of red and processed meat, high-fat dairy products and 
refined foods, whilst being low in fibre and complex carbohydrates (Adlercreutz, 
1990). Diet and other environmental factors, as opposed to genetic differences 
between populations, are thought to explain differences in CRC incidence between 
geographical regions. American-born Asian men display significantly higher CRC risk 
than their Asian-born counterparts (Flood et al., 2000). Similarly, migrants to high-
income countries from poorer regions assume the CRC risk of their adoptive country 
within a single generation (Shuldiner, Liu and Lofters, 2018). This adoption of CRC 
risk is thought to be directly attributed to acculturation and adoption of native dietary 
patterns. A study of Mexican immigrants to the United States spanning three 
generations observed correlations between increased CRC risk and dietary change, 
with both the biggest increase in CRC risk and degree of dietary change observed 
within the first two generations (Monroe et al., 2003). 
In individuals consuming a Western diet, both high meat consumption and a 
lack of dietary fibre contribute to cancer risk. The relationship between a high 
consumption of processed and red meats and CRC was sufficient for the World Health 
Organisation to classify these food products as Group 1 and Group 2 carcinogens, 
respectively, in 2015 (WHO, 2015). Tumorigenesis caused by high meat consumption 
is attributed to the production of DNA-damaging metabolites produced following 
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protein breakdown by microorganisms (Yao, Muir and Gibson, 2016). Furthermore, 
lack of fibre consumption and subsequent decrease in bacterial fermentation products 
(e.g. butyrate) has been linked to poor gut health, intestinal dysbiosis and the 
development of intestinal tumours (Schulz et al., 2014).  
In colonocytes, butyrate is primarily metabolised as an energy source. 
Oxidation of butyrate provides an alternative source of acetyl coenzyme A, which is 
incorporated into the tricarboxylic acid cycle (Roediger, 1982). Colonocytes which 
metabolise butyrate are therefore less dependent on glucose from the 
underlying lamina propria, and have downregulated glycolysis compared to cells not 
found in the colon (Leschelle et al., 2000). This constant turnover of butyrate prevents 
its accumulation in the cytosol and therefore prevents it from translocating to the 
nucleus where it exerts effects on various signalling pathways, notably Wnt signalling, 
as an HDACi (Hamer et al., 2008). In contrast to normal cells, tumour cells 
preferentially ferment glucose, even in the presence of abundant oxygen for aerobic 
respiration in what is described as the “Warburg effect” (Warburg, Wind and 
Negelein, 1927). Although this represents a far less efficient means of generating 
ATP, it allows tumours to produce and metabolise small molecules for cell 
proliferation, such as reduced nicotinamide adenine dinucleotide phosphate 
(NADPH), more rapidly (Vander Heiden, Cantley and Thompson, 2009). This switch 
to aerobic glycolysis leads to the accumulation of butyrate in the cytosol and its 
subsequent translocation to the cell nucleus.   
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Once in the nucleus, butyrate regulates DNA transcription 
through HDACi activity. It has been shown to cause cell cycle arrest and apoptosis 
in colorectal tumour cells, promote the differentiation of stem cells, supress 
inflammation through NF-κB inhibition, and promote barrier function by upregulating 
Claudin-1 transcription (Hague et al., 1993; Segain et al., 2000; Wang et al., 2012). It 
is for these reasons that butyrate significantly contributes to the protective effect of 
dietary fibre and is associated with a decreased risk of cancer development, 
particularly in the distal colon (Kunzmann et al., 2015). The concentration of butyrate 
is highest in the proximal colon, where the most fermentable substrate is available 
(Pryde et al., 2002). Strikingly, the incidence of colorectal tumours is highest in the 
sigmoid colon and rectum, where the concentration of butyrate is lowest (Figure 
Figure 1.5: Anatomical distribution of colorectal tumours. The overwhelming majority of colorectal 
tumours are diagnosed distal to the splenic flexure. Tumours in the sigmoid colon, rectosigmoid junction and 
rectum account for 62% and 49% of tumours in men and women respectively. Tumours in the distal colon are 
more commonly characterised by chromosomal instability and display a polypoid morphology described by 
the adenoma-carcinoma sequence (Baran et al., 2018). Figure reproduced and modified with permission from 
Cancer Research UK. 
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1.5).  Therefore, altering the availability of fibre is one mechanism through which diet 
exerts a significant effect on cancer risk through the action of microbiota. 
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1.5 The link between the microbiome and cancer 
1.5.1 Colorectal cancer patients exhibit distinct microbiota populations 
In healthy individuals the composition of the gut microbiota is relatively stable, with 
one study finding that approximately 60% of species persisted for the entire 5 year 
measurement period (Faith et al., 2013). Despite this, drastic alterations to diet, and 
other factors which impact the colonic microenvironment, have been demonstrated to 
rapidly alter microbiota composition within a matter of days. David et al. (2014) 
showed that diets high in animal products increased the abundance of bile-tolerant 
genera including Biliphila and Bacteroides. In contrast, Firmicutes including 
Roseburia and Eubacterium were enriched in individuals consuming plant-based diets. 
Where dietary patterns are sustained, long term drifts in microbiota composition occur, 
potentially leading to dysbiosis. As tumours develop, changes in mucus secretion, 
bleeding and lowering of pH in the colonic lumen further impact microbiota 
composition (Chénard et al., 2020).  
In CRC, microbial sampling of faeces, tumour biopsies and adjacent normal 
tissues has revealed distinct alterations in microbiota composition between CRC 
patients and healthy controls (Flanagan et al., 2014; Mori et al., 2018; Saffarian et al., 
2019). In a study comparing the faecal microbiome of patients diagnosed with 
hyperplastic polyps, low and high-risk adenomas and adenocarcinomas, Mori et al. 
(2018) identified stage-specific bacterial populations associated with each stage of the 
adenoma-carcinoma sequence. For example, Firmicutes and Actinobacteria were 
found at a high frequency in patients with pre-neoplastic lesions; whereas 
Enterobacteriaceae and Escherichia amongst others were found in patients with 
malignant lesions (Mori et al., 2018). A more recent study which used 16S rRNA 
sequencing to compare mucosa and crypt-associated microorganisms between CRC 
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patients and healthy controls revealed that Fusobacterium nucleatum and B. fragilis 
were enriched in CRC patients with both left and right-sided tumours (Saffarian et al., 
2019). These compositional shifts can also be linked to CSMs, highlighting the 
relationship between microorganisms and CRC disease progression, with oral 
pathogens including F. nucleatum and Porphorymonas gingivalis being found at 
greater abundance in CSM1 patients, and Selenomas species being more common in 
CSM2 cohorts (Purcell et al., 2017).  
Understanding microbiome alterations has the potential to revolutionise CRC 
screening; however, studying the involvement of bacteria in CRC presents some 
challenges. Early studies employed culture-based approaches to identify species 
present in faecal samples. However, the advent of 16S rRNA sequencing revealed that 
less than 30% of the gut microbiota has been cultured ex vivo (Qin et al., 2010). 
Furthermore, faecal samples have long been preferred to direct mucosal biopsies due 
to their non-invasive nature. However, direct comparison between mucosal and faecal 
microbial communities has revealed key differences in both composition and function 
(Zoetendal et al., 2002). While levels of Firmicutes are similar between faecal and 
mucosal communities, the mucosal microbiota is enriched in Bacteroides species, 
which provide immune system-regulatory functions, and carotenoid-producing 
species such as Akkermansai muciniphila (Vaga et al., 2020). In contrast, 
Bifidobacterium are far more prevalent in faecal samples.  Despite these challenges, 
some insight into the compositional microbiota changes seen during dysbiosis has 
been gained. Dysbiotic microbiotas are generally thought to exhibit a relative decrease 
in the number of Firmicutes, which are sensitive to changes in carbohydrate intake, 
corresponding with an expansion of the Bacteroides population (Mori et al., 2018). 
Crypt-associated microbiomes are also altered in CRC patients when compared to 
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healthy controls, exhibited by the overrepresentation of pathobionts (Saffarian et al., 
2019). This potentially exposes the sensitive stem cell niche to genotoxic compounds 
produced by both the pathogenic bacteria and infiltrating immune cells. 
To date, many trends in microbiome composition have been linked to CRC 
aetiology, with individual species, or specific strains, emerging as potential 
carcinogenic pathogens.  The species relevant to this body of work shall be discussed 
in detail below. 
1.5.2 Bacteroides fragilis 
Bacteroides species account for roughly 50% of the microorganisms found in faeces, 
and are also present in abundance at the mucosal surface (Wexler, 2007). They are 
anaerobic, Gram-negative rods and play important roles in host immunity and 
nutrition, as reviewed by Wexler (2007). Bacteroides fragilis, which comprises 
approximately 0.5% of the gut microbiota,  is found in association with host mucus, 
and as previously mentioned is able to reside within colonic crypts (Huang, Lee and 
Mazmanian, 2011). B. fragilis is considered a symbiotic species, and is thought to 
promote the development of CD4+ T-cell populations (Mazmanian et al., 2005). 
Despite this, B. fragilis is also an adept opportunistic pathogen, and is the most 
frequently isolated anaerobic bacterium found in sepsis patients (Tan et al., 2017).              
B. fragilis possesses multiple virulence factors, and approximately 10% of adult 
individuals harbour enterotoxigenic B. fragilis (ETBF), which is associated with 
diarrheal disease (Zhang and Weintraub, 1999). The virulence of these enterotoxigenic 
strains has been attributed to the Bacteroides fragilis toxin (BFT), a zinc-dependent 
metalloproteinase which causes diarrhoea by promoting ileal and colonic secretion of 
sodium and chloride ions (Myers et al., 1985).  
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 Despite B. fragilis being isolated from the stool of healthy controls in roughly 
equivalent amounts, using polymerase chain reaction (PCR) to analyse cultured stool 
isolates, Toprak et al. (2006) discovered that BFT was present in 38% of CRC patients 
compared to just 12% of healthy controls. ETBF virulence through the BFT is 
attributed to an increase in host epithelial cell membrane permeability. BFT cleaves 
E-cadherin, resulting in numerous downstream pro-tumorigenic effects (Rhee et al., 
2009). E-cadherin is an integral component of the zonula adherens, the integral 
junctions between epithelial cells (Hartsock and Nelson, 2008). Degradation of E-
cadherin also releases β-catenin from the intracellular domain, which is a key effector 
of the Wnt signalling pathway. Subsequent downstream signalling promotes 
colonocyte proliferation through the c-myc pathway (Wu et al., 2003). This pro-
tumorigenic effect is observed at BFT concentrations of as little as 5x10-10 mol/L (Wu 
et al., 2003). Furthermore, BFT has been shown to induce persistent colitis in murine 
models, as the reduced barrier function and subsequent stimulation of inflammatory 
cytokine secretion drastically alters the colonic microenvironment (Rhee et al., 2009). 
This chronic inflammation further contributes to CRC-promoting DNA damage.  
1.5.3 Escherichia coli 
Escherichia coli, also a Gram-negative rod, is the most abundant facultative anaerobe 
found in the gastrointestinal tract, and is easily isolated from both faecal and mucosal 
samples (Wassenaar, 2018). It is an important commensal, and one of the first species 
to colonise infant gastrointestinal tracts; however, some strains possess virulence 
factors which are associated with intestinal and extra-intestinal disease (Benno, 
Sawada and Mitsuoka, 1984). The species can be generally divided into four main 
phylotypes, A, B1, B2 and D, with almost all commensal species belonging to group 
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A. Virulent strains are most commonly found in group B2, with a small proportion in 
group D (Herzer et al., 1990).  
 Pathogenic E. coli strains have been linked to an increased risk of CRC, 
although whether these strains are causative in nature, or are incidentally increased in 
CRC patients is unclear (Wassenaar, 2018). Many strains of enteropathogenic E. coli 
(EPEC) possess virulence genes encoding cyclomodulin toxins, which are capable of 
causing double-stranded DNA breaks in eukaryotic cells (Nougayrède et al., 2005). 
Several cyclomodulin genes are expressed by EPEC strains, including cytolethal 
distending toxin, cytotoxic necrotizing factor and cycle inhibiting factor. The 
prevalence of cyclomodulin-positive EPEC isolated from CRC patients varies by 
study; however, colibactin, encoded by the polyketide synthesis (pks) locus has 
emerged as the most significant EPEC toxin in CRC (Dalmasso et al., 2015). Strains 
of colibactin-producing EPEC are significantly more prevalent in CRC patients, 
despite these strains showing lesser adhesive properties than commensal strains (Buc 
et al., 2013). 
 Initial studies on the interaction between cyclomodulins and the colonic 
epithelium indicated that the CRC-promoting effect was limited to cells in direct 
contact with the toxin (Nougayrède et al., 2006). However, more recent studies have 
revealed that intestinal epithelial cells treated with pks+ E. coli develop a senescence-
associate secretory phenotype (SASP) characterised by the secretion of inflammatory 
cytokines, proteinases and chemokines (Secher et al., 2013). These cells were able to 
promote double-stranded DNA breaks and cellular proliferation in neighbouring cells 
through a bystander effect, primarily through the induction of hepatocyte growth 
factor signalling (Cougnoux et al., 2014). Therefore, it is now clear that colibactin is 
able to contribute to tumour growth without the requirement for direct cell contact.  
Chapter 1 – Introduction  
36 
 
 The importance of colibactin expression to the mechanism of E. coli tumour 
promotion remains unclear. The pks locus is expressed by other members of the 
Enterobacteriaceae; however, as of yet no other family member has been linked to 
CRC (Putze et al., 2009). The relevance of pks+ E. coli to CRC may be attributed to 
the ability of these strains to colonise and invade the epithelium of CRC patients. In 
one study, intracellular E. coli were recovered both from within tumours  and on 
matched normal tissue in >90% of patients with colorectal adenomas or carcinomas, 
but were absent from healthy controls (Swidsinski et al., 1998). Interestingly, invasive 
E. coli were found to be more frequently isolated from mice fed a Western diet 
(Martinez-Medina et al., 2014). However, the pks+ locus is also found in some 
probiotic strains, particularly E. coli Nissle 1917 (EcN). This strain is used 
commercially to treat a number of gastrointestinal conditions, including Crohn’s 
disease and ulcerative colitis, and has been demonstrated to produce anti-
inflammatory effects and prevent the colonisation of pathogens including Salmonella 
(Deriu et al., 2013). Remarkably, invasive E. coli  (including EcN) preferentially 
locate and invade tumour tissue even when injected intravenously, which has the 
potential to be exploited as a cancer diagnostic/therapy delivery tool (Brader et al., 
2008).  However, it has been demonstrated that mutation of the pks locus in EcN 
abrogates its probiotic activity, the mechanism of which is still unclear (Olier et al., 
2012). Our understanding of the contribution of pks+ E. coli strains is further hindered 
by the inability to determine the structure of colibactin (Faïs et al., 2018), and it is 
clear that further work is needed to elucidate the role of E. coli in CRC.  
1.5.4 Enterococcus faecalis  
Enterococcus faecalis is an early coloniser of the gastrointestinal tract. Belonging to 
the Firmicutes, E. faecalis is a Gram-negative, facultative anaerobe coccus which 
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despite being predominantly found in the gut is also isolated from the oral cavity and 
vaginal mucosa (Alhajjar et al., 2020). It is one of the most commonly isolated bacteria 
from stool, usually in the range of 105-107 colony forming units per gram, and like E. 
coli Nissle, strains of E. faecalis such as EC-12 are frequently used as probiotics (Sghir 
et al., 2000). During early gut microbiome development, E. faecalis plays a crucial 
role in suppressing pathogen-associated immune responses through its regulation of 
the inflammatory cytokines IL-8 and IL-10 via MAPK signalling pathways (Wang et 
al., 2014). Despite these positive effects, elevated levels of E. faecalis are isolated 
from the stool of CRC patients, leading to some speculation as to its role in cancer 
development (Balamurugan et al., 2008). 
 E. faecalis is thought to contribute to CRC development and progression 
through the production of reactive oxygen species (ROS) and other genotoxic 
metabolites. It is one of relatively few species of bacteria which produces extracellular 
superoxide (O2-), and also produces hydrogen peroxide (H2O2; Huycke, Abrams and 
Moore, 2002). Hydrogen peroxide freely diffuses across epithelial cell membranes, 
and has been demonstrated to induce epidermal growth factor receptor (EGFR) 
signalling (Boonanantanasarn et al., 2012). As previously mentioned, chromosomal 
instability is a key mechanism through which genetic changes accumulate in CRC. 
Superoxide production by E. faecalis has been demonstrated to promote chromosomal 
instability in mammalian cells, both directly and through the induction of the COX-2 
pathway in neighbouring macrophages (Wang and Huycke, 2007). In addition to the 
production of ROS, E. faecalis also produces and secretes a matrix metalloproteinase 
toxin, gelatinase. Action by gelatinase increases epithelial barrier permeability, 
allowing microorganisms and other luminal contents to access the underlying stroma, 
causing inflammation in the colon (Steck et al., 2011). Mouse studies of E-cadherin 
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have identified cleavage sites for gelatinase, suggesting that this toxin could also 
contribute to Wnt signalling as previously discussed.  
1.5.5 Fusobacterium nucleatum 
The obligate anaerobe Fusobacterium nucleatum is a Gram-negative spindle-shaped 
rod and is not considered to be part of the normal gut microbiota. In a study of 
inflammatory bowel disease (IBD) related microorganisms, Huh and Roh found that 
F. nucleatum was present in less than 3% of samples taken from a mix of IBD and 
non-IBD subjects, highlighting its low prevalence in the normal population (Huh and 
Roh, 2020). Instead, F. nucleatum is an important constituent of the oral microbiome, 
where it is a strong biofilm former and acts as a bridge between stricter anaerobes at 
the mucosal surface and facultative anaerobes in the apical plaque layer (Okuda et al., 
2012). Despite being a member of the healthy oral microbiome, F. nucleatum is 
implicated in periodontal disease, as well as extra-oral conditions including adverse 
pregnancy outcomes, IBD and appendicitis (Han et al., 2000; Wang et al., 2013; 
Loening-Baucke et al., 2012).  
 An increased prevalence of F. nucleatum in CRC patient biopsies was first 
reported in 2012 (Castellarin et al., 2012), and was surprising, given that F. nucleatum 
was thought to primarily be an opportunistic pathogen of the oral cavity. To this date, 
the precise mechanism of translocation to the gut is unknown. Due to the concordance 
between oral and intestinal microbiota populations an oral-gut route is predicted (Ding 
and Schloss, 2014). However, the translocation of F. nucleatum to non-gastrointestinal 
tumours suggests that hematogenous spread is possible (Parhi et al., 2020).                             
F. nucleatum is more prevalent in IBD and CRC patients than healthy controls, and it 
is thought to remodel the gut microbiota in CRC by promoting the infiltration of 
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myeloid-derived immune cells which trigger erroneous immune responses against the 
microbiota (Kostic et al., 2013). 
 F. nucleatum abundance is increased 4-fold in CMS1 CRC, however, it is 
found in lower proportions in CSM2 and CSM3 populations compared to healthy 
controls (Purcell et al., 2017). Furthermore, there are conflicting reports on the 
association of F. nucleatum with various stages of CRC. F. nucleatum is over-
represented in CRC patients, and has been frequently isolated from both lymph node 
and liver metastases, suggesting that this bacterium is relevant to late-stage CRC 
progression and is able to travel to secondary sites (Bullman et al., 2017). F. nucleatum 
was also demonstrated to be enriched in colorectal adenomas (Flanagan et al., 2014). 
Furthermore, isolation of F. nucleatum from stool samples has been shown to diagnose 
both colorectal adenomas and adenocarcinomas at high sensitivity and specificity 
(Wong et al., 2017). Conversely, other research groups did not find any significant 
association between F. nucleatum and colorectal adenomas, and have suggested that 
the overabundance of F. nucleatum in CRC can be simply attributed to its adaptation 
to favourable microenvironment conditions (Amitay et al., 2017). The increased 
abundance of F. nucleatum in IBD patients suggests a contribution to chronic colonic 
inflammation (Strauss et al., 2011). Indeed, colonisation with F. nucleatum has been 
linked with the upregulation of numerous inflammatory pathways, including the 
secretion of inflammatory cytokines, infiltration of immune cells into colon tissue and 
stimulation of humoral immunity (Wu, Li and Fu, 2019).  
F. nucleatum possesses multiple virulence mechanisms; however, its surface 
adhesin, FadA, is thought to facilitate direct pro-tumorigenic activity. FadA is found 
on the surface of F. nucleatum cells and regulates its attachment and invasion of the 
colonic epithelium (Guo et al., 2020). Like BFT, FadA binds to E-cadherin, and is 
Chapter 1 – Introduction  
40 
 
thought to contribute to CRC progression by stimulating proliferation, tumour 
migration and epithelial-mesenchymal transition by modulating Wnt signalling 
through E-cadherin cleavage (Rubinstein et al., 2013). Interestingly, F. nucleatum 
invasion of colorectal adenocarcinoma cells did not appear to correlate with relative 
levels of E-cadherin expression in multiple cell lines, suggesting that the interaction 
of FadA with E-cadherin is not the limiting factor on F. nucleatum association with 
the epithelium (Rubinstein et al., 2013). Further studies from the Rubinstein research 
group have revealed that F. nucleatum modulates Wnt signalling through a secondary, 
albeit still E-cadherin-dependent mechanism, by upregulating Annexin A1 expression 
(Rubinstein et al., 2019). Therefore, despite growing evidence suggesting a causal role 
for F. nucleatum in CRC progression, further research is required.  
1.6 Models of bacterial contribution to colorectal cancer 
The concept of cancer as a microbial disease is not novel. It is estimated that 
approximately 30% of all cancerous diseases can be attributed to microorganisms. For 
example, Helicobacter pylori is thought to be responsible for approximately 89% of 
non-cardia gastric cancer cases (Plummer et al., 2015). The strong associations 
between infectious agents and cancer have allowed for novel interventions to prevent 
and diagnose cancerous diseases. Successful examples of this include vaccinations 
against human papillomavirus (primarily for the prevention of cervical cancer), and 
the urea breath test for gastric cancer screening  (Chrysostomou et al., 2018; Rahim et 
al., 2019). Recent research has demonstrated the potential for antimicrobial adjuvant 
therapy in the treatment of CRC. For example, small molecule inhibitors of the 
colibactin synthesis enzyme ClbP effectively eliminated DNA damage and tumour 
proliferation induced by colibactin-producing E. coli in murine models (Cougnoux et 
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al., 2016). However, before microbial treatment can be fully utilised in CRC treatment 
some obstacles remain.  
 Unlike other microbe-associated cancers, the contribution of microorganisms 
to CRC initiation and progression is thought to be polymicrobial. Interpersonal 
variation in gut microbiota composition means that microbiome studies conducted on 
different populations, and in different geographical areas, often report different species 
of bacteria in association with CRC (Osman et al., 2018). It is currently unclear 
whether these differences can be attributed to physiological differences (e.g. diet, host 
genetics) or inconsistencies between handling of samples and method of analysis. In 
addition to regional differences between CRC patients, temporal associations between 
oncogenic bacteria and CRC patients are also apparent. Many species isolated in 
abundance from tumour biopsies are absent, or found at significantly reduced 
abundancies in paired off-tumour tissue from the same patient (Flemer et al., 2017). 
Similarly, colorectal adenomas appear to display microbial populations distinct from 
those of advanced tumours (Mori et al., 2018). This supports the notion that just as 
microbial factors are able to influence tumour progression, the tumour 
microenvironment associated with different stages of CRC progression favours the 
growth of specific bacterial populations. In order to reconcile these issues in 
understanding the role of bacteria in CRC, several conceptual models have been put 
forward.  
1.6.1 The alpha-bug hypothesis 
One of the key issues with associating specific species of bacteria with CRC is that 
many candidate pathogens, despite being found in greater abundance in cancer 
patients, are still relatively low in abundance in the microbiome as a whole. The alpha-
bug hypothesis (Sears and Pardoll, 2011) posits that certain low-abundance species 
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exert pro-oncogenic effects sufficient to remodel the microbiome and directly initiate 
cancer formation (Figure 1.6A). It was first proposed based upon studies of ETBF, 
and a key tenet of this model is the tripartite relationship between the microbiome, the 
colonic mucosa, and the immune system. Therefore, a key characteristic of potential 
alpha-bug species is the ability to exert an influence on the immune system and 
modulate the composition of the gut microbiota. In the multiple intestinal neoplasia 
(Min) mouse model, ETBF colonisation was sufficient to drastically alter the tumour 
formation phenotype (Wu et al., 2009). Tumour development in Min mice is normally 
restricted to the small intestine, and animals usually perish within six months. In 
contrast, ETBF colonised mice developed multiple large tumours in the distal colon, 
the formation of which correlated with ETBF-induced colonic inflammation, and 
which led to premature death after 3 months (Wu et al., 2009). 
 Prospective alpha-bugs must be able to exert their effects despite being at 
relatively low abundance in the microbiome. As previously stated, B. fragilis 
constitutes less than 1% of the gut microbiota, yet its regulation of Th17 immune cells 
is sufficient to cause dysbiosis (Sears and Pardoll, 2011). This is in contrast to 
‘dominant pathogens’ which outcompete the native microbiota during their 
pathogenesis (Hajishengallis, Darveau and Curtis, 2012). For example, during 
infection Salmonella enterica subsp. enterica serovar Typhimirium, suppresses the 
microbiota by triggering IL-10 mediated  inflammation and rapidly becomes the 
predominant species in the gut after 4 days in murine models (Stecher et al., 2007). 
Other potential alpha-bugs in CRC include the previously discussed enteropathogenic 
E. coli and E. faecalis in addition to Streptococcus gallolyticus subsp. gallolyticus (Yu 
and Fang, 2015).  
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 Despite the strengths of the alpha-bug, or more recently coined ‘keystone 
pathogen’ hypothesis, some issues remain when applying it to CRC. The alpha-bug 
model does not account for asymptomatic colonisation by the candidate organism, 
which in the case of ETBF occurs in 5-30% of individuals (Sears, 2009). Furthermore, 
several CRC-associated pathogens are often absent from malignant adenocarcinomas, 
suggesting that these species are not responsible for driving late-stage disease 
(Bundgaard-Nielsen et al., 2019).  
1.6.2 The Driver-Passenger model  
The divergence between bacterial species present at different stages of the adenoma-
carcinoma sequence, and between on-tumour and off-tumour samples, is explained by 
the Driver-Passenger Model (Tjalsma et al., 2012). This theory, which has been 
frequently cited since its publication, suggests that as the tumour develops and 
progresses, its associated microbiota also experiences shifts in its composition. 
Therefore, bacteria linked to CRC can be divided into two categories: Driver or 
Passenger (Figure 1.6B). Driver bacteria are members of the core microbiome which 
possess pro-oncogenic properties and are able to directly initiate tumorigenesis, 
whether through induction of inflammation or direct virulence against the colonic 
mucosa. Due to natural variation in individuals’ microbiota compositions, some 
individuals will naturally have a higher proportion of driver species than others, and 
these differences can be exacerbated by lifestyle factors such as consuming a Western 
diet. The action of these driver species both directly and indirectly modifies the tumour 
microenvironment. For example, increased epithelial barrier permeability caused by 
previously mentioned toxins produced by ETBF or E. faecalis may provide additional 
niches for the colonisation of other species. For example, S. gallolyticus poorly 
attaches to and invades colon epithelial cells in vitro, but readily attaches to and forms 
Chapter 1 – Introduction  
44 
 
biofilms on collagen fibres. Hyperplasia induced by other species, and eventual 
tumour development greatly alters the microenvironment and may expose collagen 
fibres for colonisation by S. gallolyticus (Boleij et al., 2011). Mucosal metabolism 
also greatly affects bacterial viability, whereby colorectal tumours display distinct 
metabolic profiles from healthy epithelium (Hirayama et al., 2009). The altered 
availability of substrates to mucosa-resident bacteria applies a selection pressure, 
favouring bacteria adapted to survive in this new environment. As a result, the initial 
driver bacteria are eventually outcompeted, and replaced by passenger bacteria which 
are better adapted.  
 Passenger bacteria have a competitive advantage in the tumour 
microenvironment and are therefore enriched at tumour sites, these may include                        
F. nucleatum, which is a poor coloniser of the healthy gastrointestinal tract. However, 
unlike driver bacteria, passenger bacteria may not be pro-oncogenic, and may simply 
be commensal or even exert anti-tumour effects. For example, Coriobacteriaceae are 
enriched in CRC samples, despite being considered probiotic species (Drewes et al., 
2017). This notion has been supported by further studies which have successfully 
categorised Passenger bacteria according to whether they exert a pro-inflammatory or 
anti-inflammatory effect (Geng et al., 2014). Many commensal passenger species may 
not directly contribute to colorectal carcinogenesis, but may have altered transcription 
in the tumour microenvironment that contributes to dysbiosis (Hajishengallis and 
Lamont, 2016).  
 Passenger populations themselves are considered transient, as they too are 
subject to being outcompeted as the tumour progresses further. This poses a problem 
with the application of microbiome studies to CRC diagnosis and treatment, as Driver 
species may only be active during the very early stages of disease development. 
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However, this model does explain the conflicting results of studies analysing the role 
of specific species in CRC. Tjalsma et al. also conclude that the role of an individual 
species as a cancer driver or passenger may be determined at a strain-specific level 
and be temporally associated with disease stage.  Therefore, investigation of how 
bacteria interact with tumour cells of different stages would be beneficial in 
understanding this relationship. 
 Although the driver-passenger model expands upon the alpha-bug hypothesis, 
it raises further questions about the role of specific species in CRC development and 
progression. Firstly, it is not yet possible to conclude that initial Driver species are 
completely lost from the microbiota population, as despite advances in the sensitivity 
of sequencing technologies it cannot be guaranteed that bacteria do not remain present 
outside the limits of detection (both spatially and analytically). It is also important to 
consider that changes in the abundance of certain species are not enough to confirm a 
positive or negative effect on CRC. For this reason, RNA sequencing, in addition to 
tried and tested DNA sequencing has become more common. This allows investigators 
to determine whether species identified as being associated with tumours are 
transcriptionally active (Castellarin et al., 2012). It has been demonstrated that 
biofilms isolated from CRC patients and matched healthy controls exert pro-oncogenic 
effects after injection into murine models (Tomkovich et al., 2019). This suggests that 
the phenotypic switches, such as biofilm formation, may play a role in tumour 
initiation. However, the realistic feasibility of being able to undertake longitudinal 
microbiome studies to monitor the development of CRC in previously healthy 
populations means that definitively identifying bacteria that are cancer initiators 
remains challenging. 
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Figure 1.6: A comparison of the ‘Alpha-bug’ and ‘Driver Passenger’ models of bacterial contribution to 
colorectal cancer. (A) An ‘alpha-bug’/’keystone pathogen’ such as ETBF induces tumorigenesis through a 
variety of mechanisms. Remodelling of the microbiota and induction of Th17 cell inflammation form a feedback 
loop, which combined with direct genotoxicity (e.g. through BFT) and host mutations contributes towards a 
pro-carcinogenic colonic microenvironment. (B) In the Driver-Passenger model, remodelling of the microbiota 
by a Driver species such as ETBF facilitates colonisation by Passenger bacteria e.g. Fusobacteria. These 
Passenger bacteria may be pro-tumorigenic or may be commensal. Eventually, sustained changes to the colonic 
microenvironment mean that initial driver species are outcompeted by passenger bacteria which are better 
adapted to the tumour microenvironment. Figure reproduced from Li et al. (2017). License number: 
5055851464946. 
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1.7 The two-way relationship between the adenoma-carcinoma 
sequence and the microbiome 
Studies have shown that distinct microbial populations can be associated with specific 
stages of tumorigenesis (Sheng et al., 2019). These stages are characterised by changes 
in the tumour microenvironment, colonic structure, tumour metabolism, immune 
status, and hypoxia. It is therefore possible that certain bacterial species exert differing 
effects on tumours at different points during tumour development. Nakatsu et al. 
(2015) demonstrated that low-grade dysplasia, high-grade dysplasia, early-stage CRC, 
and late-CRC each have distinct microbial communities. For example, Fusobacterium, 
Parvimonas and Gemella species increased in CRC relative to polyps displaying low-
grade dysplasia, whereas levels of Bacteroides remained similar throughout (Nakatsu 
et al., 2015). Therefore, an acute understanding of the role of specific species at each 
stage of the adenoma-carcinoma sequence is required. A key aspect of sporadic 
colorectal tumorigenesis is the development of cancer over long time periods, usually 
decades, and many individuals will harmlessly develop colorectal polyps which never 
progress into cancer (Pan et al., 2020). As previously discussed, development of 
invasive disease from a benign adenoma has not been linked to any specific mutation. 
For example, genomic alterations such as inactivating mutations of TP53, while 
largely considered to be markers of malignant carcinoma are also seen in late-stage 
adenomas (Mamlouk et al., 2020). Therefore, bacteria able to promote the benign-
malignant transformation may have the greatest impact on cancer development.  
 Studying the induction of CRC by bacteria from normal epithelium is difficult 
in vitro, and in vivo models are not without issue. It has previously discussed how, 
although valuable, studies focussing on the changing population dynamics of bacterial 
species in CRC patients do not necessarily demonstrate a causal relationship. Mouse 
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models of tumorigenesis allow the investigation of much of the CRC timeline, from 
tumour formation to death, but are not without their nuances. Due to natural 
intertumour variation, it is often not possible to investigate metastasis in mouse models 
before the tumour burden causes death (Khanna and Hunter, 2005). In addition, 
research on the role of bacteria in CRC using mouse models has primarily been 
performed using germ-free animals, which possess no indigenous microbiota (Gordon 
and Pesti, 1971). Immune system development in these animals is therefore severely 
compromised, as is the tripartite relationship between the immune system, 
inflammation and CRC described as critical by the alpha-bug model (Sears and 
Pardoll, 2011). For this reason, some researchers have begun to incorporate 
conventional mice into their studies, to great success. Wong et al. (2017) demonstrated 
that gavage of stool samples from CRC patients into germ-free or conventional mice 
induced intestinal carcinogenesis, demonstrating that the microorganisms present in 
the stool were able to induce dysbiosis even when challenged by an established 
microbiome.  
 Tumour cell lines provide a cheaper, low-maintenance, high throughput 
alternative to mouse models, and allow for the direct study of single species 
interactions with colorectal tumour cells. However, culturing and maintaining benign 
adenoma cells in vitro has generally proved challenging. Despite this, Paraskeva et al. 
(1989) succeeded in isolating a number of colorectal adenoma cell lines. In particular, 
the RG/C2 cell line was isolated from a tubular adenoma and is relatively easy to 
manipulate in vitro. Unlike adenocarcinoma cell lines, RG/C2 cells display many 
features indicative of normal colonic mucosa, including microvilli and the formation 
of mucin droplets (Paraskeva et al., 1989). As previously discussed, changes in cell 
surface architecture and the presence of mucin are likely to significantly impact 
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interactions of bacteria with tumour cells. In addition, the authors note that RG/C2 
cells are clonogenic, which is indicative of high malignant potential. Therefore, 
comparison of this cell line with conventional adenocarcinoma cells enables 
investigation into the relationship between bacteria and distinct stages of CRC 
development, potentially identifying mechanisms through which bacteria initiate 
benign-malignant transformation.  
1.8 Aims and Objectives 
1.8.1 Aims 
Through comparison between RG/C2 cells and well-established colorectal 
adenocarcinoma cell lines, this body of work aims to investigate how specific bacteria 
interact with colorectal adenoma and adenocarcinoma cells in vitro. Once these 
interactions have been characterised, this study will aim to determine the impact of 
these bacteria on cellular behaviours associated with tumour progression. Specifically, 
the ability of bacteria to moderate tumour cell proliferation, metabolism and motility 
shall be measured, with a focus on comparing how bacteria may alter these behaviours 
differently in benign and malignant cells.  
1.8.2 Objectives 
• To develop an in vitro co-culture model which allows the treatment of 
colorectal tumour cells with bacteria under standard aerobic culture conditions. 
In addition, to quantify levels of bacterial association with tumour cells during 
co-culture. 
• To assess the effects of bacterial infection on tumour cell yield and apoptosis, 
and investigate how any differences observed in these characteristics can be 
explained by bacteria-induced changes to the cell cycle.  
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• To investigate how tumour cell metabolism differs between adenoma and 
adenocarcinoma cell lines by investigating the Warburg effect using the 
Seahorse Xf analyser to measure oxidative phosphorylation and glycolysis 
both under standard culture conditions and when challenged with bacteria. 
Similarly, selected ion flow tube mass spectrometry (SIFT-MS) shall also be 
used to compare the volatile metabolites produced by adenoma and 
adenocarcinoma cells in vitro, and how these metabolites are altered during 
infection by bacteria.  
• To assess how infection with bacteria impacts tumour cell motility using both 
wound healing and transwell filter migration and invasion assays. The 
mechanisms behind observed effects shall be explored, firstly by targeting 
commonly upregulated pathways e.g. Wnt signalling, and secondly by using 
qPCR microarrays to rapidly quantify the effect of bacteria on the expression 
of EMT and cell motility-related genes. The results of these qPCR assays will 
indicate which mechanisms may be involved in bacterial contribution to 
tumour progression




Chapter 2: Materials and Methods 
2.1 Culture of colorectal cell lines 
Throughout this study, the principle cell lines used were the colon adenoma epithelial 
cell line RG/C2 (Paraskeva et al., 1989) and the colon adenocarcinoma epithelial cell 
line HCT116 (Brattain et al., 1981). The RG/C2 cell line was derived from a tubular 
adenoma isolated in a sporadic CRC patient, and unlike most colorectal adenoma cell 
lines is clonogenic at early passages. The HCT116 cell line was initially isolated from 
a colonic carcinoma, and is tumorigenic in athymic nude mice. Both cell lines display 
a polygonal appearance in vitro typical of epithelial cells. A summary of all colorectal 
cell lines used throughout this project is presented in Table 2.1. All cell lines were 
kindly donated by Professor Ann Williams at the University of Bristol, UK.  
 
Table 2.1: Colorectal tumour cell lines used throughout this study.  
Cell line Commercial 
reference 



























RG/C2 N/A Colonic tubular 
adenoma 
59-year-old male Wild type for 
APC, KRAS, 








Duke’s B colorectal 
adenocarcinoma 
50-year-old male APC, KRAS, 
p53 – CMS4 
Fogh et al. 
(1989) 
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2.1.1 Standard tissue culture procedure 
Cells were maintained in Dulbecco’s Modified Eagle Medium (DMEM) – high 
glucose (Sigma-Aldrich Ltd., Gillingham, UK) in T25cm2 filter-capped tissue culture 
flasks (Corning® Amsterdam, The Netherlands). Media used to culture adenoma cells 
was supplemented with 20% heat-inactivated foetal bovine serum (FBS; Fisher 
Scientific UK Ltd., Loughborough, UK), 4 mM L-glutamine (Sigma-Aldrich Ltd.), 0.2 
U/ml human insulin (Sigma-Aldrich Ltd.), 1 μg/ml hydrocortisone 21-hemisuccinate 
(Sigma-Aldrich Ltd.) and 200 U/ml Penicillin-Streptomycin (Thermo-Fisher 
Scientific, Massachusetts, USA).  Media used to culture adenocarcinoma cell lines was 
supplemented with 10% FBS, 2 mM L-glutamine and 200 U/ml Penicillin-
Streptomycin. Cells were maintained in a humidified incubator at 37°C and 5% CO2 
(NuAire DH Autoflow™, NU 500 series, Triple Red Ltd., UK) and media was changed 
twice weekly.  
To subculture, cells were passaged once they reached approximately 80-90% 
confluency by washing in 5 ml of Dulbecco’s A phosphate buffered saline (PBS; 
Thermo-Fischer Scientific), followed by trypsinisation with 3 ml of 0.1% w/v trypsin-
EDTA solution (Sigma Aldrich Ltd.) in PBS for 10 minutes at 37°C and 5% CO2.  
Detached cells were collected using an equal volume of fresh complete media and 
centrifuged at 1,000 rpm for 10 minutes to remove trypsin (OptimaXP centrifuge, 
Beckman Coulter Life Sciences, Indianapolis, USA). The resulting cell pellets were 
then resuspended in an appropriate volume of fresh cell culture media and seeded into 
new flasks. Adenoma and adenocarcinoma cell lines were split at ratios of 1:3 and 
1:10, respectively. 




2.1.2 Cell line cryopreservation 
To create frozen stocks of colorectal tumour cell lines, sub-confluent cells were 
trypsinised as described in Section 2.1.1, followed by centrifugation at 1,000 rpm for 
10 minutes. Cells were resuspended in an appropriate volume to give approximately 
2x106 cells/ml, and 900 μl of this cell suspension was aliquoted into a cryovial, to 
which 100 μl of dimethyl sulfoxide (DMSO; Sigma-Aldrich Ltd.) was added. 
Cryovials were placed into a ‘Mr. Frosty’ cell freezing container (Nalgene®, Sigma-
Aldrich Ltd.) and stored at -80°C. After 24 hours, cryovials were deposited into a liquid 
nitrogen freezer and kept at -136°C. For retrieval, cryovials were removed from liquid 
nitrogen and warmed to 37°C. The cell suspension was centrifuged at 1,000 rpm for 
10 minutes and resuspended in fresh medium to remove residual DMSO. The contents 
were then added to a T25 flask containing 5 ml of fresh medium. After retrieval from 
liquid nitrogen storage, cells were grown to 80-90% confluency and allowed to recover 
for two passages before use in experiments.   
2.1.3 Cell enumeration 
To seed experiments, cells were trypsinised and resuspended as previously described. 
According to Hague et al. (1993), colonic tumour cells cultured in vitro detach from 
the monolayer as they undergo apoptosis. Therefore, all cells collected during 
trypsinisation will be viable. Thus, the total viable cell count was achieved by counting 
a 10 μl sample of the cell suspension using a haemocytometer. Once counted, cells 
were centrifuged for 10 minutes at 1,000 rpm and resuspended in an appropriate 
volume of cell culture medium, to remove the trypsin solution, and seeded into T25 
flasks or tissue culture plates (Corning®) at the required density. 
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2.2 Bacterial culture 
A summary of the bacterial reference strains used throughout this study is shown in 
Table 2.2. 
 
2.2.1 Bacterial culture media and culture conditions 
For routine non-selective culture, all bacterial strains were cultured using Brain Heart 
Infusion (BHI) agar (CM3116) or in BHI broth (CM3115; Oxoid Ltd., Heysham). Agar 
plates were supplemented with 5% defibrinated horse blood (TCS Biosciences Ltd., 
Buckingham, UK). Dehydrated media was added to deionised water and autoclaved at 
121°C for 15 minutes. For long term storage, bacterial strains were stored at -80°C 
using Micro-bank cryopreservation beads (Pro-Lab Diagnostics, UK). For revival, the 
stock was allowed to return to room temperature, and a sterile inoculating loop was 
used to streak the bacteria onto a fresh agar plate. Both strict and facultative anaerobic 
bacteria were used throughout this study (see Table 2.2). With the exception of 
transformed isolates used for plasmid extraction, all bacteria were cultured under 
anaerobic conditions in an A95 anaerobic workstation (Don Whitley Scientific Ltd., 
Bingley, UK). The gaseous composition in the workstation was calibrated to be 80% 
Nitrogen, 10% CO2 and 10% Hydrogen. Cultures were incubated at 35°C and 75% 
Table 2.2. Bacterial strains used throughout this study.  
Species Strain reference  Oxygen requirement 
Bacteroides fragilis  ATCC 43858   Strict anaerobe 
Escherichia coli Nissle Ardeypharm    Facultative anaerobe 
Enterococcus faecalis ATCC 19433   Facultative anaerobe 
Fusobacterium nucleatum ATCC 25586    Strict anaerobe 
 




humidity. Prior to use, bacteriological media was reduced by incubating under 
anaerobic conditions for 1 hour. 
2.2.2 Agar culture 
Single colonies were obtained by using a sterile inoculating loop to streak bacteria 
across a pre-reduced agar plate. Aerobic cultures were incubated at 37°C for 24 hours, 
whereas anaerobic cultures were incubated for 48 hours. 
2.2.3 Planktonic culture 
To culture bacteria in the liquid phase, a single colony from an agar plate was isolated 
using a sterile loop and used to inoculate 5 ml of BHI broth, which was pre-reduced 
before use with anaerobic bacteria. Aerobic cultures were incubated at 37°C while 
shaking at 225 rpm, whereas anaerobic cultures were not shaken due to the 
unavailability of a shaking anaerobic incubator. All broth cultures were incubated for 
approximately 24 hours. Where required, broth cultures were adjusted to a desired 
concentration of colony forming units (cfu) per millilitre by reading absorbance at    
600 nm using a Jenway Model 6715 UV/Visible Scanning Spectrophotometer (Cole-
Parmer, Saint Neots, UK). A 0.1 OD600nm culture was found to contain approximately 
1x108 cfu/ml for each test species.   
2.2.4 Bacterial enumeration 
To accurately determine the number of cfu in a bacterial suspension, the Miles and 
Misra technique was used (Miles, Misra and Irwin, 1938). A 1 in 10 serial dilution of 
bacterial broth culture was prepared to a dilution factor of 10-7 in PBS. Dilutions were 
gently vortexed to ensure homogenisation, and a 10 μl aliquot of each suspension was 
pipetted onto an agar plate and incubated for the appropriate time period (see Section 
2.2.2) to allow distinct colonies to form. Following incubation, the appropriate dilution 
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for counting was selected, where between 3 and 30 isolated colonies were visible, and 
this count was used to determine the total cfu/ml in the original sample. A calibration 
curve of cfu against optical density was created and the cfu present in subsequent 
cultures was determined by interpolating using this curve.  
  




2.3 Quantification of bacterial adhesion and invasion into tumour cells 
To infect cells with viable bacteria, tumour cells were seeded into the appropriate cell 
culture plate and grown to confluent monolayers to best mimic in vivo conditions. 
Overnight bacterial cultures were centrifuged at 10,000 xG and resuspended in serum-
free DMEM. Tumour cell monolayers were washed three times with PBS, and bacteria 
were added at the desired multiplicity of infection (MOI). After initial infection, cells 
were treated with 300 μg/ml gentamicin (Sigma-Aldrich Ltd.) and 200 μg/ml 
metronidazole (Sigma-Aldrich Ltd.) in serum-free DMEM to eliminate extracellular 
bacteria. Tumour cells were then washed a further three times with PBS and 
supplemented with fresh media before use in downstream experiments.  The general 
procedure for tumour cell infection is illustrated in Figure 2.1.  
2.3.1 Gentamicin protection assay 
To quantify the number of bacteria attaching to or invading tumour cells, the 
gentamicin protection assay was used (Edwards and Massey, 2011). Tumour cells 
were grown to confluent monolayers in 96-well plates. Overnight cultures of bacteria 
were resuspended in serum-free DMEM and added to the monolayers at an MOI of 
approximately 10,000:1. Co-cultures were then incubated for 4 hours at 37°C and 5% 
CO2. Viable counts were performed using bacteria suspended in serum-free DMEM 
under these conditions to ensure no negative effect on bacterial viability 
(Supplementary Figure 1). To quantify the total number of bacteria associated with the 
monolayer, cells were washed three times with sterile PBS, and incubated with 1% 
w/v saponin (Sigma-Aldrich Ltd.) in serum-free DMEM for 30 minutes to lyse tumour 
cells and release the bound bacteria. Bacterial invasion was quantified by incubating 
the monolayers with serum-free DMEM containing 300 μg/ml gentamicin (Sigma-
Aldrich Ltd.) and 200 μg/ml metronidazole (Sigma-Aldrich Ltd.) for 1 hour to kill 
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extracellular bacteria before lysis with saponin. Following lysis, serial dilutions were 
prepared in PBS and 10 μl aliquots were used to inoculate agar plates in triplicate (see 
section 2.2.4). Plates were incubated under anaerobic conditions and counted after 24 
or 48 hours as appropriate. The number of adherent bacteria was calculated by 
subtracting the number of invasive bacteria from the total associated bacteria. The 
concentrations of antibiotics used were confirmed to be effective against the four 
species tested (Supplementary Figure 2). In addition, solutions of 1% saponin in 
serum-free DMEM were tested to ensure there was no negative effect on bacterial 
viability (Supplementary Figure 3). 
2.3.2 Determining intracellular bacterial persistence 
To determine whether intracellular bacteria were able to survive, and replicate, within 
colorectal tumour cells, monolayers were infected with bacteria as described in section 
2.3.1. Following antibiotic treatment to eliminate extracellular bacteria, fresh medium 
was added to each well, and cells were incubated under standard conditions. At 24-
hour intervals, monolayers were washed three times with PBS, before being lysed with 
saponin. The resultant lysates were serially diluted, plated onto agar plates, incubated, 
and counted to enable bacterial enumeration (see section 2.2.4). Addition of 
penicillin/streptomycin to the medium was used to prevent the outgrowth of any 
facultative anaerobes which may have been released from the monolayer during 
experimentation.
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2.4 Imaging of colorectal tumour cells and their interactions with 
bacteria 
2.4.1 Phase contrast microscopy 
To visualise cell morphology, tumour cells were cultured in 12-well plates at the 
desired seeding density and imaged using a Nikon TE300 inverted microscope and 
analysed using Image-Pro Plus software (Meyer Instruments, Texas, USA).  
2.4.2 Scanning electron microscopy 
To visualise the interaction of bacteria with the tumour cell surface, 10 mm coverslips 
were sterilised with 70% ethanol and placed at the bottom of a 24-well plate. HCT116 
cells were seeded into the wells at a density of 5x105 cells/cm2. Cells were then 
infected with bacteria for 4 hours, as described in Section 2.3, at an MOI of 1,000:1. 
After infection, coverslip-associated cells were fixed in 4% glutaraldehyde (Sigma-
Aldrich Ltd.). Following fixation, tumour cells were then washed three times with PBS 
and subsequently dehydrated using increasing concentrations of ethanol, followed by 
hexamethyldisilazane (Acros Organics, Geel, Belgium). Coverslip-associated cells 
were then sputter coated using an Emscope SC500 gold sputter coating unit and 
imaged using an FEI Quanta 650 field emission scanning electron microscope 
(Thermo-Fisher Scientific Ltd.).  
2.4.3 Confocal laser scanning microscopy  
Intracellular bacteria were imaged by staining bacterial cells with carboxyfluorescein 
(CFSE; Sigma-Aldrich Ltd.). Bacteria were pelleted by centrifugation at 10,000 xG, 
washed three times with PBS, resuspended in 5 μM CFSE, and incubated in the dark 
at 37°C and 200 rpm for one hour. After staining, bacteria were washed three times 
with PBS and added to sub-confluent RG/C2 or HCT116 cells grown on glass 




coverslips at a MOI of 1,000:1 and incubated for 4 hours under standard conditions. 
Co-cultures were then washed three times with PBS to remove unbound bacteria 
before fixation.  
 Samples were simultaneously fixed and permeabilised using a solution of 4% 
paraformaldehyde (Sigma-Aldrich Ltd.) and 0.2% Triton X-100 (Sigma-Aldrich Ltd.) 
in PBS for 10 minutes at room temperature. Cells were blocked with 1% bovine serum 
albumin (Sigma-Aldrich Ltd.) and stained with Alexa-Fluor 555 phalloidin (Fisher 
Scientific UK Ltd.) for 1 hour. Subsequently, cells were counterstained with               
4’,6-Diamidino-2-phenylindole (DAPI; Sigma-Aldrich Ltd.) for 10 minutes. 
Coverslips were carefully removed from the wells and mounted onto glass slides using 
Vectashield® Antifade Mounting Medium for Fluorescence (Vector Laboratories 
Ltd., United Kingdom). Samples were stored in the dark at 4°C and imaged within 48 
hours of preparation using a SP8 inverted confocal microscope (Leica Biosystems, 
Milton Keynes, UK).  
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2.5 Crystal violet biofilm formation assays 
To determine how host products may impact biofilm formation in gut bacteria, the 
crystal violet biofilm assay was used (Merritt, Kadouri and O’Toole, 2005). Solutions 
of porcine mucin (Sigma-Aldrich Ltd.) were prepared in BHI broth at various 
concentrations before autoclaving. Overnight bacterial cultures were diluted 1:100 in 
either fresh BHI broth, or fresh BHI broth containing mucin, and 100 μl aliquots were 
pipetted into a 96-well plate and incubated under anaerobic conditions for 48 hours. 
Following incubation, biofilms were washed twice with sterile water and stained with 
125 μl of 0.1% w/v crystal violet (Sigma-Aldrich Ltd.). Plates were then washed a 
further three times and allowed to air dry. To solubilise the crystal violet stain, 125 μl 
of 33% w/v acetic acid (Sigma-Aldrich Ltd.) was added to each well and incubated at 
room temperature for 15 minutes. One hundred microliters of this solution was then 
transferred to a new 96-well plate, and absorbance was read at 500 nm using an Infinite 
200 microplate reader (Tecan UK Ltd., Reading, UK). The absorbance of un-
inoculated wells was subtracted as a background reading, and the effect of mucin on 
biofilm formation was assessed by comparing absorbance to the control. 
 
  




2.6 Monitoring cell yield and viability in infected tumour cells 
2.6.1 MTS assay 
To determine how contact with bacteria affected viability in RG/C2 and HCT116 
tumour cells, the MTS assay was used. After addition of the MTS assay compound 
(Abcam PLC, Cambridge, UK), viable cells reduce the tetrazolium present in the assay 
reagent to formazan, inducing a detectable colorimetric change. Cells were grown to 
confluency in 96-well plates and infected with bacteria as described in Section 2.3. 
After treatment with 300 μg/ml gentamicin and 200 μg/ml metronidazole to eradicate 
extracellular bacteria, 180 μl of fresh media was added to each well. Twenty 
microlitres of MTS assay reagent (Abcam PLC) was added and the plate was incubated 
for one hour under standard conditions. Following incubation, absorbance at 500 nm 
was measured using a FLUOstar Omega microplate reader (BMG Labtech Ltd., Bucks, 
UK). Assay wells were blanked by subtracting the absorbance of wells which 
contained media and MTS reagent only. 
2.6.2 The effect of bacterial infection on tumour cell yield 
 RG/C2 and HCT116 cells were seeded into 12-well plates at a seeding density of           
4x104 cells/cm2 or 2x104 cells/cm2, respectively. Cells were incubated under standard 
conditions for 72 hours, before being treated with bacteria at a MOI of 10:1 or 100:1 
as described in Section 2.4. Following antibiotic treatment (to eliminate extracellular 
bacteria), tumour cells were washed three times with PBS and fresh media was added. 
Plates were then incubated for a further 96 hours under standard conditions. To 
determine the number of apoptotic cells, floating cells present in the media were 
counted as described in Section 2.1.3. Cells which were adhered to the bottom of the 
well were considered viable and counted using a haemocytometer as described in 
Section 2.1.3.  
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2.7 Cell cycle analysis  
To investigate whether observed changes in cell yield were as a result of alterations to 
the cell cycle, cellular DNA content was analysed via flow cytometry on samples 
prepared in parallel with cell yield assays.  
2.7.1 Flow cytometry sample preparation and staining 
To prepare samples for analysis via flow cytometry, cells were cultured and treated 
with bacteria as described in Section 2.6.2. After trypsinisation, cells were pelleted by 
centrifugation at 1,200 rpm for 5 minutes. Cells were then resuspended in 1 ml of 70% 
ethanol at 4°C and gently vortexed, before being incubated at 4°C for 30 minutes. 
Cells were then pelleted at 2,000 rpm for 5 minutes and stored in ethanol until staining.  
 To stain DNA for analysis, the ethanol supernatant was discarded, and cells 
were washed three times by resuspending in PBS and centrifuging at 2,000 rpm for 5 
minutes. A solution of 100 μg/ml RNAse A (Sigma-Aldrich Ltd.) and 50 μg/ml 
propridium iodide (Sigma-Aldrich Ltd.) was prepared in PBS, and 400 μl of this 
solution was used to resuspend the cell pellets.  Stained cells were stored at 4°C 
protected from light for at least 12 hours before running to allow the stain to develop. 
Cell cycle analysis of stained samples was performed using a BD LSRFortessa™ X-
20 Flow Cytometer (BD Biosciences, California, USA). Forward scatter (FCS-A) and 
side scatter (SSC-A) were used to gate cell populations, excluding cellular debris and 
cell doublets. The proportion of the cell population in each cell cycle phase was then 
quantified by comparing the fluorescence of the propridium iodide stain and modelled 
using Modfit LT™ software.   
 
  




2.8 Metabolic analysis   
The Seahorse XFe24 Extracellular Flux Analyser (Agilent Technologies Ltd., 
Stockport, UK), hereafter referred to as ‘the Seahorse’, was used to measure the 
metabolism of colorectal tumour cells cultured in vitro. The instrument measures 
oxygen consumption and extracellular acidification within the media as indicators of 
cellular respiration and glycolysis, respectively.  
2.8.1 Seahorse general assay procedure 
Seahorse XF cell culture plates (Agilent Technologies Ltd.) were exclusively used for 
metabolic assays. Colorectal tumour cells were harvested as described in Section 2.1.3 
and seeded into assay plate wells in a volume of 50 μl. According to manufacturer 
guidelines, four wells are used to normalise for background readings, therefore only 
media was added to these wells. Culture plates were incubated at room temperature 
(within a biological safety cabinet) for 1 hour to promote even cell distribution 
according to manufacturer guidelines, before being transferred to a 37 °C and 5% CO2 
humidified incubator. An additional 100 μl of fresh media was added after 8 hours of 
incubation. One day before the assay, 1 ml of Seahorse XF calibrant was added to each 
well of a Seahorse XF sensor cartridge, and this sensor cartridge was placed into a 
humidified CO2-free incubator at 37°C.  
 Assay medium was prepared on the day of the assay. Seahorse XF DMEM 
medium was supplemented with 10 mM glucose (Sigma-Aldrich Ltd.), 1 mM Sodium 
pyruvate (Fisher Scientific UK Ltd.) and 2 mM L-glutamine, before being adjusted to 
a pH of 7.4. Treatment compounds were loaded into the appropriate injector port of 
the sensor cartridge. The sensor cartridge was then placed into the machine for 
validation. On the day of the assay, cells were washed three times with pre-warmed 
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Seahorse assay medium, and a final volume of 500 μl was added to each well. The cell 
culture plate was placed into a humidified CO2-free incubator for 1 hour prior to the 
commencement of the assay. Following this incubation period, the cell culture plate 
was loaded into the machine and the assay was initiated.  
2.8.2 Optimisation of seeding density and carbonyl cyanide-4 
(trifluoromethoxy) phenylhydrazone (FCCP) concentration  
Seeding density for each cell line was optimised by seeding cells at various densities 
into a Seahorse XF cell culture plate. The plate was then analysed using the Seahorse 
without injection of treatment compounds, and a seeding density was chosen where an 
increase in cell density resulted in a linear increase in oxidative phosphorylation.  
The Seahorse sensor cartridge contains four injector ports which allow the real-
time addition of compounds to the cell culture medium. By injecting compounds 
which alter cellular metabolism, the basal and maximal metabolic rates can be 
determined. Throughout this work, carbonyl cyanide-4 (trifluoromethoxy) 
phenylhydrazone (FCCP) was used to modulate oxidative phosphorylation, whereas 
Oligomycin was used to modulate glycolysis. Both compounds are provided within 
the Seahorse XF Energy Phenotype test kit.  
Oligomycin was used at the manufacturer’s recommended concentration of       
1 μM after confirming that injection increased extracellular acidification rate (ECAR) 
be a factor of at least 2-fold in each cell line. The appropriate concentration of FCCP 
was determined for each cell line once the optimal seeding density had been 
determined. For all cell lines, the largest increase in oxidative phosphorylation was 
seen at an FCCP concentration of    1 μM.  




2.8.3 Crystal violet normalisation  
Data for the rates of oxidative phosphorylation and glycolysis were normalised against 
the total number of cells within each well.  After assay completion, cells were fixed in 
4% paraformaldehyde and stained with 100 μl of 0.1% crystal violet solution (Sigma-
Aldrich Ltd.). Cells were then washed three times in PBS, before being lysed in 1% 
sodium dodecyl sulphate (SDS; Sigma-Aldrich Ltd.) at 100 rpm for 1 hour. The lysate 
was transferred to a 96-well plate and absorbance was measured at 595 nm. The 
absorbance of each well was compared to a standard curve and used to interpolate the 
number of cells in each well.  
2.8.4 Measuring the impact of bacterial invasion on cellular metabolism  
Twenty-four hours before measurement in the Seahorse, and a minimum of 24 hours 
after seeding, tumour cells were infected with bacteria as described in Section 2.3. 
Following bacterial infection, cells were washed three times with PBS and treated with 
300 μg/ml gentamicin and 200 μg/ml metronidazole for 1 hour to eliminate 
extracellular bacteria. Cells were washed a further three times with PBS before fresh 
media was added. Cells were then returned to the incubator and cultured under 
standard conditions. The Seahorse assay was then performed as described in Section 
2.8.1.  
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2.9 Analysis of volatile metabolites released by tumour cells  
Volatile compounds present in the headspace of colorectal tumour cells cultured in 
T25 cell culture flasks were detected using selected ion flow tube mass spectrometry 
(SIFT-MS). Colorectal tumour cells were grown to confluency in T25 cell culture 
flasks and infected with bacteria at a MOI of 10:1 as described in Section 2.3, or treated 
with serum-free media as a control. Following infection and antibiotic treatment, fresh 
serum-free medium was added. Flask caps were then sealed with parafilm and flasks 
were incubated at 37°C for 30 minutes to allow accumulation of volatile compounds 
in the headspace. A 21-gauge needle was attached to the sampling arm of a Voice200 
Ultra instrument (Syft Technologies, New Zealand) and passed through the parafilm-
covered cap of the cell culture flask for sampling. The instrument was operated in full 
mass scan mode over a spectrum range of 15-200 m/z using H3O+, NO+ and O2+ 
reagent ions to detect volatile product ion peaks. Three repeat scans were performed 
for each sample. To analyse data, a background subtraction was performed whereby 
T-tests were used to identify volatile product ion peaks which were significantly 
different from the control (blank media or uninfected cells). Hierarchical cluster 
analysis (HCA) and principal component analysis (PCA) were used to analyse 
significant peaks using IMB SPSS statistics for Windows version 26.  
 
  




2.10 In vitro migration and invasion assays  
2.10.1 Wound scratch assay 
RG/C2 and HCT116 cells were seeded into 6-well plates at a seeding density of      
1x105 cells/cm2 and 5x104 cells/cm2, respectively, and cultured until confluent 
monolayers were formed. Tumour cells were then infected with bacteria at an MOI of 
10:1 as described in Section 2.3. Following infection and antibiotic treatment to 
eliminate extracellular bacteria, a sterile pipette tip (P200) was used to create a wound 
of approximately 1 mm across the diameter of the well. Cells were washed three times 
with PBS to remove cellular debris and fresh DMEM supplemented with 1% FBS was 
added. For each wound, phase contrast images of three separate locations were taken 
at 0 hrs and 24 hrs at a magnification of 400x. For each image, the surface area of the 
wound was measured using the MRI Wound Healing Tool for ImageJ software (NIH, 
Maryland, USA). The degree of wound closure was expressed as the percentage 
reduction in surface area of the wound observed within a 24-hour period. 
2.10.2 Transwell filter migration assay 
Millicell hanging cell culture inserts (Millipore UK Ltd., Watford, UK), with a pore 
size of 8 μm, were coated on the basal side with 10 μg/ml VitroCol® human collagen 
type 1 (Advanced Biomatrix Inc., California, USA) and left to dry in a biological safety 
cabinet overnight. Once dry, inserts were placed into 6-well plates, which were sealed 
with parafilm and stored at 4°C until needed. Colorectal tumour cells were cultured 
and infected with bacteria as described in Section 2.3. After elimination of 
extracellular bacteria, cells were detached with 0.48 mM versene solution (Sigma-
Aldrich Ltd.) in PBS, before being counted and resuspended in Ca2+-free DMEM 
(Fisher Scientific UK Ltd.). RG/C2 and HCT116 cells were then seeded onto the apical 
surface of the collagen coated inserts at seeding densities of 4x104 cells/cm2 and    
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2x104 cells/cm2, respectively. Ca2+-free medium supplemented with 5% FBS was 
added to the lower compartment to act as a chemoattractant, and the fluid level was 
equilibrated between the upper and lower chambers. Cells were then incubated at 37°C 
for 24 hours. The design of the assay is illustrated in Figure 2.2.  
 Following incubation, inserts were removed from the 6-well plates and washed 
three times in PBS. Cells were then fixed in 100% ice-cold methanol (Fisher Scientific 
UK Ltd.) for 10 minutes, washed three times in PBS and stained with 1% w/v crystal 
violet solution. Inserts were washed a further three times with PBS to remove excess 
crystal violet, and the remaining cells on the apical surface of the insert were removed 
with a cotton swab. Cells embedded in the collagen matrix on the basal surface of the 
insert were considered migratory. The insert membrane was dissected with a scalpel 
and mounted onto a glass slide before being imaged under a microscope. Migrated 
cells were counted in ten separate fields of view at 200x magnification. Three 
independent experiments were performed, in each of which three separate inserts were 
counted in 10 separate images for each condition.  
2.10.3 Transwell filter invasion assay  
In vitro invasion was assessed using Corning® Biocoat™ Matrigel invasion chambers 
(Sigma-Aldrich Ltd.). In contrast to the transwell filter migration assays, the basal 
surface of the filter is coated in Matrigel®, and therefore cells must produce the 
necessary enzymes to degrade extracellular matrix in order to pass through the filter. 
Cells were grown to confluency in 6-well plates and treated with bacteria as described 
above. Matrigel invasion chambers were reconstituted by placing each chamber into a 
6-well plate well and adding Ca2+-free medium to the upper and lower compartments. 
Chambers were incubated at 37°C for 2 hours, after which the media was discarded, 
and cells were seeded onto the apical surface at a seeding density of 4x104 cells/cm2. 




Media containing 5% FBS was added to the lower compartment, and cells were 
incubated for 24 hours at 37°C and 5% CO2. After incubation, cells embedded in the 
Matrigel matrix were fixed, stained, and counted as described in Section 2.10.2.  
 
  
Figure 2.2: Transwell filter migration assay design. Transwell filter migration assays were 
performed using collagen-coated cell culture inserts with an 8 μm pore size. Cells migrated from 
the apical chamber through the pores and became embedded in the collagen matrix. These migratory 
cells were then stained and counted. Invasion assays were set up similarly, however inserts pre-
coated with Matrigel were used.  
Chapter 2 – Materials and Methods 
72 
 
2.11 Luciferase reporter assays 
The TOPFLASH luciferase reporter assay was used to quantify Wnt signalling activity 
in colorectal tumour cells (Molenaar et al., 1996). The TOPFLASH luciferase reporter 
plasmid contains numerous Wnt-sensitive Tcf binding sites coupled to a fos promoter, 
upstream of a firefly luciferase reporter. The TOPFLASH reporter therefore yields 
luciferase activity from its fos promoter, and its Tcf binding sites. The control reporter, 
FOPFLASH, has mutated Tcf binding sights and thus only yields luciferase activity 
from its fos promoter. Therefore, the ratio of TOPFLASH luminescence to 
FOPFLASH luminescence provides a direct measurement of Wnt signalling-specific 
transcriptional activity. A third plasmid, containing a renilla luciferase reporter bound 
to a cytomegalovirus promoter was used to control for transfection efficiency. All 
plasmids were kindly donated by Dr. Alexander Greenhough (UWE) and are 
summarised in Table 2.3.  
 
2.11.1 Bacterial transformation 
Chemically competent E. coli DH5α recipient cultures were kindly provided by Dr. 
Tim Craig (UWE), and were subsequently transformed with donor plasmid. Prior to 
transformation, 100 μl aliquots of competent bacterial cells were thawed on ice. Five 
Table 2.3: Plasmids used for the TOPFLASH assay.  
Construct Function Selective agent 
CMV Renilla Control for transfection 
efficiency 
Ampicillin 
TOPFLASH LEF/TCF responsive reporter Ampicillin 
FOPFLASH TOPFLASH control reporter Ampicillin 
 




microliters of donor plasmid were added to the bacteria, and incubated on ice for 30 
minutes, before heat shocking bacteria for 90 s at 42°C. Bacterial cultures were diluted 
1:1 in Super Optimal broth with Catabolite repression (SOC) outgrowth medium (New 
England Biolabs Ltd., Hitchin, UK) and incubated at 37°C and 200 rpm in a shaking 
incubator for 1 hour. Following incubation, serial dilutions were plated onto Luria 
broth (LB; Oxoid Ltd.) agar plates containing 100 μg/ml ampicillin (Fisher Scientific 
UK Ltd.). Non-transformed cultures were also inoculated onto ampicillin plates to 
ensure sensitivity to ampicillin was present in the initial culture.  
2.11.2 Plasmid purification from transformed E. coli 
Once bacteria had been transformed, the Qiagen Plasmid Maxi Prep Kit (Qiagen, 
Germany) was used to according to the manufacturer’s protocol to extract plasmid 
DNA. Once extracted, plasmid DNA was dissolved in pH 8.0 Tris-EDTA buffer 
(Sigma-Aldrich Ltd.) and stored at 4°C. The yield and purity of extracted plasmid 
DNA was determined using the Qubit dsDNA high-sensitivity assay (Thermo-Fisher 
Scientific).  
2.11.3 Tumour cell transfection 
Transfection was performed by diluting 3.6 μg of either TOPFLASH or FOPFLASH 
plasmid, combined with 0.36 μg of CMV-Renilla plasmid in 500 μl of OptiMem™ 
medium (Fisher Scientific UK Ltd.). In a separate tube, 18 μl of Lipofectamine 2000 
transfection reagent (Invitrogen, California, US) was diluted in 500 μl of OptiMem, 
and this was then added to each plasmid mix and incubated at room temperature and 
100 rpm in a shaking incubator for 20 minutes. Sub-confluent tumour cells were 
trypsinised and 1.8 x106 cells were resuspended in OptiMem. The transfection mix 
containing either TOPFLASH or FOPFLASH plasmid, in addition to CMV-Renilla 
plasmid, and Lipofectamine 2000 was added to the cell suspension, and cells were 
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immediately seeded into 96-well plates at a seeding density of 1x105 cells/cm2. For 
each cell line, cells transfected with TOPFLASH or FOPFLASH were seeded into a 
96-well plate and incubated for 24 hours at 37°C and 5% CO2.  
2.11.4 Dual-Luciferase® Reporter assay 
Once transfected, cells were grown to confluency before infection with bacteria as 
described in Section 2.3. The Dual-Luciferase Reporter Assay System (Promega, 
Southampton, UK) was then used to quantify luciferase activity from treated cells. 
Cells were washed three times with PBS and 20 μl of passive lysis buffer was added 
to each well. Plates were placed on a shaker at 200 rpm for 1 hour and complete cell 
lysis was visually confirmed using a microscope. Fifty microliters of LAR II reagent 
were added to each well of a black, clear-bottomed 96-well plate (Corning®). Ten 
microliters of lysate were added to the LAR II reagent, and Firefly luminescence was 
immediately measured using a FLUOstar Optima microplate reader (BMG Labtech, 
Bucks, UK) plate reader. Fifty microliters of Stop&Glo® reagent were then added to 
each well and Renilla luminescence activity was recorded. Wells containing 
untransfected cells were used to control for background luminescence and the average 
of these wells was subtracted from all readings. Catenin-related transcription was 
expressed as the ratio of luminescence of TOP:FOP, after normalising for cell number 
using the CMV reporter. 
 
  




2.12 Western blots 
2.12.1 Preparation of protein lysates 
Protein samples were prepared from RG/C2 and HCT116 cells grown in 6-well plates 
and infected as described in Section 2.3. Following infection, cell monolayers were 
incubated for 24 hours under standard conditions. Plates were then placed on ice and 
cells were washed three times with ice-cold PBS, before the addition of 1 ml of ice-
cold lysis buffer to each well. The formulation of all buffers and gels used for Western 
blotting can be found in Table 2.4. Cell monolayers were further disrupted using a cell 
scraper and the lysates were transferred into pre-cooled Eppendorf tubes and incubated 
at 4°C for 30 minutes, whilst being briefly vortex mixed approximately every 5 
minutes. Lysates were then centrifuged at 12,000 xG for 20 minutes at 4°C. 
Supernatants were collected and transferred to fresh, pre-cooled Eppendorf ml tubes 
and stored at -80°C until required.  
2.12.2 Estimation of protein concentrations 
To determine protein concentration, the Bradford assay was used (Bradford, 1976). 
Bovine serum albumin (BSA) protein standards were prepared in sterile ddiH2O at 
concentrations ranging from 0.1-1.5 μg/μl. Five microliters of protein standard or 
protein sample was added to the base of each well in a 96-well plate. Two hundred 
microliters of Bradford reagent (Sigma-Aldrich Ltd.) were then added to each well. 
The binding of protein to Coomassie dye present in Bradford reagent causes a colour 
change from brown to blue, and absorbance of samples after the addition of dye was 
measured at 595 nm using an Infinite 200 microplate reader. The concentration of 
protein within samples was estimated by interpolating with a BSA standard curve 
prepared by measuring the absorbance of known quantities of BSA diluted in ddiH2O 
using the Bradford assay.  




Proteins were separated according to their molecular weight using SDS-
polyacrylamide gel electrophoresis (SDS-PAGE). Resolving gels were prepared to a 
concentration of 10% acrylamide and overlaid with a 4% stacking gel (see Table 2.5). 
Protein samples were prepared by adding 25% loading dye (Sigma-Aldrich Ltd.) and 
0.05% μl β-mercaptoethanol (Sigma-Aldrich Ltd.) to 50 μg of protein, before 
denaturation in a 95°C water bath for 10 minutes. Samples were then loaded into the 
gel, leaving an empty lane between each sample. In addition, 5 μl of protein ladder 
was added to the leftmost lane (Amersham Biosciences plc., Buckinghamshire, UK). 
The gel tank (Bio-Rad Laboratories, California, USA) was then filled with running 
buffer (see Table 2.4). Samples were initially run at 100 V for 20 minutes, or until the 
dye front had passed through the stacking gel. Voltage was then increased to 150 V 
and samples were run for a further 90 minutes.  
2.12.4 Wet transfer and antibody probing 
Following electrophoresis, gels were removed from the tank and the stacking gel was 
removed. Proteins were transferred onto Amersham™ Hybond® 0.45 μm 
polyvinylidene difluoride (PVDF) blotting membrane which had been activated by 
briefly soaking in 100% methanol. PVDF membranes and the remaining resolving gel 
were sandwiched between layers of filter paper, followed by sponge, which had been 
soaked in transfer buffer (see Table 2.4). A roller was used to eliminate air bubbles 
which may have interfered with efficient transfer.  Transfer was performed in a Bio-
Rad transfer tank filled with transfer buffer (see Table 2.4) at 4°C for two hours at     
50 V. Following transfer, membranes were washed three times for 5 minutes in TBST, 
before being blocked for 1 hour in blocking buffer (see Table 2.4). Primary antibodies 
were diluted in blocking buffer and added to membranes in sterile petri dishes, which 




were then placed on a rocker and incubated overnight (16 hours) at 4°C. A summary 
of the primary antibodies used (and their dilutions) is presented in Table 2.6. After 
incubation with primary antibody membranes were washed a further three times with 
TBST and secondary antibody (see Table 2.7) prepared in blocking buffer, was added 
to the membrane. After incubation with secondary antibodies for one hour, membranes 
Table 2.4: A list of buffers used for Western blotting. All buffers were made up in diH2O.  
Buffer Composition  
Cell lysis buffer 150 mM NaCl 
1% Triton X-100 
50 mM Tris 
 1x Protease inhibitor cocktail tablet per 10 ml 
Running buffer 25 mM Tris  
190 mM Glycine  
0.1% SDS 
Transfer buffer 25 mM Tris  
190 mM Glycine  
0.1% SDS  
25% Methanol 
Tris-buffered saline (TBS) – pH 7.5 200 mM NaCl  
19 mM Tris 
Tris-buffered saline + Tween (TBST) 200 mM NaCl  
19 mM Tris 
0.1% Tween-20 
Blocking buffer 5% w/v dried skimmed milk in TBST 
Resolving buffer – pH 8.8 1.5M Tris 
Stacking buffer – pH 6.8 0.5M Tris 
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were imaged using a Li-Cor Odyssey gel imager (Li-Cor, Nebraska, USA). Protein 
bands were identified after exposure to fluorescent light at 600 or 700 nm for 2 minutes 
and densitometry was used to determine relative protein concentrations. 
Table 2.5: Gel compositions used for Western blots.  
10% Resolving gel 4% Stacking gel 
diH2O 6.4 ml diH2O 3.05 ml 
Resolving gel buffer 2.5 ml Stacking gel buffer 1.25 ml 
30% Acrylamide 3.3 ml 30% Acrylamide 650 μl 
10% SDS 100 μl 10% SDS 50 μl 
TEMED 6 μl TEMED 5 μl 
10% APS 100 μl 10% APS 50 μl 
 
Table 2.6: List of primary antibodies used to probe PVDF membranes from proteins of interest.   










1:500 120 kda 







1:500 92 kda 





1:500 72 kda 





1:500 240 kda 







1:2000 50 kda 
 





Table 2.7: Secondary antibodies used for protein visualisation and densitometry using the Li-Cor gel imager.  
Antibody Host Reactivity Supplier Concentration 
IRDye® 800CW Donkey Mouse Li-Cor 1:15,000 
IRDye® 680RD Donkey Mouse Li-Cor 1:15,000 
 
Chapter 2 – Materials and Methods 
80 
 
2.13 Quantitative PCR Microarrays  
Changes in genes expression as a result of bacterial infection were analysed using 
quantitative polymerase chain reaction (qPCR). RG/C2 or HCT116 cells were grown 
to confluency in 6-well plates, before being infected with bacteria as described in 
Section 2.3. RNA was extracted and reverse transcribed into cDNA, which was then 
analysed using Qiagen RT² Profiler PCR Arrays (Qiagen, Germany).  
2.13.1 RNA extraction and cDNA production 
Following infection, RNA was isolated from colorectal tumour cells using the RNeasy 
Mini Kit (Qiagen). Before work with RNA commenced, the biological safety cabinet 
was sterilised with ultraviolet light overnight, and all surfaces were cleaned using 
RNAZap™ (Thermo-Fisher Scientific Ltd.). After isolation and elution of RNA using 
the RNeasy Mini kit, purity was assessed by running samples on a 1% agarose gel 
containing 0.5% ethidium bromide. An equal volume of loading dye was added to        
5 μl of sample, which was run at 100 V until the dye front had travelled sufficiently 
though the gel. Gels were carefully transferred removed and imaged under ultraviolet 
light. The intensity of the 28S and 18S RNA bands were compared, with the intensity 
of the 28S band being approximately double that of the 18S band representing high 
quality RNA. The integrity of the RNA was also assessed by comparing absorbance 
at 260:280 nm using a Nanodrop™ spectrophotometer (Thermo-Fischer) which was 
also used to determine RNA concentration. After quantification, 0.5 μg of sample was 
immediately reverse transcribed into cDNA using the RT² First Strand Kit (Qiagen) 
according to the manufacturer’s instructions. The concentration and purity of cDNA 
was analysed using a Nanodrop™ spectrophotometer. cDNA samples were stored at -
20°C until required.  




2.13.2 RT² Profiler PCR Arrays 
Quantitative PCR was performed using the ABI StepOnePlus system (Applied 
Biosystems, California, USA). Arrays were used to investigate both cell motility and 
epithelial-mesenchymal transition, and the full lists of target primers present in each 
array are described in Supplementary Tables 1 and 2, respectively. SYBR Green 
Mastermix was added to entire cDNA samples as per the manufacturer’s instructions 
and 25 μl of the PCR components were loaded into each well of an RT2 Profiler PCR 
Array microplate (Qiagen). Plates were then loaded into the PCR machine and cycled 
once for 10 minutes at 95°C, followed by 40 cycles of 15 s at 95°C and 1 minute at 
60°C. Threshold values were manually determined and kept constant across similar 
assays.  The layout of these primers in each assay plate is illustrated in Figure 2.3. 
Data was analysed using the Qiagen GeneGlobe Data analysis centre.  






Figure 2.3: RT2 Profiler PCR array format. Wells A1 to G12 contained primers for individual genes. Wells 
H1-H5 contained a housekeeping gene panel to normalize array data (HK1–5), full gene lists for both assay 
can be found in Supplementary Table 1 and 2. Well H6 contained a genomic DNA control (GDC). Wells H7-
H9 contained replicate reverse-transcription controls (RTC). Wells H10-H12 contained replicate positive PCR 
controls (PPC). 




2.14 Statistical analysis 
All data presented in graphical form represent the mean ± standard deviation of the 
mean. Three biological replicates were performed in triplicate for each assay. All data 
analysis and production of graphs was performed using GraphPad Prism 7 for 
Windows, with the exception of the analysis of SIFT-MS data which was performed 
using SPSS. Unless otherwise stated, non-paired T-tests were used to determine 
statistical significance, with a p-value of less than 0.05 considered to be statistically 
significant. Where data has been normalised prior to statistical analysis this is stated 
in the figure legend.
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Chapter 3: Quantifying the interactions between gut 
bacteria and colorectal tumour cells 
3.1. Introduction 
In the healthy colon, homeostasis between the epithelium and the microbiota is 
maintained through spatial separation by host mucins, and the secretion of 
antimicrobial peptides (Schroeder, 2019). Bacterial colonisation is normally restricted 
to the outer mucus layer, as increasing concentration of antimicrobial peptides and 
decreasing mucin pore size nearer the mucosal surface restricts bacterial growth 
(Johansson et al., 2008). However, specific species have become adapted to colonise 
this inner layer, as demonstrated by unique microbiota of the colonic crypts which 
includes Bacteroides fragilis and Akkermansia muciniphila (Swidsinski et al., 2005; 
Donaldson, Lee and Mazmanian, 2015). The spatial organisation of the microbiota is 
altered in CRC, with mucosa-adherent microbial biofilms frequently identified on both 
tumour tissue and paired normal tissue (Kinzler et al., 2014). These biofilms allow 
aberrant colonisation of the inner mucus layer and increase the frequency and duration 
of contact between bacteria and the epithelium (Johansson et al., 2014). Furthermore, 
the formation of mucosal biofilms is thought to provide a niche for invasive species 
such as F. nucleatum, which are not found in biofilm-negative tissue, to colonise the 
colon (Dejea et al., 2018). 
 A key aspect of colonic biofilm virulence is thought to be the increased 
prevalence of invasive microorganisms found within them. This includes B. fragilis 
(Nakano et al., 2008), E. coli (Martin et al., 2004) and F. nucleatum (Strauss et al., 
2011). This invasion of the epithelium, which includes direct invasion of the 
colonocytes and the underlying tissue, is associated with pro-tumorigenic effects. 




Entry of B. fragilis and F. nucleatum into colonic epithelial cells is facilitated by the 
virulence factors BFT and FadA, respectively, which bind to and cleave E-cadherin 
(Saidi and Sears, 1996; Rubinstein et al., 2013). Furthermore, a study of F. nucleatum 
strains isolated from IBD patients demonstrated that strains isolated from inflamed 
tissue possess greater invasive potential than those identified from non-inflamed tissue 
taken from IBD patients or controls (Strauss et al., 2011).  
 Bacterial interactions with host cells, and the ability of bacteria to attach to and 
invade the epithelium is largely dependent upon cell surface architecture, which alters 
dramatically during oncogenesis (Weidle et al., 2011). During the progression from 
healthy epithelium to adenocarcinoma, epithelial surface area, secretion of mucins, 
structure of cellular junctions and expression of surface proteins are all significantly 
altered (Filipe and Branfoot, 1974; Soler et al., 1999; Weidle et al., 2011;  Sewda et 
al., 2016). Therefore, interactions between bacteria and tumour cells are likely to 
change throughout the adenoma-carcinoma sequence (Vogelstein and Kinzler, 1993). 
Studying these interactions in vivo is challenging as both immune development and 
mucus secretion are severely compromised in germ-free models, which influences 
bacteria-epithelium interactions (Cebra, 1999; Johansson et al., 2015). In addition, the 
high cost and time investment can be prohibitive to high throughput experiments. This 
chapter will describe the development of a simple 2D in vitro model for comparing 
the interactions of bacteria with RG/C2 and HCT116 monolayers. This model will 
then be used to quantify the level of attachment and invasion of tumour cells by CRC-
associated bacteria.  
3.2. Aims 
The aim of this chapter was to investigate the differences in the interaction of bacteria 
with benign and malignant colorectal tumour cells.  




• To develop a laboratory model to study the infection of RG/C2 and HCT116 
tumour cells, enabling quantification of any resultant downstream effects using 
the gentamicin protection assay. These included bacterial attachment, 
invasion, and intracellular persistence.  
• To visualise bacteria-tumour interactions using confocal microscopy and 
scanning electron microscopy, to gain insight into bacterial binding to tumour 
cell surfaces and sub-cellular localisation.  
• To determine how interaction with mucin alters bacterial growth, to inform the 
future development of a laboratory model more closely mimicking in vivo 
conditions.  
  





3.4.1. Benign and malignant colorectal tumour cells display distinct 
morphologies in vitro  
When developing a co-culture model for colorectal tumour cells and gut bacteria, it 
was important to work with confluent monolayers to best imitate in vivo conditions. 
The ability of RG/C2 adenoma cells to form monolayers in vitro was compared with 
the adenocarcinoma cell lines HCT116, HT29 and SW480. Cells were seeded at equal 
seeding densities and imaged at 24-hour intervals using phase contrast microscopy 
(Figure 3.1). The three adenocarcinoma cell lines readily attached to the surface of the 
cell culture well. Clear evidence of cell division was visually observed within 24 
hours, and confluent monolayers formed within 72 hours. In contrast, a visual increase 
in RG/C2 cells was not observed until 72 hours post-seeding. Furthermore, the visual 
inspection of plates revealed numerous floating cells and cellular debris, indicative of 
reduced viability. To determine the time necessary for RG/C2 cells to reach 
confluency, cultures were continued with media changes every 48 hours. After 2 
weeks of continuous culture, RG/C2 cells formed large islands which eventually began 
to merge with adjacent colonies to form a confluent layer. In contrast to the 
adenocarcinoma cell lines which appeared to form single cell-thick monolayers, 
RG/C2 cultures appeared to grow in three dimensions. 
 Future experiments primarily used the RG/C2 and HCT116 cell lines. To 
further investigate the structural differences present in RG/C2 and HCT116 
monolayers, cells were examined using confocal laser scanning microscopy (CLSM). 
The actin cytoskeleton was stained, and colonies were imaged in series at 0.3 μm 
intervals which enabled the creation of three-dimensional reconstructions. RG/C2 
cells grew in layers 4-5 cells thick (Figure 3.2A), whereas HCT116 cells were 
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confirmed to grow as single cell-thick monolayers (Figure 3.2B). Confocal 
microscopy also revealed differences in individual cell morphology between RG/C2 
and HCT116 cells. RG/C2 cells were rounded, and DAPI counterstaining showed that 
the nucleus dominated the intracellular space. In contrast, much larger angular 
cytoskeletons were observed in HCT116 cells which displayed numerous projections.  





Figure 3.1: A comparison of the monolayer forming capabilities of colorectal adenocarcinoma and 
adenoma cell lines. Four colorectal tumour cell lines were seeded into 6-well plates at a seeding density of 
4x104 cells/cm2. Adenocarcinoma cell lines (HCT116, HT29, SW480) showed high viability after seeding, and 
rapidly formed confluent monolayers. RG/C2 cells formed smaller, isolated colonies, which grew at a 
significantly slower rate. Images were taken at 100 x objective using a Leica phase contrast microscope and 
are representative of three independent experiments. Scale bar represents 20 μm. 















































































































































































































































































3.4.2. Co-culture with bacteria does not impact tumour cell viability 
Before attempting to quantify bacterial interactions with tumour cell monolayers, the 
impact of bacterial infection on RG/C2 and HCT116 tumour cell monolayers was 
assessed using the MTS assy. The reduction of tetrazolium in the MTS assay reagent 
produces a soluble formazan dye and causes a detectable colour change. This reaction 
is performed by NADPH-dependent enzymes in metabolically active cells, and the 
resulting colour change provides an indication of cell viability.  
Bacteria were added to confluent tumour cell monolayers at multiplicities of 
infection (MOIs) of 10:1, 100:1 and 1,000:1. Following a 4-hour incubation period, 
no significant reduction in cell viability was observed in RG/C2 or HCT116 cells 
treated with B. fragilis, E. faecalis or F. nucleatum (Figure 3.3). However, a reduction 
in cell viability was observed in RG/C2 cells co-cultured with E. coli Nissle (Figure 
3.3B), with a 40% reduction observed at an MOI of 10:1 and 100:1. Conversely, 
absorbance in wells containing HCT116 cells increased as a result of bacterial co-
culture, with significant increases observed in cells cultured with E. coli Nissle (Figure 
3.3B) and E. faecalis (Figure 3.3C) at an MOI of 1,000:1. Over the course of the assay, 
monolayers were also visually inspected under a light microscope to monitor 
observable changes in cell morphology and appearance. However, no visible changes 
to the tumour cell monolayers were observed under any condition (data not shown). 
As the 1-hour MTS reagent incubation period would not have been sufficient for cell 
division to occur, the observed increases in tetrazolium reduction are hypothesized to 
be as a result of altered cellular metabolism in response to bacterial infection.  
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  Figure 3.3: Viability of RG/C2 and HCT116 monolayers after bacterial co-culture. The effect of B. fragilis 
(A), E. coli Nissle (B), E. faecalis (C) and F. nucleatum (D) on cell viability was measured using the MTS 
assay. Data expressed as normalised absorbance at an optical density of 500 nm. Error bars represent standard 
deviation and data represents the results of three independent experiments performed in triplicate. (T-test: * = 









































































































































3.4.3. Bacterial attachment to colorectal tumour cell monolayers is 
dependent upon tumour cell type 
To study the interactions between tumour cell monolayers and bacteria, RG/C2 and 
HCT116 cells were grown in 96-well plates and infected with bacteria at an MOI of 
1,000:1. Prior to infection, confluency was confirmed by visual inspection under a 
light microscope. The survival and viability of the selected bacterial species in DMEM 
cell culture media under aerobic conditions was confirmed via serial dilution and 
Miles and Misra counting after a 4-hour incubation (Supplementary Figure 1). This 
revealed that all species remained viable for the entire 4-hour duration. Following this, 
the gentamicin protection assay was used to quantify bacterial attachment and invasion 
of tumour cell monolayers (see Materials and Methods 2.3). The total number of 
bacteria attached to the monolayer surface was calculated by subtracting intracellular 
bacterial cfu from the total associated bacterial cfu. Both attachment and invasion were 
expressed as the total cfu present in the whole lysate.  
 These results show that all four species readily adhered to the surface of RG/C2 
and HCT116 tumour cells (Figure 3.4). Bacteria were present on the cell surface in the 
range of 1x104-1x107 total cfu, with approximately 3x105 tumour cells present in both 
RG/C2 and HCT116 monolayers. Therefore, the estimated number of bacteria per cell 
ranged from 0.03-33 across all species.  Despite all bacteria being initially added to 
the culture at an MOI of 1000:1, replication of the facultative anaerobes E. coli Nissle 
and E. faecalis during aerobic incubation led to an increased bacterial load at the end 
of treatment. This may be responsible for the much higher total cfu when compared 
with the strict anaerobes B. fragilis and F. nucleatum, making direct comparison 
between bacterial species difficult. However, when analysing each species in isolation, 
clear differences were observed in bacterial attachment to RG/C2 and HCT116 
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monolayers. Attachment of B. fragilis (p = 0.0015), E. coli Nissle (p = 0.0049), E. 
faecalis (p = 0.050) and F. nucleatum (p < 0.001) was significant higher for RG/C2 
monolayers compared to HCT116 monolayers. An increase of >50% was observed 
across each species, suggesting that the cellular characteristics specific to the benign 
RG/C2 cell line are able to promote the adhesion of bacterial cells to their surface.  
  












































































Figure 3.4: Attachment of bacteria to colorectal tumour cell monolayers. B. fragilis (A), E. coli Nissle 
(B), E. faecalis (C) and F. nucleatum (D) were co-cultured with tumour cell monolayers at an MOI of 1000:1 
for 4 hours. After incubation, monolayers were washed with PBS to remove non-associated bacteria, lysed and 
serial dilutions were enumerated onto blood agar plates. Total attachment was calculated by subtracting 
intracellular bacteria from total associated bacteria. Bacterial numbers are expressed as total colony forming 
units present in the whole lysate. Error bars represent standard deviation and data represents the results of three 
independent experiments performed in triplicate. (T-test: * = p < 0.05, ** = p < 0.01, *** = p < 0.001).  
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3.4.4 Imaging the attachment of bacteria to HCT116 cells 
To visualise the attachment of bacteria to tumour cells, HCT116 cells were grown to 
60-70% confluency on 10 mm glass coverslips and were imaged via scanning electron 
microscopy (SEM). The dehydration process required for SEM sample preparation 
causes cell shrinking, which can result in the tearing of cells in regions of high cell 
density. Therefore, only regions containing clearly identifiable isolated cells were 
chosen for imaging. Figure 3.5 illustrates that these isolated HCT116 cells display a 
rounded morphology, with small projections on the upper cell surface providing a 
larger surface area. Longer, filament-like projections appear to be anchoring the cells 
to the slide surface. These structures are thought to be filopodia; however, many of 
these structures appear to have been damaged and/or distorted by dehydration.  
 All four species tested clearly adhered to the cell surface (Figure 3.5, white 
arrows), and this adhesion was strong enough to remain intact during washing, 
fixation, and dehydration. B. fragilis and F. nucleatum (Figure 3.5B and 3.5E) 
appeared to attach to HCT116 cells in small numbers, in contrast to the multicellular 
aggregates of E. coli Nissle and E. faecalis (Figure 3.5C and 3.5D, black arrows). 
These aggregates, in addition to the visible bacterial cells present on the glass surface, 
would suggest that co-aggregation between bacterial cells plays a key role in 
facilitating the attachment of these species in large numbers. However, it was also 
demonstrated that these species multiply under the experimental conditions 
(Supplementary Figure 1), and it is therefore possible that these aggregates are the 
result of bacterial cell division. F. nucleatum cells ranged in size from 5-30 μm, in 
contrast to B. fragilis, E. coli Nissle and E. faecalis cells which were approximately 1 
μm in diameter. Furthermore, F. nucleatum attachment appeared to span multiple 
tumour cells (Figure 3.5E). Large F. nucleatum cells were observed in contact with 




multiple tumour cells and the surface of the glass coverslip, whereas cells of 
approximately 5 μm in length were observed in full contract with the tumour cell 
surface. This suggests that individual cell morphology may be an important 
determinant of F. nucleatum interaction with epithelial cells. No rupture of HCT116 


















































































































































































































































































































3.4.5. RG/C2 and HCT116 colorectal tumour cells are readily invaded by 
gut bacteria 
The gentamicin protection assay was also used to quantify the number of bacteria 
which invaded colorectal tumour cells. After a 4-hour infection period, monolayers 
were washed with PBS before being treated with 300 μg/ml gentamicin and 200 μg/ml 
metronidazole to eliminate extracellular bacteria. Antibiotic concentrations were 
based upon recommendations from the literature and optimised before beginning the 
assay (Rubinstein et al., 2013; Supplementary Figure 2). All four species tested were 
able to invade both RG/C2 and HCT116 cells. Invasion of B. fragilis was higher in 
RG/C2 monolayers, whereas E. coli Nissle, E. faecalis and F. nucleatum showed 
significantly higher invasion when co-cultured with HCT116 monolayers (Figure 3.6). 
Invasion by all species was approximately 100-fold lower than attachment after a 4-
hour infection period, with the exception of F. nucleatum where more intracellular 
bacteria were recovered than surface bacteria in HCT116, and numbers were 
comparable for RG/C2.  
 To visualise bacterial invasion, bacteria were pre-stained with 
carboxyfluorescein (CFSE) before being added to tumour cell cultures. CFSE 
effectively stained all four species tested, however, there was some variability both 
between species and between samples. The anaerobic species B. fragilis and F. 
nucleatum showed the best stain retention, whereas E. coli Nissle and E. faecalis 
staining was less clear and exhibited increased background (e.g. Figure 3.8D). In some 
cases, non-stained E. coli Nissle and E. faecalis where observed, evidenced by DAPI 
staining without CFSE detection (not shown). This could be attributed to incomplete 
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staining of the initial culture or bacterial cell division generating unstained daughter 
cells.  
 Figures 3.7-3.10 illustrate representative CLSM micrographs taken of infected 
tumour cells immediately after a 4-hour infection period. Intracellular bacteria were 
detected between the stacks stained with phalloidin, definitively proving that the 
bacteria are either intracellular, or are within the intercellular space. In all cases (e.g. 
Figure 3.7B, 3D reconstructions of Z-stacks demonstrated that bacteria are able to 
penetrate the cell colony to reach the basal surface. As described in Section 3.1, the 
morphology of RG/C2 and HCT116 cells differs, with RG/C2 cells growing in 
colonies 2-4 cells deep, in comparison to HCT116 cells which grow as single cell-
thick monolayers. In infected RG/C2 cells, bacteria were detected at multiple locations 
within the cell colony, best illustrated by F. nucleatum-infected cells (Figure 3.10B). 
The increased cell density and intercellular spaces may represent an additional niche 
provided by benign tumour cells for bacteria, or could be an indicator of increased 
invasion time needed to reach the basal layer due to the density of the cell layer. In 
summary, CFSE staining provided an inexpensive and simple proof of the presence of 
intracellular bacteria, particularly for anaerobic species.  
  














































































Figure 3.6: Invasion of gut bacteria in RG/C2 and HCT116 tumour cell monolayers. Cells were cultured 
with B. fragilis (A), E. coli Nissle (B), E. faecalis (C) and F. nucleatum (D) for 4 hours, before being washed 
and treated with 300 μg/ml gentamicin and 200 μg/ml metronidazole for 1 hour to eliminate extracellular 
bacteria. Monolayers were then washed and lysed, with serial dilutions being enumerated onto blood agar 
plates. Bacterial numbers are expressed as total colony forming units present in the whole lysate. Error bars 
represent standard deviation and data represents the results of three independent experiments performed in 
triplicate. (T-test: * = p < 0.05, ** = p < 0.01, *** = p < 0.001).  
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3.4.6 Intracellular bacteria persist within colorectal tumour cells 
Once invasion of tumour cell monolayers had been established, the ability of the 
bacteria to survive and remain viable within tumour cells over extended time periods 
was assessed. After co-culturing cell monolayers and bacteria for 4 hours, extracellular 
bacteria were eliminated with antibiotics. Fresh media was added, and total 
intracellular bacteria were quantified every 24 hours (see Materials and Methods 2.3). 
Monolayers were visually inspected for signs of damage/cell death, with bacterial 
infection having no visually observable effects on tumour cell morphology or 
appearance over the 96-hour incubation period.  
 Monolayers infected with B. fragilis experienced no significant change in 
bacterial load for the first 48 hours (Figure 3.10A). After this time, there was a 
significant decrease in the remaining viable bacteria in RG/C2 monolayers (p = 0.022). 
In comparison, there was no significant reduction in B. fragilis within HCT116 
monolayers until 96 hours (p = 0.013). The total viable cfu of E. coli Nissle did not 
significantly change in either cell line over the course of the 96-hour incubation period 
(Figure 3.11B). Similarly, E. faecalis cfu did not significantly decrease in either cell 
line until 96 hours post-infection in RG/C2 cells (p = 0.0004). F. nucleatum exhibited 
the lowest overall survival of the tested species across both cell lines, with no viable 
cfu recovered in RG/C2 monolayers after 72 hours or in HCT116 monolayers after 96 
hours (Figure 3.11D). With the exception of a non-significant increase B. fragilis cfu 
recovered from HCT116 monolayers between 24-72 hours, no increases in bacterial 
cfu were recorded for any species. This suggests that bacteria are not able to replicate 
within the tumour cells. 
 As highlighted in Figure 3.6, initial invasion of RG/C2 and HCT116 
monolayers was statistically different in all four species, and this corresponds to the    




0-hour time point presented in Figure 3.11. To determine whether the survival of 
intracellular bacteria was statistically different in RG/C2 and HCT116 monolayers, a 
two-way ANOVA was performed to analyse the relationship between bacterial 
survival and host tumour cell line, accounting for differences in total starting cfu. With 
the exception of E. coli Nissle, where the tumour cell line had no effect on bacterial 
survival (p = 0.756), survival of each species was significantly higher in HCT116 
monolayers (p values illustrated on Figure 3.11). These results demonstrate that once 
infection of tumour cell monolayers has occurred, all species tested are able to survive 
within the intracellular space under standard cell culture conditions for a minimum of 
24 hours. Therefore, viable intracellular bacteria will be present within tumour cells 
throughout the duration of all future downstream experiments.  
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Figure 3.11: Persistence of bacterial within colorectal tumour cell monolayers. After initial infection with 
bacteria, co-cultures were continued in the presence of antibiotics to prevent the growth of extracellular 
bacteria. Monolayers were lysed at 24-hour intervals and viable bacteria enumerated onto blood agar plates. 
The survival of each species within RG/C2 and HCT116 monolayers was compared using a two-way ANOVA 
(inset). Error bars represent standard deviation and data represents the results of three independent experiments 
performed in triplicate. (Two-way ANOVA: * = p < 0.05, ** = p < 0.01, *** = p < 0.001).  




3.4.7. Gastrointestinal mucin has the potential to promote biofilm 
formation in vitro 
In the colon, the epithelium is protected by two layers of mucus which serve as a 
substrate for bacterial growth and acts as a barrier to limit direct contract between the 
epithelium and the microbiota (Schroeder, 2019). To investigate whether the addition 
of mucins could promote a more in vivo-like phenotype in the tested bacteria, the effect 
of mucins on biofilm formation was quantified using the crystal violet biofilm 
formation assay (O’Toole, 2011). Three species, B. fragilis, E. coli Nissle and                
F. nucleatum displayed a dose-dependent increase in biofilm formation when grown 
in the presence of porcine mucin. In all cases, the increase in biofilm formation was 
statistically significant at a mucin concentration of 1.0%, compared to the 0% control 
(Figure 3.12). F. nucleatum biofilm formation was also significantly increased at 
lower mucin concentrations of 0.4, 0.6 and 0.8% (Figure 3.12D). Interestingly, in the 
absence of mucin, F. nucleatum formed weak biofilms under these experimental 
conditions. Mucin had no effect on the biofilm forming capabilities of E. faecalis, 
which despite having the highest absorbance readings showed a high of degree 
variability (Figure 3.12C). These data suggest that the relative abundance of mucin at 
the mucosal surface may promote bacterial biofilm formation but is not essential for 
all species.  
  



























































Figure 3.12: The effect of mucin on bacterial biofilm formation. B. fragilis (A), E. coli Nissle (B), E. 
faecalis (C) and F. nucleatum (D) were cultured in BHI broth containing increasing concentrations of porcine 
mucin type II. Biofilms were quantified using the crystal violet staining method after 48 hours of growth under 
anaerobic conditions. Error bars represent standard deviation and data represents the results of three 
independent experiments performed in triplicate. (T-test: * = p < 0.05, ** = p < 0.01).  
 





The adenoma-carcinoma sequence in CRC normally unfolds over several decades, and 
the colonic mucosa is in constant contact with the microbiome throughout this process 
(Vogelstein and Kinzler, 1993). CRC has been associated with changes in the relative 
abundance of microbiota species (dysbiosis), and colonisation by species that are not 
present in the normal colonic microbiota e.g. F. nucleatum (Chen, Domingue and 
Sears, 2017). In CRC bacteria are found in closer proximity to the mucosa, at increased 
abundance in privileged sites such as the colonic crypts, and directly within tumour 
tissue (Weinberg et al., 2020). The formation of mucosal biofilms characterised by the 
presence of highly invasive species has also been implicated in CRC development 
(Drewes et al., 2017). Bacterial invasion of the colonic epithelium involves the 
targeting of cell surface and junction proteins such as E-cadherin, which triggers pro-
tumorigenic downstream effects (Guo et al., 2020). Furthermore, the presence of 
invasive bacteria in direct contact with the epithelium has been shown to correlate with 
indirect mechanisms of microbe-induced tumorigenesis including induction of chronic 
inflammation and remodelling of the microbiota (Strauss et al., 2011; Hajishengallis, 
Darveau and Curtis, 2012). Distinct microbial populations are associated with 
different stages of CRC progression (Mori et al., 2018); and as CRC progresses, 
changes in cell architecture and the tumour microenvironment may alter the 
interactions of these invasive bacteria with the epithelium (Li et al., 2020). The Driver-
Passenger model suggests that these stage-specific changes may alter the phenotype 
of tumour-associated microorganisms (e.g. increased toxin production), and that 
specific species may act as drivers or passengers at different stages of CRC (Tjalsma 
et al., 2012). Therefore, the interactions between bacteria and benign adenomas may 
be vastly different from those with malignant adenocarcinomas.  
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 The main aim of this chapter was to investigate whether the interactions of 
three species associated with CRC and one probiotic species differed between the 
benign RG/C2 and malignant HCT116 cell lines. As demonstrated in Figure 3.1, there 
is a marked difference in the morphology of adenoma and adenocarcinoma cells 
cultured in vitro, suggesting that the bacteria-tumour relationships may shift during 
this transition due to the altered surface architecture and presence of cell surface 
molecules. Adenocarcinoma cell lines rapidly reached confluency in the culture 
vessel, growing in uniform two-dimensional layers. However, the RG/C2 cell line 
displayed slower growth, with irregular colonies. Initial adherence of RG/C2 cells to 
the surface of the culture plate was also lower, resulting in an extended lag time for 
cell growth. The confocal micrographs presented in Figure 3.2 illustrate how HCT116 
cells remain as single-cell thick cultures regardless of their confluence. In comparison, 
RG/C2 cells readily grow outwards on the Z axis, often before spreading outwards to 
cover the surface of the culture vessel.  
 Before beginning to quantify how bacteria attach to and invade colorectal 
tumour cell monolayers, it was important to establish that the selected bacterial species 
remained viable under the experimental conditions. It was empirically determined that 
all test bacterial species could survive within DMEM cell culture medium 
(Supplementary Figure 1). Furthermore, suspension in cell culture media did not 
impact the viability of the obligate anaerobes during the 4-hour infection period. This 
is supported by current literature which states that both B. fragilis and F. nucleatum 
can tolerate oxygen at low concentrations. B. fragilis has been demonstrated to survive 
and be able to replicate at nanomolar levels of oxygen (Baughn and Malamy, 2004). 
Furthermore, tolerance to atmospheric oxygen has been suggested as a key 




characteristic of F. nucleatum which enables it to act as a ‘bridge organism’ that allows 
stricter anaerobes to colonise the oral cavity (Okuda et al., 2012).  
 The impact of bacterial infection on colonic tumour cell viability was also 
investigated. Tumour cell death during the gentamicin protection assay may cause 
inaccurate estimations of bacterial attachment and invasion; and it was also important 
to establish the feasibility of using infected tumour cells in downstream experiments. 
The MTS assay demonstrated that no significant reduction in tumour cell viability 
occurred when tumour cells were co-cultured with bacteria. This is surprising, as some 
adverse effect on tumour cell viability would be expected during bacterial infection. 
B. fragilis, E. coli Nissle and F. nucleatum are Gram negative bacteria, with outer cell 
walls containing lipopolysaccharide (LPS) which has been demonstrated to induce the 
production of pro-inflammatory mediators TNF-α and IL10 in Caco-2 monolayers 
(Stephens and von der Weid, 2020). Furthermore, production of LPS by B. fragilis is 
significantly higher under aerobic conditions (Chmelař et al., 2016). E. faecalis is also 
able to induce cell damage through the production of genotoxic compounds e.g. 
superoxide (Wang et al., 2008). The lack of a reduction in cell viability observed 
through the MTS assay, or via microscopic inspection, suggests that the tumour cells 
tested are not significantly impacted by the aforementioned factors, or that these 
factors are not apparent under these experimental conditions. It is however important 
to consider that the MTS assay is based upon cellular metabolism and is therefore an 
indirect measure of cell viability. It is possible that stress placed on tumour cell 
monolayers by bacterial infection may have triggered metabolic shifts, which may 
obscure the true effect on viability. To account for this, an additional measure of cell 
viability could have been performed such a CellTiter-Glo or Annexin V staining. 
Despite the limitations of the MTS assay, the lack of any obvious indicator of a 
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detrimental effect on tumour cell viability provided confidence in the suitability of the 
model for investigating bacteria-tumour cell interactions and the resulting effects on 
tumour cell behaviour.  
 Once it was established that both bacteria and tumour cells remained viable 
after 4 hours of co-culture under standard cell culture conditions, bacterial attachment 
and invasion of tumour cell monolayers were quantified. For all species tested, 
bacterial adhesion to colorectal tumour cells was significantly higher in RG/C2 co-
cultures, although significant adhesion to HCT116 monolayers was also observed. 
Many of the species investigated in this study have previously been reported to bind 
to E-cadherin, expression of which is higher in colorectal adenomas than 
adenocarcinomas (Rees and Qualtrough, unpublished data). Furthermore, this 
increased attachment could be attributed to a possible larger surface area of RG/C2 
colonies, which in contrast to the flat monolayers formed by HCT116 cells grow 
outwards and form three dimensional structures. One caveat of the co-culture model 
is the proliferation of facultative anaerobes during incubation impacting cfu counts. 
Additionally, Figure 3.5 demonstrates that co-aggregation of E. coli Nissle and E. 
faecalis cells also occurs at the tumour cell surface. It is unclear what effect bacterial 
replication and co-aggregation may have on the cfu counts for bacterial attachment; 
however, their proximity to the tumour cell surface means that they may remain 
capable of influencing tumour cell behaviour through signalling to adjacent bacteria 
and secretion of metabolites.  
 Invasion of tumour cell monolayers was assessed using the gentamicin 
protection assay. Invasion of HCT116 monolayers by bacteria was higher than RG/C2 
monolayers for all species, with the exception of B. fragilis. It could be expected that 
higher levels of attachment to the tumour cell surface would facilitate increased 




invasion into the cell (see Figure 3.4); however, it is possible that invasion of HCT116 
cells occurs at a faster rate, whereas bacteria are blocked from entering RG/C2 cells. 
Also surprising was the apparent virulence of the probiotic E. coli Nissle, which 
displayed both adhesion and invasion to both cell lines. However, sepsis induced by 
E. coli Nissle has been previously reported (Guenther et al., 2010), and its 
pathogenicity is thought to be heavily influenced by the microbiota and immune status 
of the host (Gronbach et al., 2010).  
Evidence of invasion was also demonstrated via CLSM. In all cases, bacteria 
were found within the tumour cell monolayer; however, it is unclear whether the 
detected bacteria were present within the cytoplasm or within the intercellular space. 
Nevertheless, in vitro this invasion protects the bacteria from antibiotics used 
throughout the gentamicin protection assay and atmospheric oxygen. In vivo, this 
intra-tumour environment may provide bacteria with a metabolic niche and protection 
from the immune system. Several bacteria cells could be seen at the basal region of 
the tumour monolayer, highlighting the ability of these bacteria to rapidly penetrate 
through multiple tumour cells within the 4-hour incubation period. CRC formation is 
associated with aberrant tight junction regulation and an increase in intestinal barrier 
permeability which may facilitate bacterial invasion of underlying tissue (Soler et al., 
1999). Furthermore, bacteraemia caused by CRC-associated species, including            
B. fragilis and F. nucleatum, has been linked to subsequent CRC diagnosis (Kwong et 
al., 2018). This suggests that the increased prevalence of species such as B. fragilis 
and F. nucleatum may be attributed to changes in the tumour microenvironment which 
facilitate bacterial proliferation and dissemination. 
 When investigating invasion of tumour cells by different bacterial species, it 
is important to consider that methods of entry into epithelial cells may differ. The 
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gentamicin protection assay is unable to discriminate between active bacterial invasion 
and phagocytosis of bacteria by the epithelial cells themselves. Non-professional 
phagocytes, such as colonocytes, do not possess the receptors necessary for opsonic 
phagocytosis, instead bacterial pathogens trigger their endocytosis by reorganising the 
host cytoskeleton (Günther and Seyfert, 2018). Electron micrographs appeared to 
show B. fragilis, E. coli Nissle and E. faecalis cells being encapsulated by pits on the 
tumour cell surface. However, single F. nucleatum cells appeared to span multiple 
tumour cells and only partially penetrate the cell surface. This is likely attributable to 
the unusually large size of F. nucleatum cells, which are on average 5-10 μm long, but 
were observed at lengths up to 30 μm in this study. This perhaps necessitates a 
different mode of entry into host cells compared to the other test species which are 1-
2 μm in diameter. It could be hypothesised that F. nucleatum cells only penetrate the 
intercellular space; however, intracellular F. nucleatum have been demonstrated in 
numerous previous studies, and it is thought that reorganisation of the tumour cell 
cytoskeleton is key it its invasion (Gursoy, Könönen and Uitto, 2008; Ji et al., 2010). 
 Bacterial pathogens utilise multiple pathways in order to invade host cells. For 
example, F. nucleatum has been suggested to exclusively invade epithelial cells via 
the “zipping” mechanism, whereby close contact between bacteria and epithelial cells 
leads to interactions between bacterial surface proteins, with host proteins triggering 
cytoskeletal rearrangements (Han et al., 2000). In contrast, species such as E. faecalis 
are able to employ multiple mechanisms to invade epithelial cells including receptor-
mediated endocytosis and the induction of membrane ruffling (Bertuccini et al., 2002). 
Differences in cell architecture and cell surface receptors between benign and 
malignant cells are likely to impact bacterial virulence. For example, attachment and 
invasion of both B. fragilis and F. nucleatum is thought to be mediated by binding to 




E-cadherin (Rubinstein et al., 2013; Devaux, Mezouar and Mege, 2019). Expression 
of E-cadherin is downregulated during CRC progression (Khoursheed et al., 2003); 
therefore, it would be expected that these species show a greater capacity to invade 
benign RG/C2 cells than malignant HCT116 cells due to their higher levels of E-
cadherin (Qualtrough 2021, personal communication). The gentamicin protection 
assay results presented in this project are contrary to this and suggest that other factors 
may play a pivotal role in influencing bacteria interactions with tumour cells.   
 In addition to intracellular invasion, the results of this study successfully 
demonstrated that the four species tested were able to survive, and remain viable, 
within tumour cells for a period of at least 24 hours. Persistence of B. fragilis,                  
E. faecalis and F. nucleatum was significantly higher in HCT116 monolayers, whereas 
no significant difference was found in the persistence of E. coli Nissle between the 
benign and malignant tumour cells (Figure 3.11). Persistence of intracellular bacteria 
at high levels may be specific to tumour/epithelial cell type. A study of F. nucleatum 
degradation in gingival epithelial cells found that bacterial cells are rapidly 
internalised within endosome and lysosome structures before being degraded (Ji et al., 
2010). Genes encoding lysosomal proteins such as cathepsin B are frequently 
dysregulated in CRC, and therefore bacteria may benefit from improper endosome 
formation (Campo et al., 1994). Furthermore, increased microbial tumour load is not 
specific to CRC, and Nejman et al. (2020) found that cancers including ovarian, breast, 
pancreas and brain all harbour unique microbiotas, with bacteria found at significantly 
higher abundancies than in paired normal tissues (Nejman et al., 2020). It is therefore 
likely that the tumour cell intracellular environment is more conducive to bacterial 
survival than that of normal tissue; however the exact mechanism of bacterial survival 
is yet to be elucidated.  
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 None of the bacteria analysed are considered to be intracellular pathogens. It 
is therefore not surprising that, with the exception of B. fragilis in HCT116 
monolayers, no increase in intracellular bacterial cfu representative of bacterial 
replication was observed. In all species, bacterial survival decreased after 96 hours of 
incubation, suggesting that the bacteria cannot survive indefinitely within the tumour 
cells in this model. It has previously been reported that secondary tumours arising 
from CRC harbour unique microbiomes consistent with those found within the 
primary tumour (Bullman et al., 2017). Thus, it is likely that bacteria are able to 
survive within tumour cells for much longer periods in vivo. This limitation is possibly 
a result of unidentified selection pressures present in the culture conditions. 
Furthermore, penicillin-streptomycin was added to the culture medium to prevent 
outgrowth of facultative anaerobes released from tumour cells from obfuscating 
counts of intracellular bacteria. Therefore, bacterial cells which persisted within 
tumour cells and subsequently translocated to the media (either through active 
movement or tumour cell lysis) would not have been counted in this assay. A further 
limitation is the inability to detect intracellular bacteria which are viable but non-
culturable, a phenotype adopted by bacteria facing adverse environmental conditions 
that has been found in E. coli and other pathogenic species (Zhang et al., 2018). To be 
absolutely certain of the absence of bacteria after prolonged time periods in this model, 
more sensitive non-culture-based techniques such as 16S rRNA sequencing or 
fluorescence in situ hybridisation should be used. However, the confirmation that 
bacteria persist for a minimum of 24 hours in this model highlights its suitability as a 
means of studying the effects of bacterial infection on tumour cell behaviour in 
downstream assays. To the author’s knowledge, these data represent the first 




demonstration of in vitro intracellular persistence within colon tumour cells for these 
species. 
 In order to progress this model, the addition of factors which better imitate in 
vivo conditions is needed. Colonic mucin is a key regulator of the intestinal microbiota, 
providing both a habitat and nutrient source for microbial colonisation (Schroeder, 
2019). The formation of biofilms in the mucus layer is highly relevant to colorectal 
tumorigenesis, with mucosal biofilms observed almost universally in patients with 
proximal CRC (Kinzler et al., 2014). Furthermore, mucosal biofilms from both 
healthy and CRC hosts were able to induce inflammation and tumour formation when 
transplanted into healthy mice (Tomkovich et al., 2019). This suggests that the 
phenotype of biofilm-resident bacteria is more tumorigenic than that of non-biofilm 
growing cells, and that the formation of biofilms on normal colon tissue is a precursor 
to carcinogenesis. In addition, a key difference between the RG/C2 and HCT116 cell 
lines is the formation of mucin droplets by RG/C2, and so the RG/C2 cell line better 
represents the mucosal barrier observed in vivo (Paraskeva et al., 1989) To determine 
if the presence of mucin glycoproteins could alter bacterial phenotype, the ability of 
bacteria to form biofilms with and without mucin was determined. The results of this 
assay demonstrate that the presence of mucin promotes biofilm formation in three of 
the species tested. Although this was not the case for E. faecalis, mucin had no 
detrimental effect on its biofilm-forming capabilities and other unobserved phenotypic 
changes relevant to CRC may have been present e.g. altered metabolite production. 
Therefore, the addition of mucin promotes a bacterial phenotype more representative 
of that seen in vivo; and should be considered for future work to more accurately 
investigate the role of these bacteria in CRC.  
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 In conclusion, the results presented in this chapter clearly demonstrated the 
differences in the interactions of bacteria with benign and malignant tumour cells. 
These differences may be attributed to the differing morphology of RG/C2 and 
HCT116 cells as demonstrated by phase contrast microscopy and CLSM, although 
future investigation of tumour cell surface proteins would be required to fully explore 
this phenomenon. Despite high levels of bacterial attachment to cell surfaces, RG/C2 
monolayers experienced lower bacterial invasion, and were less conducive to 
harbouring viable bacteria over prolonged time periods than HCT116 cells. This 
suggests that more advanced tumours may be more permissive to pathogenic bacteria 
in vivo. It is important to consider that these experiments were performed using 2D 
co-culture techniques, and therefore the impact of the colonic tumour 
microenvironment, the immune system and other microorganisms has not been 
addressed. Furthermore, while the specific microbiotas of CMS1, CMS2 and CMS3 
tumours have been established, there is less data available concerning microbial 
composition of CMS4 tumour, to which the HCT116 cell line belongs (Purcell et al., 
2017). Despite these limitations, clear differences in bacterial interaction between 
tumour cell lines representing benign adenomas and malignant carcinomas were 
observed. The effects of these bacterial interactions and their implications for tumour 
progression will be explored in Chapter 4 and Chapter 5. 
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Chapter 4: Bacterial infection increases tumour cell yield 
and induces metabolic changes in colorectal tumour cells 
4.1. Introduction 
Of the six hallmarks of cancer proposed by Hanahan and Weinburg (2000), four are 
concerned with sustaining cell growth and avoiding cell death. In 2011 these hallmarks 
were expanded to include both immune evasion and, notably, deregulation of cellular 
metabolism (Hanahan and Weinberg, 2011). Increased cellular proliferation and 
inhibition of apoptosis, in addition to the metabolic reprogramming which facilitates 
these changes, are therefore essential to tumour formation. In colorectal 
carcinogenesis, reduced apoptosis at the mucosal surface is a key early event (Moss et 
al., 1996). Furthermore, an increased rate of proliferation facilitates the acquisition of 
pro-oncogenic mutations, which are then selected for through successive cell 
divisions. From a clinical perspective, tumour size has a direct impact on patient 
prognosis, with larger tumours being associated with an increased frequency of lymph 
node involvement and higher mortality (Mejri et al., 2017).  
The tumour microenvironment (TME) plays a vital role in cancer progression, 
with microorganisms being a fundamental component of this TME in CRC. Numerous 
species of bacteria have demonstrated CRC-potentiating properties, and APCmin 
mouse models have demonstrated that tumour-associated microorganisms are able to 
induce cancer within disease-free colonic tissue (Kostic et al., 2013). Many of the 
previously described mechanisms for bacterial CRC promotion involve remodelling 
of the microbiome, inflammatory signalling and other indirect pathways to tumour 
formation (Arthur et al., 2014; Wong et al., 2017). However, imaging of tumour 
biopsy samples has revealed that tumour cells are in direct contact with resident 
Chapter 4: Bacterial infection increases tumour cell yield and induces metabolic changes in 
colorectal tumour cells 
122 
 
microorganisms, with many tumours harbouring intracellular bacteria (Tomkovich et 
al., 2019). The results presented in Chapter 3 demonstrate that these interactions may 
differ between benign and malignant tumour cells. It is therefore possible that this 
direct contact with CRC-associated microorganisms may influence the behaviour of 
benign and malignant tumour cells differently. 
Tumour cell growth is intrinsically linked to cellular metabolism, particularly 
in CRC (having been extensively reviewed by Cairns, Harris and Mak, 2011; Hagland 
and Søreide, 2015). The Warburg effect describes the phenomenon whereby cancer 
cells preferentially utilise aerobic glycolysis over oxidative phosphorylation 
(Warburg, Wind and Negelein, 1927). This provides cells with increased quantities of 
small molecules for cell growth (e.g. NADPH), despite the apparent disadvantage to 
ATP production. This mechanism is particularly relevant to colonocytes, as this 
metabolic switch leads to the accumulation of butyrate in the cytosol, leading to its 
translocation to the nucleus and facilitating its effects as an HDACi (Donohoe et al., 
2012). It is now known that metabolic reprogramming occurs early on in the adenoma-
carcinoma sequence, and is therefore a key driver of carcinogenesis (Satoh et al., 
2017).  
 The altered metabolism seen in tumours can be exploited for cancer diagnosis 
and treatment. For example, positron emission tomography scanning tracks 
fluorescently tagged glucose molecules to regions of high metabolism and is able to 
diagnose CRC in asymptomatic individuals with high sensitivity (Lin et al., 2011). 
More recently, technologies such as gas chromatography mass spectrometry (GC/MS) 
and selected ion-flow tube mass spectrometry (SIFT-MS) have demonstrated that 
tumours display distinct metabolic profiles, which in the case of CRC can be detected 
from faecal samples (Batty et al., 2015). These technologies, which detect volatile 
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organic compounds present in the headspace above samples, have also shown great 
promise in identifying specific microorganisms present within clinical samples (Slade 
et al., 2017). Given the association between shifts in microbiota composition and CRC 
development, identification of tumour-associated microorganisms through their 
metabolic profiles could potentially be exploited to provide novel biomarkers to aid in 
determining CRC prognosis and suggest targeted adjuvant antibiotic therapies. This 
chapter will explore the impact of B. fragilis, E. coli Nissle, E. faecalis and F. 
nucleatum on tumour cell growth and metabolism, with a focus on any differences 
between benign and malignant cells. 
4.2. Aims 
The aim of this chapter was to determine the effects of bacterial invasion on tumour 
cell growth. In addition, this chapter also aims to investigate the metabolic differences 
between colorectal adenoma and adenocarcinoma cells. Once established, changes in 
these metabolic profiles upon bacterial infection will be investigated to determine if 
bacteria are capable of triggering metabolic shifts which potentiate tumour growth.  
4.3. Objectives 
• To investigate how tumour cell yield is impacted after direct treatment with 
bacteria. Apoptosis and changes to cell cycle will also be investigated to 
attempt to explain any observed changes to cell yield. 
• To investigate the Warburg effect in colorectal adenoma and adenocarcinoma 
cells by quantifying rates of oxidative phosphorylation and glycolysis. The 
ability of bacterial infection to alter this metabolic phenotype will also be 
investigated.  
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• To examine the volatile profiles of adenoma and carcinoma cell lines, in 
addition to determining how bacterial invasion alters cellular metabolism, and 
whether infected tumour cells display species-specific metabolic profiles.  
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4.4.1 Bacteria significantly increase cell yield in RG/C2 and HCT116 
tumour cells 
In the previous chapter, it was established that bacteria invade RG/C2 and HCT116 
cells and persist within the intracellular space without significantly decreasing cell 
viability (see Section 3.4.2). To investigate whether this bacterial invasion altered cell 
growth behaviour, tumour cell yield was quantified by counting viable cells 96 hours 
post-invasion. Bacterial MOIs of 10:1 and 100:1 were selected to eliminate the effect 
of altered cell viability observed in tumour cells infected at an MOI of 1000:1 (Figure 
3.3). The average yield of untreated RG/C2 cells, initially seeded at 1.6x105 cells/well 
in 12-well plates, was approximately 2.8x105 cells/well at 96 hours (Figure 4.1). In 
contrast, the cell yield of untreated HCT116 cells was considerably higher (7.8x105 
cells/well) despite being seeded at the lower density of 8x104 cells/well.  
 Despite the relative differences in cell number between untreated RG/C2 and 
HCT116 wells, bacterial invasion by all four species tested significantly increased cell 
yield in both cell lines (Figure 4.1). MOIs of 10:1 and 100:1 were tested for each 
species, and under each experimental condition an increase in cell yield of at least 1.5 
relative to untreated cells was observed. These data demonstrate that an MOI as low 
as 10:1 is sufficient to alter tumour cell behaviour; however, increasing bacterial 
concentration did not significantly impact the effect on cell yield in either cell line. 
Across all species and MOIs, the average cell yield in infected RG/C2 cells was 
8.3x105 cells/well, a value greater than the cell yield observed in untreated HCT116 
cells. This suggests that under the conditions of this experiment, bacterial invasion can 
promote a growth phenotype in benign tumour cells similar to that of malignant cancer 
cells. 
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Figure 4.1: Bacterial invasion results in increased tumour cell yield in adenoma and adenocarcinoma cells. RG/C2 
and HCT116 cells were seeded in 12-well plates and cultured for 72 hours before being infected with B. fragilis (A), E. 
coli Nissle (B), E. faecalis (C) or F. nucleatum (D) for four hours. Cell yield was measured using viable cell counts 
after 96 hours of incubation under standard conditions and demonstrated that bacterial infection significantly increases 
cell yield in all cases. Error bars represent standard deviation and data represents the results of three independent 
experiments performed in triplicate. T-test, * = p < 0.05, ** = p < 0.01, *** = p < 0.001.  
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4.4.2 RG/C2 cells infected with colonic bacteria display lower rates of 
apoptosis 
In order to determine whether the observed increases in cell yield could be attributed 
to a reduction in cell death, changes in the apoptotic cell number between untreated 
and infected tumour cells were measured. As previously described, apoptotic 
colorectal tumour cells detach from the culture surface as they undergo apoptosis 
(Hague et al., 1993). As such, floating cells collected from the aspirated cell culture 
medium before trypsinisation can be counted, and by expressing the number of 
floating cells as a proportion of the total cell count (attached plus floating) be used to 
quantify relative levels of apoptosis in a cell population. All floating cell counts were 
performed in parallel with the viable cell counts described in section 4.4.1.  
 In untreated RG/C2 cultures, apoptotic cells accounted for an average of 18.8% 
of the total cell count. This was significantly higher than HCT116 cultures, where the 
basal level of apoptosis was 0.52% (p < 0.01). This was visually apparent due to the 
large number of floating cells and other debris seen in RG/C2 cultures under the 
microscope. In most cases, bacterial infection lowered the proportion of apoptotic 
cells. Infection by B. fragilis reduced apoptosis at an MOI of 10:1 and 100:1 in RG/C2 
and HCT116 cells; however, the reduction of apoptosis in RG/C2 cells treated at an 
MOI of 10:1 was not statistically significantly. RG/C2 cells treated with E. coli Nissle, 
E. faecalis and F. nucleatum at MOIs of 10:1 and 100:1 exhibited a significant 
reduction in apoptosis. The largest decrease in apoptosis was observed in E. faecalis-
treated cells, which produced a decrease of 60% and 64% at MOIs of 10:1 and 100:1, 
respectively (Figure 4.2C). This is consistent with the observed effects on cell yield, 
where E. faecalis induced the largest increase in RG/C2 cell count (Figure 4.1C).  
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 In contrast, bacterial invasion did not have a consistent effect on floating cell 
number in HCT116 cultures. A significant reduction in apoptosis was only observed 
in HCT116 cells infected with B. fragilis and with E. faecalis at an MOI of 100:1          
(p < 0.01). However, non-significant reductions were seen in cells infected with E. 
coli Nissle (MOI 10:1 and 100:1), E. faecalis (MOI 10:1) and F. nucleatum (MOI 
10:1). Surprisingly, apoptosis appeared to increase in HCT116 cells infected with         
F. nucleatum at an MOI of 100:1, although this increase was not statistically 
significant (p = 0.09, Figure 4.2D). The lack of statistical significance observed could 
perhaps be attributed to the relatively low numbers of apoptotic cells counted (less 
than 1% of the total cell count).  
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Figure 4.2: Floating cell counts in RG/C2 and HCT116 cultures 96 hours post-infection. Floating cell 
counts were performed in parallel with cell yield experiments. Floating cells were collected 96 hours post-
infection and counted using a haemocytometer. Values are expressed as a percentage of the total cell 
population. Error bars represent standard deviation and data represents the results of three independent 
experiments performed in triplicate. T-test, * = p < 0.05, ** = p < 0.01, *** = p < 0.001.  
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4.4.3 The relative impact of bacterial infection on tumour cell yield and 
apoptosis is consistent across RG/C2 and HCT116 cells 
Due to the natural disparities in growth rate and viability of RG/C2 and HCT116 cells 
in vitro, it is beneficial to compare the fold change in cell yield and apoptosis 
percentage caused by bacterial infection. Towards the end of the 96-hour incubation 
period, bacteria-treated HCT116 cultures were beginning to reach confluency, which 
may have obscured the overall impact of infection on cell yield. However, Figure 4.3A 
demonstrates that despite the obvious difference in cell numbers seen in Figure 4.1, 
bacterial infection induced a minimum 1.5-fold increase in cell yield across all 
experimental parameters. A Two-way ANOVA was used to determine whether the 
differences in the fold increase in cell yield between RG/C2 and HCT116 cultures 
were significant. This revealed that the cell line did not statistically impact the degree 
of cell yield increase for each species (p = 0.79), highlighting that both RG/C2 and 
HCT116 cells exhibit similar growth responses to bacterial infection.  
 With the exception of HCT116 cells infected with F. nucleatum at an MOI of 
100:1, bacterial infection reduced apoptosis in all cases with varying levels of 
significance. B. fragilis infection caused a greater reduction in apoptosis in HCT116 
cells (-0.29), with the fold decrease at an MOI of 10:1 being significantly higher than 
that of RG/C2 cells (p = 0.03; Figure 4.3B). In cells infected with either E. coli Nissle 
or E. faecalis, the fold change in apoptosis was approximately equivalent for both 
RG/C2 and HCT116 cells. For example, RG/C2 apoptosis was reduced by a factor of 
0.35, compared to a reduction of 0.34 in HCT116 cells. The greatest divergence was 
observed when cells were infected with F. nucleatum. Despite an MOI of 10:1 
reducing apoptosis in both cell lines, an MOI of 100:1 significantly increased 
apoptosis in HCT116 cells, despite reducing apoptosis in RG/C2 cultures. Regardless 
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of the direction of change, Figure 4.3 demonstrates that bacterial infection clearly 
influences tumour cell behaviour in a manner which is largely consistent between 
benign and malignant cells.  
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Figure 4.3: Comparison of the fold change in cell yield and floating cell proportion between RG/C2 and 
HCT116 cells infected with bacteria. Values for cell yield (A) and floating cell percentage (B) were 
normalised to the control group (untreated cells) to allow for better comparison between cell lines. BF = B. 
fragilis, EcN = E. coli Nissle, EF = E. faecalis, FN = F. nucleatum. Numbers on the x-axis indicate the 
multiplicity of infection. Error bars represent standard deviation and data represents the results of three 
independent experiments performed in triplicate. Two-way ANOVA * = p < 0.05.  
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4.4.4 Bacterial infection does not promote proliferation in tumour cells in 
vitro 
Figure 4.1 demonstrates that bacterial infection with the four species investigated 
significantly increases cell yield regardless of cell type. To determine whether this was 
due to changes in the cell cycle, analysis of DNA content was performed via flow 
cytometry. Cells were fixed 24 hours post-infection and stained with propidium 
iodide. After staining, DNA content was quantified and the proportion of cells within 
G1-phase, S-phase and G2-phase was modelled. In RG/C2 cells infected with either 
B. fragilis or E. coli Nissle, a small non-statistically significant increase in the 
proportion of cells in S-phase was observed (Figure 4.4A). E. faecalis and                         
F. nucleatum infection decreased the proportion of cells in S-phase, but this was only 
statistically significant in E. faecalis-infected cells (p = 0.0219). The proportion of 
RG/C2 cells in G2-phase was significantly increased in cells infected with E. faecalis 
(p<0.001) and F. nucleatum (p < 0.001). There was also a small, non-statistically 
significant increase in G2-phase in RG/C2 cells infected with B. fragilis (p = 0.33). 
No difference in G2-phase was observed in E. coli Nissle infected cells. In HCT116 
cells the percentage of cells in G1-phase was significantly increased regardless of the 
bacterial species tested (Figure 4.5A). The largest increase was seen in cells infected 
with F. nucleatum, with a 15% rise in G1-phase cells. In contrast, the percentage of 
RG/C2 cells in G1-phase was decreased upon bacterial infection (Figure 4.5). This 
decrease was significant in cells infected with B. fragilis (p=0.0387), E. faecalis            
(p = 0.0219) and F. nucleatum (p = 0.0068), although not in cells infected with E. coli 
Nissle. Infection with all species decreased the proportion of HCT116 cells in both S-
phase and G2-phase, however these decreases were not statistically significant.  
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4.4.5 Benign RG/C2 cells display a metabolic profile distinct from 
malignant adenocarcinoma cell lines 
Cellular metabolism is an important limiting factor on the expansion of tumour cell 
populations. In CRC, as in many other cancers, the Warburg effect is thought to be a 
key characteristic which facilitates increased tumour growth and allows tumour cells 
to outcompete neighbouring cells for nutrients (Liberti and Locasale, 2016). However, 
there is some debate surrounding the point in the adenoma-carcinoma sequence at 
which the Warburg effect occurs. To investigate whether metabolic differences are 
apparent between adenoma and adenocarcinoma cell lines, cellular metabolism in 
RG/C2 cells and three adenocarcinoma cell lines, HCT116, HT29 and SW480 was 
analysed using the Seahorse Xf analyser.  
Before commencing Seahorse experiments, the optimal seeding density for 
each cell line was determined (Figure 4.6). According to the manufacturer’s 
recommendations, a seeding density should be chosen where a linear increase in cell 
number corresponds to a linear increase in the oxygen consumption rate (OCR). A 
range of seeding densities were tested for each cell line. Figure 4.6 demonstrates that 
for all cell lines, a linear relationship between cell number and OCR is present at low 
seeding densities. For example, increasing the seeding density of HT29 cells from 
4x105 to 6x105 increased OCR from 195 pmol/min to 288 pmol/min, a fold increase 
of 1.47. This linear relationship was not present between RG/C2 and SW480 cells 
seeded at higher densities (Figure 4.6A and 4.6D). Therefore, lower seeding densities 
were selected for each cell line. The final selected seeding density for HCT116 cells 
was 3x104 cells/well. A density of 4x104 cells/well was selected for HT29 and SW480 
cells, and 6x104 cells/well for RG/C2 cells. In addition, RG/C2 cells were incubated 
for a further 24 hours post-seeding to allow cells to fully recover before all assays. 
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Final cell numbers post-assay were determined using crystal violet staining and used 
to normalise results. The optimal concentration of FCCP was also determined by 
testing a range of concentrations between 0.5-2 μM (data not shown). The 
manufacturer’s recommended concentration of 1 μM was sufficient to induce a two-
fold increase in OCR for all cell lines and so was chosen for all future experiments.  
The metabolic rates of the four cell lines were then analysed using the Seahorse 
Energy Phenotype test. OCR and extracellular acidification rate (ECAR) are 
quantified as indirect measures of oxidative phosphorylation and glycolysis, 
respectively. First, basal levels of metabolism are recorded, followed by maximal rates 
of glycolysis and oxidative phosphorylation which are stimulated by the real-time 
injection of Oligomycin and FCCP. Each cell line exhibited distinct rates of both basal 
and maximum oxygen consumption (Figure 4.7A and B, respectively). RG/C2 cells 
displayed the highest basal and maximal OCR, in addition to the highest potential for 
increased OCR (Figure 4.7D). OCR in SW480 cells was also significantly higher than 
HCT116 and HT29 cells, which were not statistically different from each other.  
 The basal ECAR of RG/C2 cells was lower than both HCT116 and SW480 
cells (Figure 4.7D), although this difference was only statistically significant against 
HCT116 cells (p = 0.0318). Interestingly, the maximum ECAR of the four cell lines 
were not significantly different (Figure 4.7E), demonstrating that RG/C2 cells have 
the capacity when under stress to reach levels of glycolysis similar to that of the 
adenocarcinoma cells despite having a lower basal rate. This was reflected in the spare 
glycolytic capacity of RG/C2 cells, which was significantly higher than HCT116 (p = 
<0.001) and SW480 (p = 0.0041) cells (Figure 4.7F). Due to the similarity in basal 
ECAR between RG/C2 and HT29 cells, no statistically significant difference in their 
glycolytic capacities was observed.  
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 Energy phenotype was visualised by dividing the OCR by the ECAR for each 
cell line (Figure 4.8A). The energy phenotypes of all four cell lines tested were 
statistically distinct, as assessed by a Two-way ANOVA. However, the benign 
adenoma cell line RG/C2 displayed the greatest ratio of oxidative phosphorylation to 
glycolysis. Figure 4.8B demonstrates that despite exhibiting significantly different 
metabolic profiles, the basal metabolic rates of the three adenocarcinoma cell lines 
form a distinct cluster away from that of the RG/C2 cell line. This difference becomes 
more pronounced when analysing maximum metabolic rates. The three 
adenocarcinoma cell lines shifted markedly towards a glycolytic phenotype when 
placed under stress. This is in contrast to RG/C2 cells (blue line) where the rate of 
increase of oxidative phosphorylation and glycolysis were approximately equal. This 
demonstrates that regardless of whether a Warburg effect occurs in the transition from 
normal epithelial to colorectal adenoma, further metabolic shifts also occur between 
adenoma and adenocarcinoma cells.  
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Figure 4.6: Seeding density optimisation for Seahorse assays using colorectal tumour cell lines. RG/C2 
(A), HCT116 (B), HT29 (C) and SW480 (D) cells were seeded at various densities and oxygen consumption 
rate (OCR) was measured using the Seahorse Xf24 analyser. For each cell line, the lowest seeding density was 
chosen, as higher seeding densities for RG/C2 and SW480 cultures did not result in a linear increase in OCR.  
Error bars represent standard deviation and data represents the results of three independent experiments 
performed in triplicate.  
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4.4.6 F. nucleatum increases glycolytic capacity in infected HCT116 cells 
The ability of bacteria to modify cellular metabolism was investigated by performing 
the Energy Phenotype test on HCT116 tumour cells 24 hours post-infection. As the 
cell monolayers were incubated for an additional 24 hours, higher basal levels of OCR 
and ECAR were observed (Figure 4.9A and 4.9D) in comparison to the values seen in 
Figure 4.7. Bacterial infection did not significantly affect OCR for any of the species 
tested (Figure 4.9A&B). Small decreases in maximum OCR and spare respiratory 
capacity were witnessed, however these were not statistically significant. In contrast, 
infection of HCT116 cells by B. fragilis and F. nucleatum significantly increased basal 
ECAR (Figure 4.9D). Basal ECAR was also increased in response to E. faecalis, 
however this result was not statistically significant (p = 0.1101). Infection by                 
F. nucleatum also significantly increased maximal ECAR (p = 0.0283) by 
approximately 30% (Figure 4.9E). As both B. fragilis and F. nucleatum infection 
caused the basal ECAR to increase, the spare glycolytic capacity was reduced in 
comparison to un-infected cells, suggesting that infection by bacteria caused cells to 
perform glycolysis closer to their maximum rate. When comparing energy phenotypes, 
both B. fragilis and F. nucleatum-treated cells displayed a lower ratio of OCR:ECAR 
(Figure 4.10A), and Figure 4.10B demonstrates that infection by F. nucleatum causes 
HCT116 cells to shift to the right, exhibiting a greater capacity for glycolysis.  
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4.4.7 Discrimination between adenoma and adenocarcinoma cells using 
volatile product ion peak detection 
Having shown that the metabolism of the benign colorectal tumour cell line RG/C2 
differs from that of malignant cell lines, and that certain bacterial species can influence 
tumour metabolism, we then aimed to determine whether these changes are reflected 
in the volatile profiles of these tumour cells. The headspace above colorectal tumour 
cell cultures was analysed by SIFT-MS in full scan mode over a spectrum range of 15-
200 m/z in order to detect the volatile product ion peaks produced by these cells in 
culture. Using the HCO3+ reagent ion data, a background subtraction was performed 
by comparing the volatile product ion peaks detected from the headspace above 
tumour cells with those detected in the headspace above cell culture media controls. 
The product ions peaks present in tumour cell samples that were significantly elevated 
(p < 0.05) compared to these controls are presented in Supplementary Table 3.  
 To further analyse the detected volatile profiles, hierarchical cluster analysis 
(HCA) was performed, and the resulting dendrogram is presented in Figure 4.11. 
Individual replicates of specific cell lines clustered together, demonstrating that each 
cell line possesses a reproducible distinct volatile metabolome. Furthermore, the three 
adenocarcinoma cell lines tested (Figure 4.11, red box) clustered together, with HT29 
and SW480 showing the greatest degree of similarity. These three cell lines were 
distinctly different from the benign adenoma cell line RG/C2. The SIFT-MS data was 
also analysed via principal component analysis (PCA). Figure 4.12 illustrates a scatter 
plot of the first two principal components, which accounted for 22% and 18% of the 
total variation, respectively. Principle component 1 (X-axis) separated benign cells 
(Figure 4.12, blue circle) from malignant cells (Figure 4.12, red circle). 
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Adenocarcinoma samples were separated on the Y-axis by the second principal 
component; however, individual replicates of each cell line did not cluster together. 
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 Squared Euclidian distance 
Figure 4.11: Dendrogram of volatile product ion peaks detected from cell culture headspace after 
hierarchical cluster analysis. HCA was performed on 82 volatile peaks detected above colorectal tumour cell 
cultures using SIFT-MS. Cell culture flasks were capped for 30 minutes prior to sampling. Red box designates 
colorectal adenocarcinoma cell lines, which clustered separately from the benign adenoma cell line RG/C2.   
Chapter 4: Bacterial infection increases tumour cell yield and induces metabolic changes in 








RG/C2 HCT116 HT29 SW480 
Figure 4.12: Principal component analysis of volatile product ion peaks detected from colorectal tumour 
cell cultures. Scatter plot produced using the first and second scores of the principal component analysis 
performed on 82 volatile peaks detected in the headspace above colorectal tumour cell cultures. Cell culture 
flasks were capped for 30 minutes before sampling.  Benign RG/C2 cells clustered together (blue circle) away 
from malignant adenocarcinoma cell lines (red circle). However, biological replicates of adenocarcinoma cell 
lines did not cluster together.  
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4.4.8 Identification of intracellular bacteria using SIFT-MS 
Analysis of tumour cell metabolism using the Seahorse Xf analyser revealed that 
metabolic shifts occur upon infection with specific species e.g. F. nucleatum. To 
further investigate these metabolic changes, SIFT-MS was used to analyse the 
headspace above bacteria-infected cells. For each species, a background subtraction 
was performed against non-infected cells, and the significant product ion peaks (p < 
0.05) for infected RG/C2 and HCT116 samples are presented in Supplementary Table 
4 and 5, respectively. RG/C2 cells infected with B. fragilis displayed numerous peaks; 
however, all other species induced much smaller metabolic changes. For example, in 
RG/C2 cells infected with F. nucleatum only five significant peaks were detected 
across all replicates. Hierarchical cluster analyses revealed that samples of RG/C2 
cells infected with B. fragilis displayed a high degree of similarity, with volatile 
profiles dissimilar to any other species tested (Figure 4.13). F. nucleatum-infected 
cells were also closely related, whereas E. coli Nissle and E. faecalis-infected cells 
could not be discriminated through HCA. This was attributed to a lack of significant 
peaks, as opposed to multiple shared peaks. Figure 4.13 displays these samples plotted 
against the first and second principal components following PCA; however, individual 
replicates of each species were not found to cluster together.  
 In contrast, HCT116 cells exhibited a significant metabolic shift upon 
infection, with numerous significant peaks detected which presented a similar profile 
to RG/C2 cells infected with B. fragilis. The majority of these peaks were significantly 
different from the control in cells infected with any of the four bacterial species tested, 
with notable large peaks detected at m/z 27 and m/z 50. HCA was also performed on 
this data set; however, individual replicates for each species were not found to cluster 
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together (Figure 4.14). Similarly, bacterial species could not be separated after PCA 
(Figure 4.15).  
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Squared Euclidian distance 
Figure 4.13: Dendrogram of volatile product ion peaks detected from the headspace above infected 
RG/C2 hierarchical cluster analysis. HCA was performed on 84 volatile peaks detected above infected 
RG/C2 cells. B. fragilis and F. nucleatum-infected cells clustered discretely, but no discrimination between E. 
coli Nissle and E. faecalis-infected cells could be achieved. Cell culture flasks were capped for 30 minutes 
prior to sampling.  
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Figure 4.14: Principal component analysis of volatile product ion peaks detected from the headspace 
above infected RG/C2 cells. Scatter plot produced using the first and second scores of the principal component 
analysis performed on 84 volatile peaks detected in the headspace above infected cultures. Cell culture flasks 
were capped for 30 minutes before sampling.  B. fragilis and F. nucleatum samples (red circle) were distinct 
from E. coli Nissle and E. faecalis samples.  
B. fragilis E. coli Nissle E. faecalis F. nucleatum 
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Squared Euclidian distance 
Figure 4.15: Dendrogram of volatile product ion peaks detected from the headspace above infected 
HCT116 cells.  HCA was performed on 88 volatile peaks detected above infected HCT116 cells. No 
discrimination between infective bacterial species could be achieved. Cell culture flasks were capped for 30 
minutes prior to sampling. 
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Figure 4.16: Principal component analysis of volatile product ion peaks detected from the headspace 
above infected HCT116 cells. Scatter plot produced using the first and second scores of the principal 
component analysis performed on 88 volatile peaks detected in the headspace above infected HCT116 cell 
cultures. Cell culture flasks were capped for 30 minutes before sampling.  
B. fragilis E. coli Nissle E. faecalis F. nucleatum 
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This chapter aimed to investigate how direct interactions with bacteria influenced 
tumour cell growth and metabolism. After previously establishing in Chapter 3 that 
these bacteria infiltrate and persist within tumour cells without negatively impacting 
viability, the potential tumour-promoting effects of this bacterial invasion was studied. 
Firstly, cell yield in response to bacterial infection was investigated. Bacterial 
infection significantly increased tumour cell yield in both cell lines, with similar fold 
increases observed for all four species of bacteria tested. Chapter 3 highlighted that 
levels of bacterial invasion are significantly different between tumour cell lines and 
between bacterial species. It is therefore surprising that the degree of cell yield 
increase was similar across species, and across two separate MOIs. This could suggest 
that relatively small numbers of bacteria are needed to significantly impact cell 
growth, which is consistent with current opinions on bacterial drivers and ‘alpha-bugs’ 
in CRC, which are thought to be present at very low concentrations (see Section 1.6; 
Sears and Pardoll, 2011). Induction of tumour growth by gut bacteria is not a novel 
concept; however, much of the current literature attributes the promotion of tumour 
formation by bacteria to genetic damage induced by the production of toxic 
metabolites or stimulation of the immune system, as opposed to direct interactions 
between tumour cells and bacteria (see reviews by Candela et al., 2014; Louis, Hold 
and Flint, 2014). Furthermore, comparative analysis of the effects of bacteria on 
adenoma and adenocarcinoma cells is also lacking. The results of the present study 
demonstrate that these bacteria directly contribute to an increase in tumour cell yield 
in benign and malignant cells through contact-dependent mechanisms. The similar 
increases observed in RG/C2 and HCT116 cells suggest that the mechanism is likely 
to be conserved between adenomas and adenocarcinomas. Crucially, this suggests that 
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bacteria may contribute to the progression of CRC, as an increase in tumour cell yield 
allows for clonal expansion and the subsequent accumulation of further driver 
mutations (Greaves and Maley, 2012).  
 Aberrant cell growth is the most fundamental hallmark of cancer formation, 
and can be attributed to sustained proliferation and resistance to cell death (Hanahan 
and Weinberg, 2011). To investigate whether bacterial infection was increasing 
proliferation or reducing apoptosis in colorectal tumour cells, parallel counts of 
floating cell populations were performed during cell yield assays. A simple count of 
floating cells is a viable measure of apoptosis in in vitro colon tumour cell cultures, as 
>99% of floating cells are apoptotic, as confirmed by acridine orange staining (Hague 
et al., 1993). With the exception of HCT116 cells treated with F. nucleatum at a high 
MOI, bacterial infection reduced apoptosis, although this was not statistically 
significant in all cases. Apoptosis at the mucosal surface is essential to gut 
homeostasis. Cells are continuously sloughed into the lumen to be replaced by cells 
emerging from the crypts; this removes damaged cells and prevents abnormal cell 
proliferation (Sträter et al., 1995). In contrast, apoptosis within the colonic crypts is 
relatively rare in healthy epithelium. The distribution of apoptosis is reversed in 
colorectal tumours, with reduced apoptosis at the mucosal surface and increased 
apoptosis in the crypts (Moss et al., 1996). This highlights the influence of apoptosis 
deregulation to cancer development. There is much controversy surrounding the 
relative levels of apoptosis in adenomas and adenocarcinomas in vivo, which has been 
extensively reviewed by Koornstra et al. (2003). However, in vitro adenomas display 
much higher levels of apoptosis when compared to adenocarcinoma-derived cells 
(Qualtrough et al., 2004), as highlighted by the relative levels of floating cells 
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presented in Figure 4.2. Nevertheless, the overall effect of bacterial infection reducing 
apoptosis was consistent across both cell lines.  
 For each of the four species of bacteria investigated, distinct mechanisms have 
been proposed which could explain the observed increases in cell yield and reductions 
in apoptosis (see Section 1.5). For example, cleavage of E-cadherin by BFT has been 
shown to induce c-myc expression, resulting in sustained proliferation (Wu et al., 
2003). F. nucleatum is also thought to promote aggressive tumour behaviour through 
the interaction of its FadA adhesin with E-cadherin (Rubinstein et al., 2019). However, 
as previously discussed levels of E-cadherin expression differ between cell lines, 
suggesting this cannot be the sole mechanism responsible (see Section 1.5.5). Multiple 
other genetic and phenotypic differences between RG/C2 and HCT116 cells exist 
which make their near-identical response to bacterial infection surprising. For 
example, RG/C2 cells are hemizygous for TP53, an important tumour suppressor gene 
which influences apoptosis, with the remaining allele being non-functional (Williams 
et al., 2000). In contrast, HCT116 cells possess wild-type TP53 and therefore the 
mechanism of apoptosis reduction by bacteria is likely to be TP53-independent. 
Further investigation is required to elucidate this mechanism, which may differ 
according to each bacterial species.  
It could be deemed counterintuitive that invasion by bacteria decreased 
apoptosis in colonic tumour cells, given that intracellular gut pathogens such as 
Salmonella serovars and invasive E. coli have been shown to induce apoptosis in 
infected epithelial cells (Kim et al., 1998). However, suppressing apoptosis is an 
important virulence factor for many intracellular pathogens, as it provides time for 
intracellular replication and subsequent dissemination (reviewed by Behar and Briken, 
2019). The similar results observed across all bacterial species suggest that a common 
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characteristic may be responsible. It was recently discovered that intracellular Shigella 
flexneri lipopolysaccharide (LPS), found in the outer membrane of Gram negative 
bacterial cell walls, binds to and inhibits pro-apoptosis caspases (Günther et al., 2020). 
This activity was specific to the LPS O-antigen moiety and would not account for anti-
apoptotic activity of Gram-positive species such as E. faecalis, but is an example of 
how fundamental structural components of prokaryotes may influence tumour cell 
behaviour.  
 The fold increase in cell yield across all species was far larger than the fold 
decrease in apoptosis. Furthermore, high infection doses of F. nucleatum increased the 
apoptotic cell count, albeit non-significantly, despite infection with these species 
significantly increasing cell yield. This raises questions as to whether a reduction in 
apoptosis could be solely responsible for the increases in cell yield. However, it should 
be considered that apoptotic floating cells were only sampled at the end of the 
experiment. Therefore, additional floating cells may have been discarded during media 
changes, or have degraded to debris during the incubation period and therefore not 
have been counted.  To determine whether the observed increases in tumour cell yield 
could be attributed to an increase in proliferation upon bacterial infection, the tumour 
cell cycle was analysed. S-phase analysis was performed after staining tumour cell 
DNA. RG/C2 cells exhibited decreased proportions of cells in G1-phase after infection 
with almost all species. E. faecalis and F. nucleatum infection caused a significant 
increase in the number of cells in G2-phase, which is perhaps indicative of a delay in 
mitosis (Sorenson, Barry and Eastman, 1990).  
Conversely, increased proportions of cells in G1-phase were observed in 
HCT116 cells infected with all species. A G1-phase cell cycle arrest would be 
expected in colorectal tumour cells experiencing serum starvation or density inhibition 
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(Tay, Bhathal and Fox, 1991); however, cell cycle arrest at various stages of the cell 
cycle have been observed upon bacterial infection. For example, DNA damage caused 
by infection with Staphylococcus aureus leads to G2/M-phase delay in HeLa cells 
(Deplanche et al., 2019). Similarly, the gut pathogen Salmonella enterica subsp. 
enterica ser. Typhimurium induces a G1-phase arrest in HCT116 cells, which 
facilitates further bacterial invasion (Mambu et al., 2020). The results of the analysis 
performed in this thesis appear to suggest that bacterial infection did not increase 
tumour cell proliferation, which would be demonstrated by an increase in the 
proportion of cells in S-phase. However, it must be considered for this analysis that 
cells were only sampled at a single time point post-infection (24 hours), and so 
additional effects on cell cycle as a result of bacterial infection may not have been 
observed. To better understand the effect of bacterial infection on tumour cell yield 
and apoptosis, parallel tumour cell counts and flow cytometry samples should be taken 
at regular intervals across the complete 96-hour period and compared.  
 Tumour cell growth is intrinsically linked to tumour metabolism. In cancer 
cells, the rate-limiting factor on cell growth is not the rate of ATP production, but the 
availability of small molecules such as NADPH (Vander Heiden, Cantley and 
Thompson, 2009). Therefore, tumour cells exhibit the Warburg effect, whereby cells 
preferentially undergo aerobic glycolysis, despite the availability of sufficient oxygen 
for oxidative phosphorylation (Warburg, Wind and Negelein, 1927). In addition to the 
increased small molecule availability, the Warburg effect confers numerous additional 
benefits to tumour cells. For example, increased glucose uptake allows tumour cells 
to out-compete neighbouring cells with slower metabolic rates (Pfeiffer, Schuster and 
Bonhoeffer, 2001). In addition, secretion of increased amounts of lactate, produced by 
aerobic glycolysis, into the microenvironment inhibits the activity of T-cells and 
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natural killer cells (Brand et al., 2016). Finally, despite aerobic glycolysis being a far 
less efficient means of generating ATP when compared to oxidative phosphorylation, 
the speed at which cells are able to perform glycolysis means that the net rate of ATP 
production is comparable (Shestov et al., 2014).  
 The Warburg effect has been observed in many types of cancer, but there is 
ongoing debate as to whether it initiates tumorigenesis or is a consequence of tumour 
formation (Devic, 2016). In CRC, loss of APC induces PKM2 and LDHA expression 
via β-catenin-related transcription, resulting in increased glucose uptake and lactate 
secretion (Cha et al., 2021). Due to the prevalence of APC mutations in CRC, the 
Warburg effect is therefore thought to be activated early in colorectal tumours (Satoh 
et al., 2017). In this study, the Seahorse Xf analyser was used to investigate the 
metabolic profiles of selected colorectal tumour cell lines. Although oxygen 
consumption rate (OCR) differed between all cell lines, benign RG/C2 cells displayed 
a higher OCR than all three adenocarcinoma cell lines. This was best reflected by the 
maximal OCR of the RG/C2 cell line, which was three-fold higher than the nearest 
adenocarcinoma cell line (SW480). In contrast, extracellular acidification rates 
(ECAR) were similar across all cell lines. This would suggest that under these 
conditions adenocarcinoma cells have a lower metabolic rate due to a decreased rate 
of oxidative phosphorylation.  
 Many tumour cells face hypoxia as their rate of growth overtakes the rate of 
angiogenesis needed to maintain sufficient blood supply (Brahimi-Horn, Chiche and 
Pouysségur, 2007). In CRC, hypoxia has been demonstrated to increase along the 
adenoma-carcinoma sequence, with the expression of hypoxia-inducible factor 1 alpha 
(HIF-1α) occurring in early adenomas and being highest in invasive cancers 
(Simiantonaki et al., 2008). Hypoxia-inducible factors regulate gene expression to 
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allow adaptation to hypoxic environments, and actively downregulate oxygen 
consumption by the mitochondria through pyruvate dehydrogenase kinase 1 (PDK1) 
while stimulating glycolysis-related genes (Papandreou et al., 2006). In order to 
further investigate the metabolic differences between RG/C2 cells and 
adenocarcinoma cells, investigating the activation of HIF-1α-related genes would be 
appropriate. This could be achieved using commercially available luciferase-based 
hypoxia reporter assays (Doran et al., 2011).  
Finally, although the OCR and ECAR data presented have been normalised to 
cell number, it must be considered that each cell line may respond differently to the 
experimental conditions required to perform Seahorse assays. In particular, RG/C2 
cells are routinely cultured in media containing insulin, hydrocortisone and increased 
concentrations of serum and L-glutamine, all of which are absent from Seahorse assay 
media. In addition, these cells are more susceptible to anoikis when seeded at lower 
densities (Qualtrough 2020, personal communication). Therefore, the use of non-
buffered, non-supplemented Seahorse media, incubation in a CO2-free incubator, and 
the necessity to seed at lower densities may influence the metabolic profiles of specific 
cell lines depending on their sensitivity to these factors. In an attempt to overcome 
issues relating to seeding density, one assay was performed comparing the metabolic 
profiles of confluent cell monolayers. As cells become confluent, changes in 
membrane structure and signalling pathways including YAP/TAZ and cAMP occur 
which alter cellular metabolism. Furthermore, the diffusion dynamics of molecules 
such as glucose are altered in confluent monolayers, and this change in nutrient 
accessibility may be reflected in altered OCR and ECAR rates (Pelletier et al. 1990). 
However, when attempting to investigate the metabolism of confluent cell 
monolayers, the increased number of cells produced OCR and ECAR values which 
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exceeded the limits of detection for the Seahorse (data not shown). The manufacturer 
now supplies Seahorse assay plates with an increased volume, and therefore increased 
capacity for detection of metabolic changes. Repeating these assays with these plates 
would allow comparison of the metabolic profiles of confluent cells, which may 
reduce any effects of low seeding density and be more representative of in vivo 
conditions. However, the metabolic effect of confluence in vitro is also significant, 
and could influence metabolic outputs. For example, lactate is produced at high 
quantities in actively dividing cultured cells, whereas there is a net consumption of 
lactate in stationary phase (which represents the majority of cells in a confluent 
monolayer) cells (Zagari et al., 2013). Altered lactate metabolism not only impacts 
mitochondrial oxidation, but also alters media acidity, which can have further 
metabolic affects.  
 The impact of bacterial infection on the metabolism of HCT116 cells was also 
analysed using the Seahorse. The OCR did not increase upon infection with any of the 
species studied. However, both B. fragilis and F. nucleatum increased the basal 
ECAR, with F. nucleatum also increasing the maximal ECAR. This suggests that 
while both species are capable of triggering a metabolic shift towards aerobic 
glycolysis, the action of F. nucleatum increases tumour cells’ capacity for glycolysis 
and therefore may promote aggressive behaviours as discussed above. Metabolic 
changes are part of the ‘core host response’ to bacterial infection and are used as a 
means to suppress bacterial survival and proliferation (Boldrick et al., 2002). These 
are often triggered by non-specific bacterial factors (e.g. LPS) and result in the 
production of antimicrobial reactive oxygen species (Hsu and Wen, 2002). The lack 
of metabolic response to the Gram positive (and therefore LPS-negative) E. faecalis 
suggests that this may be the case in infected HCT116 cells. It has been reported that 
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immune cells, such as M1 and M2 macrophages, shift to a Warburg-like metabolism 
upon infection with bacteria (Escoll and Buchrieser, 2018). Despite being an innate 
response of the immune system, there is evidence to suggest that intracellular 
pathogens may benefit from these metabolic changes. For example, Salmonella 
enterica sv. Typhimurium requires abundant intracellular glucose during infection, in 
addition to the associated glucose transport to invade and replicate within 
macrophages (Bowden et al., 2009). Furthermore, intracellular pathogens such as 
Mycobacterium tuberculosis benefit from increased glycolysis as they are able to 
metabolise the resulting lactate (Billig et al., 2017). It is therefore plausible that 
species such as B. fragilis and F. nucleatum trigger glycolysis in colonocytes to 
potentiate their own survival and replication.  
 To complement the metabolic analysis performed using the Seahorse, the 
volatile product ion peaks detected from the headspace above tumour cell cultures 
were analysed using SIFT-MS. The detection of volatile compounds from a range of 
biological materials has shown potential as a novel diagnostic tool. Benefits of this 
approach are the speed of analysis and the non-invasive nature of sample collection; 
and there is a wealth of research investigating the application of volatile analysis to a 
range of pathologies including bacterial infection, gastrointestinal disorders and 
cancer (Altomare et al., 2013; Slade et al., 2017; Rondanelli et al., 2019). These 
studies have demonstrated discrimination between bacterial species, and between 
diseased and healthy individuals; however, the underlying metabolic pathways 
responsible for the production of specific volatile peaks remains less understood.  
 Analysis of the statistically significant volatile product ion peaks produced by 
RG/C2, HCT116, HT29 and SW480 cell lines revealed that colorectal adenomas can 
potentially be discriminated from colorectal adenocarcinomas based upon their 
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volatile profiles. Numerous peaks were present across all cell lines, representing 
conserved metabolic pathways. This is consistent with previous studies using gas 
chromatography mass spectrometry (GC/MS) which demonstrated that SW480 cells 
shared many peaks with NCM460 cells, which are considered a model of normal colon 
(Zimmermann et al., 2007). More recently, analysis of urine volatile product ion peaks 
via gas chromatography with ion-mobility spectroscopy was shown to be able to 
discriminate between healthy patients, patients with adenomas and patients with 
adenocarcinomas by analysing urine samples from individuals diagnosed with 
colorectal adenomas, CRC patients and healthy controls (Mozdiak et al., 2019). 
Similar studies have shown distinct biomarkers present in the blood of lung cancer 
patients (Deng, Zhang and Li, 2004). This research highlights that the differences in 
tumour cell metabolism may be reflected in systemic metabolite levels and be 
detectable from relatively less-invasive samples.  
 The bulk of research into the use of volatile analysis for cancer detection has 
focussed on the use of GC/MS and liquid chromatography mass spectrometry 
(LC/MS). However, SIFT-MS offers the advantages of being simple to use, having 
high sensitivity and specificity, and the ability to simultaneously analyse a wide range 
of volatile compounds. Regardless of the method of mass spectrometry used, 
metabolite-based screening methods of patient samples could complement or even 
replace current CRC screening methods. Bond et al. (2019) demonstrated that analysis 
of propan-2-ol detected from the headspace above faecal samples using solid-phase 
microextraction (SPME) GC/MS displayed greater diagnostic capabilities than the 
currently employed faecal immunochemical test (FIT) programme in a UK cohort 
(Bond et al., 2019). However, it must be considered that uptake of faecal-based 
screening programmes worldwide is low. A recent study in a Dutch population 
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investigating FIT participation failed to achieve an uptake of greater than 63% despite 
multiple rounds of invitation (Van Der Vlugt et al., 2017). There are various reasons 
for this low uptake rate, although stigma surrounding the handling of faeces and a 
general lack of medical knowledge are thought to contribute. It has been demonstrated 
that simplifying the screening procedure (by reducing the number of samples required) 
significantly improves participation (Cole et al., 2003). Volatile screening could 
represent a further simplification of this process, particularly as breath analysis via 
SIFT-MS has shown promise in diagnosing other cancers including head and neck 
squamous cell carcinoma (Chandran et al., 2019). The results of the principal 
component analysis (PCA) presented in this study demonstrate that colorectal 
adenoma cells can be discriminated from adenocarcinoma cells when cultured in vitro. 
The next goal of this research would be to identify the specific compounds responsible 
for these differences. Once identified, these products could be analysed from in vivo 
samples to determine whether they represent an appropriate biomarker for advanced 
disease.  
Numerous studies have shown the potential for detection and discrimination 
of infectious agents by volatile analysis alone (Slade et al., 2017; Traxler et al., 2019). 
Furthermore, it has been reported that CRC can be identified via volatile markers 
detected from the headspace above faecal samples using SIFT-MS with similar results 
to the faecal occult blood test (FOBT; Batty et al., 2015). In addition, CRC patients 
have been found to possess unique breath biomarkers which can diagnose with greater 
accuracy than current screening techniques (Altomare et al., 2013; Woodfield et al., 
2018). The majority of the detected compounds are thought to be attributed to CRC-
specific microorganisms. Therefore, detecting bacteria within patient tumours could 
be greatly beneficial to CRC diagnosis and treatment. One study demonstrated that 
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mice with F. nucleatum-positive colorectal tumours treated with metronidazole 
exhibited reduced F. nucleatum load and decreased tumour growth (Bullman et al., 
2017). However, it has also been found that indiscriminate use of antibiotics can 
promote colorectal adenomas and CRC (Cao et al., 2018; Zhang et al., 2019). 
Therefore, the use of SIFT-MS to detect biomarkers for tumour cells infected with 
specific bacteria could lead to diagnostic approaches that help guide the administration 
of adjuvant antibiotic therapy in CRC patients.  
 Bacterial infection did produce a number of statistically significant volatile 
product ion peaks in both HCT116 and RG/C2 cells. However, RG/C2 cells infected 
with E. coli Nissle, E. faecalis and F. nucleatum only produced a small amount of 
significant m/z peaks. Hierarchical cluster analysis was able to separate B. fragilis and 
F. nucleatum in RG/C2 cells, but no discrimination between species was possible in 
infected HCT116 cells. To the author’s knowledge discrimination between these 
species via volatile analysis has not been previously demonstrated. However, mass 
spectrometry has been shown to accurately discriminate between other infectious 
agents in other laboratory co-culture models. For example, Detroit cells infected with 
Streptococcus pyogenes and influenza A virus exhibited distinct volatile profiles 
which allowed for discrimination between both infectious agents and between co-
infection using needle-trap microextraction coupled with GC/MS (Traxler et al., 
2019). The level of specificity, and the abundance of compounds detected in HCT116 
cells suggests that discrimination between infecting bacterial species may be possible 
using a more refined method. Metabolites detected from cultured CRC cells can vary 
significantly in both intensity and distribution depending upon the solvent used for 
extraction (Ibáñez et al., 2017). Therefore, the use of a solvent (e.g. formic acid) may 
allow for more in-depth analysis of these samples. Finally the length of the incubation 
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period post-infection, in addition to the period for which the filter caps were sealed to 
allow volatile compound accumulation should be further optimised to ensure any 
changes in volatile profile are adequately detected. 
 The results presented in this chapter demonstrate that infection of colorectal 
tumour cells by gut bacteria promotes an increase in tumour cell yield. Crucially, this 
effect was observed in both benign and malignant cells, indicating that these bacteria 
can contribute towards multiple stages of CRC development and progression. There 
are numerous mechanisms through which tumour cell yield can be upregulated. 
Quantification of floating cells suggests that these bacteria inhibit apoptosis in tumour 
cells, supported by the results of S-phase analysis. The metabolic differences between 
benign and malignant colorectal tumour cell lines were highlighted using Seahorse 
assays and SIFT-MS, with B. fragilis and F. nucleatum inducing higher rates of 
glycolysis in HCT116 cells. In summary, these results demonstrate a bacterial 
contribution to increased tumour growth, which is a key hallmark of cancer and an 
important prognostic indicator. The following chapter will aim to investigate the 
effects of these species on tumour cell migration and invasion, an equally important 
hallmark of cancer which governs the progression of late-stage disease and has the 
largest impact on patient prognosis. 
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Chapter 5: Gut bacteria influence tumour cell motility in a 
tumour stage-dependent manner 
5.1 Introduction 
In the UK, approximately 25% of CRC patients present with synchronous metastases 
upon diagnosis, and just 44% of these individuals survive for longer than one year 
(Cancer Research UK, 2021). This is in stark contrast to pre-metastatic patients, where 
one year survival rates exceed 90%. The most common sites for CRC metastasis are 
the liver and lungs, and secondary tumours at these sites are found in more than 50% 
of metastatic-CRC patients (Riihimaki et al., 2016). Tumour spread to the peritoneum 
is also a common feature of advanced CRC, although there is some debate as to 
whether this represents metastasis or local invasion (Pretzsch et al., 2019). It is often 
reported that cancer metastasis is responsible for 90% of all cancer-related deaths 
(Mehlen and Puisieux, 2006). A recent study investigating deaths caused by cancer 
across a range of diseases found that metastasis was present in 80.2% of CRC deaths, 
the second highest proportion behind ovarian cancer (90.4%) (Dillekås, Rogers and 
Straume, 2019). The contribution of metastatic spread to cancer mortality can be 
attributed to two factors: (1) secondary tumours are difficult to detect (Menezes et al., 
2016), and can cause disease recurrence at secondary sites decades after initial 
treatment (Baird et al., 2020). (2) despite the identification of numerous potential 
therapeutic targets, there is currently a paucity of treatment options for metastatic 
disease (Ganesh and Massagué, 2021).  
 Tumour metastasis is a multistep process which involves local invasion of 
surrounding tissue, intravasion into the circulatory system, followed by transportation 
to a secondary site, extravasion from the vasculature and eventual tumour colonisation 
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(Pantel and Brakenhoff, 2004). Tumour cells can migrate through a number of 
mechanisms including as single mesenchymal-like cells or as multicellular clusters 
(Lintz, Muñoz and Reinhart-King, 2017). A fundamental prerequisite for the 
formation of metastatic tumour cells is the gaining of motility and the ability to 
remodel the surrounding extracellular matrix (ECM). In epithelial tumours such as 
those seen in CRC, this involves reorganisation of the cytoskeleton, a loss of adherens 
junctions and resistance to anoikis (Friedl and Wolf, 2003). Upregulation of several 
pathways has been associated with colorectal tumour motility, however, this process 
is thought to be primarily driven by the TME (Gout and Huot, 2008). 
 The gut microbiome is both a key component and regulator of the TME and 
has been suggested as a modulator of tumour motility in CRC. For example, virulence 
by gut microorganisms can lead to increased tight junction permeability, which is also 
a hallmark of CRC (Soler et al., 1999).  Disruption of adherens junctions in the colon 
is also a virulence factor of many bacterial species, with the increased epithelial barrier 
permeability facilitating bacterial access to underlying tissue (Desai et al., 2016). 
Furthermore, bacterial effectors including BFT and FadA, produced by B. fragilis and 
F. nucleatum, respectively, have been demonstrated to upregulate β-catenin signalling, 
an important regulator of both migration and epithelial-mesenchymal transition (EMT; 
Wu et al., 2003; Rubinstein et al., 2019). This corresponds with nuclear accumulation 
of β-catenin which is a common feature of the invasive front in metastatic CRC 
(Suzuki et al., 2008). In the previous chapter, it was established that direct contact 
with selected species may contribute to disease progression by promoting an increase 
in cell yield. The acquisition of motile characteristics in benign cells is a crucial step 
in malignant transformation, and as previously discussed, the migration and invasion 
of malignant tumour cells is the largest contributor to patient mortality. Therefore, any 
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contribution to migratory behaviour by bacteria would represent a key role for bacteria 
in the progression of CRC.  
5.2 Aims 
The aim of this chapter was to investigate whether direct treatment with CRC-
associated bacteria can induce motile and invasive behaviour in either benign and/or 
malignant colorectal tumour cells. Furthermore, where an effect on tumour migration 
or invasion was observed, this chapter also aimed to elucidate the underlying 
mechanisms responsible, with a view to identifying novel targets for further 
investigation.  
5.3 Objectives 
The objectives of this chapter were as follows: 
• To investigate how infection with bacteria effects single and multiple cell 
migration in RG/C2 and HCT116 cells. 
• To determine whether species which demonstrate an ability to promote 
migration are also capable of promoting tumour invasion in vitro.  
• To investigate how bacteria influence β-catenin signalling activity using 
luciferase reporter assays.  
• To use qPCR microarrays to quantify the expression a wide range of cell 
motility and EMT-related genes and determine how this expression alters upon 
bacterial infection. 
  




5.4.1 E. coli Nissle and F. nucleatum promote migration in HCT116 cells  
The migration of infected colorectal tumour cells was assessed by seeding cells 24 
hours post-infection into transwell filter migration assays (see Section 2.10.2). During 
this assay, tumour cells seeded in the apical compartment of the filter are attracted to 
the serum present in the lower compartment via chemotaxis and migrate through the 
filter towards it. As cells migrate, they become embedded in the collagen coating on 
the basal layer of filter, and can subsequently be fixed, stained and counted. The 
average number of migratory RG/C2 cells counted was 17 per field of view (Figure 
5.1), which was significantly lower than the average number of HCT116 cells (91; 
Figure 5.2) despite being initially seeded at twice the density to protect the benign 
cells from the negative effects associated with a lack of cell-cell contact. Infection 
with bacteria had no effect on the migration of RG/C2 cells, although E. coli Nissle,               
E. faecalis and F. nucleatum caused small, non-statistically significant reductions in 
the number of migratory cells counted. In contrast, E. coli Nissle and F. nucleatum 
significantly increased the migration of HCT116 cells. E. coli Nissle-treated HCT116 
cells had an average of 129 migratory cells (p = 0.0169), but the largest effect on 
migration was seen in F. nucleatum-treated cells, with an average of 173 cells counted 
(p = 0.0257). 
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5.4.2 Wound healing in HCT116 cells is increased by E. coli Nissle and    
F. nucleatum infection 
The results presented in Section 5.4.1 established that both E. coli Nissle and                  
F. nucleatum increased single-cell migration in HCT116 cells. As the mechanisms of 
single-cell migration can differ from those of collective cell migration, the ability of 
bacteria to promote collective cell migration was also investigated using the wound 
healing assay. Furthermore, to the author’s knowledge the experiments performed in 
Section 5.4.1 are the first to use previously infected cells in a transwell filter migration 
assay. Therefore, performing a secondary migration assay had the added benefit of 
providing validity to these results.  
Confluent monolayers of tumour cells were infected with bacteria, before a 
sterile pipette tip (P200) was used to create a wound. Phase contrast images were taken 
of the wound at three separate locations per well, and the reduction in wound surface 
area was calculated after 24 hours. Untreated RG/C2 cells exhibited an average 
reduction in wound area of 11.53% (Figure 5.3). Infection with all species of bacteria 
tested inhibited wound healing, although not to a statistically significant degree. The 
largest decrease was seen with cells infected with F. nucleatum, where a reduction of 
5.71% was observed (p = 0.0736). HCT116 cells displayed a greater capacity for 
wound healing than RG/C2 cells, with an average reduction of 15.01% in untreated 
cells (Figure 5.4). In contrast to RG/C2 cells, infection with bacteria increased wound 
healing, with the exception of E. faecalis-treated cells where the average wound area 
reduction was 14.89%. Infection with B. fragilis increased wound area reduction to 
17.87%, although this was not statistically significant (p = 0.0574). However, both      
E. coli Nissle (p = 0.0380) and F. nucleatum (p = 0.0399) infection significantly 
increased wound healing in HCT116 cells to 27.90% and 24.53%, respectively. 
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Finally, RG/C2 cultures exhibited a large number of cellular debris during wound 
healing, despite cells being washed in PBS after wound creation to remove debris. In 
contrast, minimal debris was observed in HCT116 cultures (Figure 5.3B and 5.4B), 
suggesting that scratching RG/C2 monolayers using a pipette tip may reduce viability 
in the remaining cells. 
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5.4.3 F. nucleatum promotes invasion in HCT116 cells 
Having established that E. coli Nissle and F. nucleatum infection is able to promote 
both single and collective cell migration in HCT116 cells, the effect of these species 
on HCT116 invasion was investigated. In addition to migration, cellular invasion 
requires the remodelling of the extracellular matrix, which is facilitated by the 
secretion of enzymes such as matrix metalloproteinases which degrade ECM 
components e.g. gelatin (Murphy et al., 1985). Invasion was quantified using transwell 
filters coated in Matrigel®, a gelatinous protein mixture produced by mouse sarcoma 
cells which resembles complete mammalian ECM (Hughes, Postovit and Lajoie, 
2010). Therefore, unlike transwell filter migration assays where cells are able to freely 
pass through the filter pores, these invasion assays require tumour cells to produce the 
necessary enzymes to digest and subsequently invade the Matrigel® substrate. 
On average, 37 invasive HCT116 cells were counted per field of view in the 
control group (Figure 5.5). Infection with F. nucleatum significantly increased 
HCT116 invasion, with an average of 61 cells counted (p = 0.0326). Infection with    
E. coli Nissle had no effect on HCT116 invasion. The effect of infection with by            
B. fragilis or E. faecalis was not assessed due to the cost of performing Matrigel® 
invasion assays, and the assumption that there was unlikely to be an effect on tumour 
cell invasion when no effect on migration was observed.  A single invasion assay was 
also performed using RG/C2 cells infected with both E. coli Nissle and F. nucleatum; 
however, no invasive cells were detected in the control or either of the treated cell 
groups, and so no further replicates were performed (data not shown). This was 
expected, as RG/C2 cells were derived from a benign (and therefore non-invasive) 
tumour.  
  



































Figure 5.5: Invasion of HCT116 cells after bacterial infection. Average number of invasive HCT116 cells 
counted after migration through Matrigel® coated transwell filter inserts. Error bars represent standard 
deviation, and results of three independent experiments repeated in triplicate. *= p < 0.05. 
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5.4.4 Promotion of migration and invasion of HCT116 cells by                                   
F. nucleatum is not accompanied by a change in catenin-related 
transcription 
It has been reported in the literature that F. nucleatum promotes catenin-related 
transcription (CRT) in colorectal tumour cells (Rubinstein et al., 2019). Furthermore, 
the acquisition of an invasive phenotype normally involves epithelial-mesenchymal 
transition (EMT), which is accompanied by accumulation and nuclear translocation of 
β-catenin (Schmalhofer, Brabletz and Brabletz, 2009). To determine whether the 
observed effects on tumour cell migration and invasion seen in F. nucleatum-infected 
cells could be attributed to this signalling pathway, SDS-PAGE followed by Western 
blotting was performed on protein samples collected from infected cells. Figure 5.6B 
illustrates a representative image of a Western blot for β-catenin performed on RG/C2 
and HCT116 cells infected with F. nucleatum. Infection with F. nucleatum had no 
significant effect on the level β-catenin recovered in either cell line. This was 
confirmed using densitometry to quantify relative levels of protein concentration in 
each band (Figure 5.6A), which after normalisation using beta-tubulin revealed that 
RG/C2 cells possessed approximately five times the amount of β-catenin protein when 
compared to HCT116 cells.  
 As nuclear localisation of β-catenin is essential for CRT, a change in CRT is 
possible without a change in overall levels of protein due to changes in sub-cellular 
localisation. To accurately quantify CRT in infected tumour cells, the TOPFLASH 
assay was performed (see Section 2.11; Molenaar et al., 1996). The ratio of 
TOPFLASH/FOPFLASH luminescence accurately quantifies CRT, after 
normalisation to cell number using luminescence produced by the Renilla plasmid. 
TOP/FOP ratios were expressed as a fold change of the control for both RG/C2 (Figure 
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5.7A) and HCT116 (Figure 5.7B) cells. The high-throughput nature of this assay also 
allowed investigation of the effects of the other bacterial species used throughout this 
project on CRT. RG/C2 cells exhibited increased TOP/FOP upon bacterial infection, 
with increased CRT observed relative to the control in cells infected with B. fragilis 
and F. nucleatum (+20.6% and +39.55 respectively). CRT was almost doubled in cells 
infected with E. coli Nissle (+98.2%) and E. faecalis (+93.2%), however due to the 
large variation seen in TOP/FOP ratios these results were not statistically significant. 
In contrast, bacterial infection of HCT116 cells resulted in a non-significant decrease 
in TOP/FOP, which ranged between -10% and -13% for all species.  
  







Figure 5.6: Analysis of protein expression in RG/C2 and HCT116 cells after F. nucleatum infection. (A) 
After Western blotting and SDS PAGE, densitometry was performed to quantify relative levels of β-catenin 
protein present in infected cells. Error bars represent standard deviation and results of three independent 
experiments performed in triplicate. (B) Representative image of β-catenin and β-tubulin bands following SDS 
PAGE used to quantify protein expression.  




Figure 5.7: TOPFLASH luciferase activity in RG/C2 and HCT116 cells after bacterial infection. Fold 
change in TOPFLASH/FOPFLASH ratio after normalisation using Renilla luminescence relative to non-
infected tumour cells. Despite large increases in TOP/FOP in RG/C2 cells, the effect was not statistically 
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5.4.5 Regulation of cell motility genes upon infection of HCT116 cells with 
F. nucleatum 
To investigate the underlying mechanism responsible for the induction of tumour cell 
migration and invasion by F. nucleatum infection, qPCR microarrays were performed 
analysing the expression of 84 cell motility-related genes (Supplementary Table 1). 
The difference in CT (the point at which fluorescence for a particular gene crosses the 
threshold value) between untreated and F. nucleatum-infected cells was compared, 
and the fold regulation of each gene is presented in Figure 5.8. A total of 19 genes 
were upregulated by a factor of 1.3 or more, indicating an increased concentration of 
mRNA in infected cells. Three genes were downregulated to the same degree. The 
largest increase was seen in the expression of Supervillin (+21.11), with the largest 
decrease seen in Integrin beta 2 (-8.13). 
In order to further investigate the impact of the modulation of these genes on 
cell motility, the 10 genes for which the greatest change in expression were detected 
were cross-referenced with current literature on CRC motility (Table 5.1). This 
included the endogenous control gene ACTB, for which a fold regulation of +8.31 was 
recorded. The increased expression of this control gene did not interfere with data 
analysis, as the PCR microarrays used in this study contain a panel of 6 housekeeping 
genes allowing for normalisation to be performed on a stably expressed gene.  
Where no available literature on the expression of these genes in CRC was 
available, research investigating the role of these genes in other cancers was 
considered. Seven of these changes were associated with a tumour cell motility-
promoting effect. In contrast, alterations in the expression of two genes, ITGB2 (-8.13) 
and WIPF1 (3.23), were considered to have negative effects on cell motility. Parallel 
assays were performed in RG/C2 cells, with F. nucleatum regulating gene expression 
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differently in RG/C2 and HCT116 cell lines (Supplementary Figure 4). The impact of 
F. nucleatum infection on the 10 genes described in Table 5.1 was compared in both 
cell lines (Figure 5.9). ACTB, ITGB3, MMP2, RAC2 and SVIL were all negatively 
regulated by F. nucleatum infection in RG/C2 cells, despite being upregulated in 
HCT116 cells, highlighting a difference in response by these cell lines. ACTN3, FAP, 
ITGB2 and WIPF1 were regulated in the same manner in both cell lines, however a 
greater degree of change was seen in infected HCT116 cells when compared with 
RG/C2 cells, suggesting that the gene expression profile of this cell line is more 
sensitive to influence by bacterial infection.  




































































































































































   
   
   
   
   






   
   
   
   
   
   
   
   











   
   
   








   







   
   








   
   















   
   
   
   































































































































































































   
   
   









































































































































































































































































































































































Increased expression correlates with 
cell motility in LS180 colorectal 
adenocarcinoma cell line variants 
(Nowak et al., 2005).  
Essential for bleb formation in colon 











Limited literature on ACTN3 in 
cancer. Increased expression of 
ubiquitously expressed ACTN 
proteins e.g. ACTN4 enhances 
colorectal tumour invasion by 
suppressing focal adhesions 
(Fukumoto et al., 2015). 
FAP – Fibroblast 
activation protein 
Cell surface 
serine protease. +5.10 Positive 
High stromal levels of FAP in CRC 
linked to advanced disease and poor 
prognosis (Henry et al., 2007).  
Promotes angiogenesis via ERK 








liver tissue.  
+2.74 Positive 
Increased levels of circulating IGF1 
linked to future CRC development 
(Ma et al., 1999).  
Promotes invasion and apoptosis 
resistance in CRC through Akt/Bcl-
x(L) pathway (Sekharam et al., 
2003).  







Reduction in ITGB2 is associated 
with reduced migration, and 
specifically reduced hepatic 
metastasis (Benedicto et al., 2017).  





ECM binding.  
+2.61 Positive 
Expression induced by ROS 
increases migration and invasion in 
SW480 and SW620 cells (Lei et al., 
2011).  
Increased expression in CRC leading 
to enhanced invasion after loss of 
MiR-30a-5p (Wei et al., 2016).  
 









Increased activity in CRC, which is 
associated with invasion depth, 
lymph node involvement and Duke’s 
stage (Li et al., 2005).  
Activated by Twist1/2 binding to 
MMP2 promoter (Lu, Dong and Fan, 
2018). 
Effective prognostic marker for 
overall survival, recurrence and 
distant metastasis in breast cancer 
patients (Jiang and Li, 2021).  




GTPase. +2.27 Positive 
Expression of Rho GTPases is 
associated with a reduction in cell-
cell adhesion, and an increase in 
Table 5.1: Literature review of cell motility genes modified by infection of HCT116 cells with F. nucleatum. 
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actin punctae.  
+21.11 Positive 
Reorganises actin cytoskeleton to 
facilitate invadopodia formation in 
COS-7 cells (Crowley et al., 2009).  
Promotes EMT and metastasis in 
hepatocellular carcinoma under 
hypoxic conditions (Chen et al., 
2018) and promotes angiogenesis in 












Sequesters the β-catenin destruction 
complex in glioblastoma and 
promotes tumour proliferation and 
stemness(Gargini et al., 2016). 
Promotes disease aggressiveness in 
BRAF V600E thyroid cancer (Zhang 
et al., 2017). 
 
  





Figure 5.9: Comparison of regulation of cell motility genes by F. nucleatum in RG/C2 and HCT116 cells. 
Parallel qPCR arrays were carried out in RG/C2 and HCT116 cells infected with F. nucleatum. The genes 
which were most affected by F. nucleatum infection in HCT116 cells were compared with RG/C2 experiments.  
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5.4.6 Regulation of EMT-associated genes upon infection of HCT116 cells 
by F. nucleatum 
A qPCR microarray was also performed to investigate the regulation of genes 
associated with EMT (Supplementary Table 2). In total, 9 genes were upregulated by 
a factor of 1.3 or greater, compared to 8 genes which were similarly downregulated 
(Figure 5.10). The largest increase in expression was observed in IGFBP4 (+19.51), 
compared to COL1A2 which exhibited the largest decrease in expression (-6.08). Five 
of the observed genetic changes were associated with a net increase in EMT, compared 
with 4 changes associated with a downregulation of EMT (Table 5.2). The literature 
surrounding the role of SOX10 in CRC seems to implicate it as a negative regulator of 
EMT, despite being positively associated with EMT in other diseases. Once again, 
parallel assays were performed using RG/C2 cells (Supplementary Figure 5). When 
comparing these changes in gene expression with F. nucleatum-infected RG/C2 cells, 
BMP2, COLIA2, GSC, TFPI2 and WNT5A all displayed similar patterns of regulation 
by F. nucleatum infection in both cell lines (Figure 5.11). However, the intensity of 
the regulation differed between cell lines.  In comparison, GNG11, IGFBP4 and 
SOX10 displayed increased expression in HCT116 cells and decreased expression in 
RG/C2 cells. WNT11 was increased upon infection of RG/C2 cells but was decreased 
in infected HCT116 cells. Finally, the fold regulation of BMP2, MMP3, TFPI2 and 
WNT5A was greater in infected RG/C2 cells.  
  



































































































































































































































































































































































































































































































































































































































































































































































































Induces stemness and EMT in 
HCT116 and SW480 cells through 
STAT3 activation (Kim et al., 2015). 
Facilitates SNAIL1 signalling in 
colon and mammary tumour cells 
(Frey et al., 2020). 
COL1A2 – 
Collagen type I 






Expression increased during 
upregulation of SNAIL1 in DLD-1 
cells (Tanaka et al., 2016). 
Loss of BMP1 in SW620 cells 
increases expression of COL1A1 and 












Promotes survival in circulating 
colon and pancreatic tumour cells 
(Yadavalli et al., 2017). 







Expression in hepatocellular 
carcinoma promotes invasion and 










Increased apoptosis in HT29 cells 
through Bcl-2/Bax dependent 
mechanism (Durai et al., 2007). 
 








High expression of MMP3 leads to 
formation of invasive, mesenchymal 
tumours in breast cancer (Sternlicht 
et al., 1999).  
Stimulates EMT through Rac1b, and 
causes cell spreading in mouse 
mammary epithelial cells (Nelson et 










SOX10 expression has been 
demonstrated to inhibit Wnt/β-
catenin signalling in a range of 
digestive cancer cell lines, including 
HCT116 (Tong et al., 2014). 
However, found to promote EMT by 
inducing a mesenchymal phenotype 
in breast (Dravis et al., 2015) and 
nasopharyngeal (He and Jin, 2018) 
cancers. 









Induces differentiation in 
hepatocellular carcinoma (Li et al., 
2017). 
Inhibits progression of breast cancer 
through TWIST1 expression (D. Zhao 
et al., 2020). 
Table 5.2: Literature review of EMT genes modified by infection of HCT116 cells with F. nucleatum. 
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Silenced through methylation during 
CRC progression (Jung et al., 2020).  










Antagonises canonical Wnt signalling 
in CRC, inhibiting proliferation and 
EMT (Cheng et al., 2014).  
Lower expression in metastatic 
SW620 than SW480 cells due to 
silencing through histone 
modifications (Li and Chen, 2012). 
Potentially different activity 
depending on differential expression 
of mRNA isoforms, with the Wnt5a-
short being associated with invasion 
by HCT116 and tumour depth, 
whereas Wnt5a-Long suppressed β-
catenin expression (Huang et al., 
2017). 







High Wnt11 expression is associated 
with increased invasion and 5-year 
mortality in a CRC patient cohort 
(Gorroño-Etxebarria et al., 2019).  
AGR2 signalling promotes EMT and 
tumour invasion through Wnt11 in 
CRC cell lines including HCT116. 
HT29 and SW480 (Tian et al., 2018).  





Figure 5.11: Comparison of regulation of EMT genes by F. nucleatum in RG/C2 and HCT116 cells. 
Parallel qPCR arrays were carried out in RG/C2 and HCT116 cells infected with F. nucleatum. The genes 
which were most affected by F. nucleatum infection in HCT116 cells were compared with RG/C2 experiments.  
 




 The previous chapter demonstrated that infection with the four bacterial species 
tested, B. fragilis, E. coli Nissle, E. faecalis and F. nucleatum increased tumour cell 
yield after a relatively short infection period in both RG/C2 and HCT116 cell lines. 
This represents one clear means by which these species may contribute towards 
tumour progression in vivo. However, perhaps the most significant event in 
carcinogenesis is the development of migratory and invasive tumour characteristics; 
as patients with metastatic disease face significantly lower survival prospects and an 
increased likelihood of disease recurrence (Yu et al., 2019). As previously discussed, 
development of metastatic CRC from healthy epithelium normally occurs over several 
decades (Vogelstein and Kinzler, 1993). However, the predicted increase in global 
CRC incidence, coupled with the increased rates of CRC detected in younger 
populations in developed countries, suggests that the burden of metastatic CRC is set 
to rise (Rawla, Sunkara and Barsouk, 2019). It is therefore imperative that the 
contribution of microorganisms to colorectal tumour invasion and metastasis is fully 
understood in order to allow for the development of targeted treatments and improved 
diagnostics. 
This chapter begins by assessing the impact of bacterial infection on tumour 
migration using the transwell filter migration assay. This assay measures single cell 
migration, which in tumour cells can be classified into two types: amoeboid or 
mesenchymal (Friedl and Wolf, 2003). There are notable differences between these 
two forms of migration. Amoeboid migration is characterised by a rounded cell body 
shape, cell blebbing and weak adhesions to the substrate (Lintz, Muñoz and Reinhart-
King, 2017). In contrast, cells adopting a mesenchymal phenotype polarise to form a 
leading and trailing edge, which involves the formation of stress fibres (Hecht et al., 
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2015). Migratory RG/C2 cells primarily displayed a rounded morphology indicative 
of amoeboid migration (Figure 5.1). In contrast, both amoeboid and mesenchymal-
like HCT116 cells were observed, and the frequency of mesenchymal-like cells 
appeared to increase in F. nucleatum-infected cells (Figure 5.2F). Carcinoma cell lines 
are able to switch between these two forms of motility as required, in a Rho-signalling 
dependent manner (Paňková et al., 2010), and the results presented in this study may 
suggest that F. nucleatum infection specifically promotes mesenchymal migration. 
This hypothesis is supported by the cell motility array data which showed that                 
F. nucleatum infection increased the expression of Rac2, a Rho GTPase, by a factor 
of +2.23.  
 When analysing the number of migrated cells observed for each cell line, it is 
clear that RG/C2 cells are far less migratory than HCT116 cells. The average number 
of migrated cells in the RG/C2 control group was 17, which is consistent with previous 
studies which have quantified migration in this cell line using the same approach 
(Qualtrough et al., 2007). This is in stark contrast to HCT116 cells, where an average 
of 91 cells were counted in the control group, despite initially being seeded at half the 
density. Direct comparisons between cell lines in transwell filter assays are difficult, 
as each cell line will respond differently to the assay parameters. These include the 
use of Ca2+-free medium and relatively low seeding densities, reducing cell-cell 
contact. Normal epithelial cells undergo anoikis upon loss of ECM attachment and the 
breakdown of adherens junctions with neighbouring cells (Bretland, Lawry and 
Sharrard, 2001). Therefore, acquisition of anoikis resistance is essential for cells to 
become metastatic, as reviewed by Kim et al. (2012). As RG/C2 cells were originally 
isolated from a benign adenoma, they are more closely related to normal epithelium 
than the adenocarcinoma cell line HCT116. It could therefore be suggested that anoikis 
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may negatively impact RG/C2 cell migration in the transwell filter assay, which 
should be considered when comparing migration between these two cell lines. 
 Upon bacterial treatment of RG/C2 and HCT116 cells, these assays revealed 
that two of the four bacterial species tested, E. coli Nissle and F. nucleatum, were able 
to promote tumour migration. However, effect was only observed in HCT116 cells, 
with E. coli Nissle and F. nucleatum increasing migration by 42% and 91%, 
respectively. After extensive review of the literature, no previous example of the use 
of pre-infected cells within a transwell filter migration assay could be found. 
Therefore, in order to verify the observed effects on tumour migration, and examine 
whether the migration-promoting effects of E. coli Nissle and F. nucleatum extended 
to collective cell migration, wound scratch assays were also performed. It is also 
important to consider the impact of bacteria on collective tumour cell migration as it 
has been suggested that collective cell migration and the entry of ‘circulating tumour 
microemboli’ into the vasculature is linked to poorer patient prognosis when compared 
to individual circulating tumour cells (Hou et al., 2012). 
 Wound scratch assays also demonstrated that E. coli Nissle and F. nucleatum 
infection promotes motility in HCT116 cells. In contrast to the transwell filter 
migration assays, E. coli Nissle infection had a greater effect on migration in the 
wound scratch assay than F. nucleatum (+86% compared with +63%). RG/C2 cells 
experienced a decrease in migratory ability when treated with bacteria in both the 
transwell filter migration and wound scratch assays. F. nucleatum reduced RG/C2 
wound healing by 51%, although a large degree of variation was observed and 
therefore this was not statistically significant. This could possibly be attributed to 
varying cell depth of RG/C2 cultures which could influence cell migration. The lack 
of migration promotion in RG/C2 cells demonstrates that bacteria, in particular             
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F. nucleatum, can promote a migratory phenotype in HCT116 cells, but crucially 
cannot confer this phenotype to RG/C2 cells. This suggests that the mechanism of 
migration promotion may be specific to adenocarcinoma cells, as although RG/C2 
cells display lower basal levels of migration, several studies have demonstrated that 
their motility can be increased using other methods e.g. prostaglandin F2α and fascin 
over-expression (Qualtrough et al., 2007, 2009). When considering the Driver-
Passenger model of bacterial contribution to CRC (Tjalsma et al., 2012), this 
potentially implicates F. nucleatum as a driver of late-stage metastatic disease, as it 
may require the tumour to have already acquired aggressive characteristics to exert its 
effects on migration.  
 Unlike the effect on tumour cell yield observed in tumour cells infected with 
bacteria, the promotion of migration in HCT116 cells was species-specific. The 
increase in migration seen in E. coli Nissle-infected cells is surprising, as this species 
is often administered as a probiotic for intestinal disorders such as ulcerative colitis 
(Kruis et al., 2004). It should be considered that motility in the colonic epithelium is 
necessary for efficient cell turnover, with colorectal tumours initially displaying a 
reduction in motility after APC loss (Näthke et al., 1996). Therefore, the combination 
of the anti-inflammatory and pro-motility effects of E. coli Nissle may be necessary 
to stimulate the wound healing required for remission in ulcerative colitis patients, and 
protect the colon from tumour formation. However, pathogenicity of this probiotic 
strain has previously been reported. In 2010, a case of severe sepsis was reported in 
an infant administered with E. coli Nissle, with subsequent blood cultures identifying 
this species as the causative agent (Guenther et al., 2010). A study published in the 
same year found that E. coli Nissle pathogenicity was enhanced where microbiota 
dysbiosis and perturbation of the immune system occurred, as is often the case in CRC 
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patients (Gronbach et al., 2010; Gonzalez, Hagerling and Werb, 2018). The effect of 
E. coli Nissle on adenocarcinoma motility demonstrated in this chapter, coupled with 
its ability to invade epithelial cells, and promote tumour growth highlighted in 
previous chapters suggests that greater consideration should be given to its use as a 
probiotic in immunocompromised individuals and those at high risk of CRC 
development. As E. coli Nissle is commonly administered to IBD patients, an at-risk 
group for future CRC development, longitudinal studies may be necessary to 
determine the long-term effects of this treatment on CRC risk.   
 In the case of F. nucleatum, a role in in colorectal tumour motility has 
previously been suggested. F. nucleatum strains can be detected in both primary CRC 
tumours and their distant metastases, suggesting some association between F. 
nucleatum colonisation and tumour dissemination (Bullman et al., 2017). In this 
project, it was also demonstrated that F. nucleatum is able to promote invasion in 
HCT116 cells, a trait which was not shared with E. coli Nissle. In contrast to cell 
migration, invasion requires the degradation and remodelling of the ECM (Wolf et al., 
2007). The results of the PCR microarrays revealed that several genes associated with 
invasion were upregulated by F. nucleatum infection in HCT116 cells. The most 
upregulated gene was Supervillin (SVIL), a member of the gelsolin family of 
cytoskeletal organising proteins (Silacci et al., 2004). Reorganisation of the 
cytoskeleton is essential for cell motility, and the upregulation of both ACTN3 and 
ACTB supports the notion that F. nucleatum is able to influence this process. This is 
supported by literature demonstrating that F. nucleatum infection induces the 
formation of new actin filaments during its intracellular replication (Gursoy, Könönen 
and Uitto, 2008). Although no evidence for intracellular replication was observed 
during the investigation of bacterial persistence (see Section 3.4.6), it is possible that 
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bacterial replication occurred before the initial 24-hour time point, or that rates of 
bacterial replication and cell death were equivalent, resulting in no observable change 
in colony forming units.  
 SVIL specifically reorganises lamellipodial proteins, particularly cortactin, to 
co-localise with proteins required for the formation of invadopodia (Crowley et al., 
2009). At the tip of invadopodia, enzymes such as matrix metalloproteinases (MMPs) 
are expressed which digest the surrounding ECM to facilitate invasion (Jacob and 
Prekeris, 2015). Upon F. nucleatum infection of HCT116 cells, both MMP2 and 
MMP3. Interestingly, MMP2 is dependent upon cortactin organisation for its vesicular 
transport to invadopodia, potentially highlighting a synergistic effect between SVIL 
and MMP2 expression after F. nucleatum infection which increases invasive potential 
(Clark and Weaver, 2008). It should also be considered that the gentamicin protection 
assay data presented in Chapter 3 illustrated that F. nucleatum infection does not occur 
in all tumour cells present in the monolayer. Therefore, it is unlikely that each cell 
showing aberrant migration in the migration assays presented in this chapter are 
infected with bacteria, and thus, a bystander effect on neighbouring cells by infected 
cells may also occur to promote migration. 
 In addition to reorganisation of the cytoskeleton, tumour migration and 
invasion is often characterised by epithelial-mesenchymal transition (EMT). This 
process occurs in normal development and wound healing responses, but is 
dysregulated in many cancers including CRC, as reviewed by Brabletz et al. (2018). 
F. nucleatum has been implicated in the promotion of EMT across a number of cancers 
and through a wide range mechanisms. For example, in mouse models, F. nucleatum 
was demonstrated to colonise and promote the metastasis of breast tumours through 
its Fap2 surface protein (Parhi et al., 2020). A study investigating the effect of                
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F. nucleatum on oral squamous cell carcinoma cells found that F. nucleatum regulated 
the expression of multiple EMT-associated genes including Snail-1, Slug, Vimentin 
and E-cadherin (CDH1). In this study these genes were not found to be affected by      
F. nucleatum using PCR microarrays. However, BMP2, a regulator of Snail-1 
signalling was found to be increased by 1.7-fold in HCT116 cells following                      
F. nucleatum infection.  
 The net effect on EMT was unclear, as expression of EMT promoters and 
antagonists was increased upon F. nucleatum. One of the most important regulators of 
EMT in both human development and cancer is the Wnt signalling pathway (Clevers, 
2006). F. nucleatum is considered to be a regulator of this pathway through the binding 
of its FadA adhesin to the adherens junction protein E-cadherin during bacterial 
invasion (Rubinstein et al., 2013). In this study, F. nucleatum did not have a large 
effect on E-cadherin at the transcription level (as evidenced by the -1.18 fold change 
in expression of CDH1), although infection did decrease the expression of both Wnt5a 
and Wnt11 which are considered by antagonists of canonical Wnt signalling (Bisson 
et al., 2015). The effect of F. nucleatum infection on Wnt activity was further 
investigated by analysing the activity of the Wnt-regulating protein β-catenin. 
Surprisingly, and contrary to current literature, a small non-significant reduction in β-
catenin protein level was detected by SDS-PAGE. In addition, no effect on CRT was 
observed in F. nucleatum-infected HCT116 cells via the TOPFLASH assay, although 
a significant increase in FOPFLASH activity was observed. The FOPFLASH plasmid 
contains mutated TCF binding sites, and therefore only yields luciferase activity from 
its minimal c-fos promoter (Molenaar et al., 1996). During analysis of TOPFLASH 
assay data, the ratio of TOP/FOP is used to calculate the relative level of CRT. 
Therefore, an increase in FOPFLASH attributable to upregulation of the c-fos 
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promoter decreases the TOP/FOP ratio. The reduction in TOP/FOP observed in            
F. nucleatum-infected HCT116 cells may therefore be caused by an upregulation of c-
fos, which has emerged as a regulator of EMT in other cancers such as head and neck 
squamous cell carcinoma (Muhammad et al., 2017). Upregulation of this promoter 
may represent a novel mechanism through which F. nucleatum regulates EMT, 
although further investigation is clearly required.  
The absence of an effect on CRT in HCT116 cells after infection with                  
F. nucleatum is in direct contrast to an aforementioned paper by Rubinstein et al. 
which demonstrated a greater than 4-fold increase in gross TOPFLASH activity, with 
no effect on FOPFLASH in HCT116 cells treated with F. nucleatum (Rubinstein et 
al., 2013). Their study reported a similar upregulation of TOPFLASH activity in 
multiple CRC cell lines, which was suggested to be a result of FadA-mediated E-
cadherin cleavage. However, previous studies have shown that the adenocarcinoma 
cell lines used in this study possess vastly different levels of E-cadherin expression 
and would therefore not be expected to a show a comparable response (Qualtrough et 
al., 2015). In addition, if E-cadherin cleavage was the primary mechanism, an effect 
on the motility of benign cells which have higher E-cadherin expression compared to 
malignant cells would be expected. Furthermore, a difference in the promotion of cell 
yield demonstrated in Chapter 4 between RG/C2 and HCT116 cells would also be 
expected due to their significantly different levels of E-cadherin (Rees & Qualtrough, 
unpublished data).   
 A reduction in β-catenin expression upon infection by F. nucleatum has been 
demonstrated using PCR in oral squamous cell carcinoma, suggesting that the 
interaction between F. nucleatum and Wnt signalling may be highly variable 
(Abdulkareem et al., 2018). This variation may be attributable to experimental 
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conditions. For example, the Rubinstein group treated their cells at an MOI of 1000:1 
for a 2-hour period, in contrast to the MOI of 10:1 and 4-hour infection used in this 
study. Finally, when introducing the Driver-Passenger model, Tjalsma et al. posited 
that the ability of bacteria to drive tumorigenesis may be highly dependent upon strain-
specific virulence, and therefore this must be considered when comparing results 
across research groups (Tjalsma et al., 2012).  
The differences in the effect of F. nucleatum infection on RG/C2 and HCT116 
motility are reflected in the TOPFLASH and PCR results. In RG/C2 cells, infection 
with all four species of bacteria tested increased TOPFLASH activity. The divergent 
effects of bacterial infection on TOPFLASH activity in RG/C2 and HCT116 cells 
could be attributed to the Wnt signalling-specific mutations in these two cell lines. 
Although both are wild type for APC, the HCT116 cell line contains an activating β-
catenin mutation, whereas the RG/C2 cell line possess a heterozygous deletion in the 
β-catenin gene CTNNB1 (Greenhough et al., 2010; Dallosso et al., 2012). It should be 
noted that increase in TOPFLASH activity upon bacterial infection in RG/C2 cells 
was not statistically significant, and no increases in CTNNB1 gene expression were 
detected upon F. nucleatum infection in either cell line using PCR microarrays. 
However, the increase in RG/C2 TOPFLASH activity is supported by the change in 
Wnt5a expression seen in F. nucleatum-infected cells, where a decrease in expression 
greater than the decrease seen in HCT116 cells was detected (Figure 5.10). 
When analysing PCR microarray data, a general trend was observed whereby 
the net effect of F. nucleatum infection on cell motility and EMT appears to be 
promotive and support the migration and invasion data presented in this study. In the 
cell motility array, only a downregulation of ITGB2 and WIPF1 could be associated 
with reduced motility. However, many of the other genes influenced by F. nucleatum 
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supported a role of bacterial infection in the promotion of migration, with plausible 
mechanisms for their activation by bacteria. For example, F. nucleatum infection 
increased ITGB3 expression. This gene has also been demonstrated to be induced 
through radical oxygen species (ROS), which are commonly produced by immune 
cells during bacterial infection, and specifically produced by some microorganisms 
such as E. faecalis (Huycke, Abrams and Moore, 2002; Lei et al., 2011).  
The microarrays presented a less clear picture of EMT regulation by                    
F. nucleatum. The change in expression of four genes, COL1A2, IGFBP4, TFPI2 and 
the previously discussed Wnt11 were associated with a reduction in EMT. 
Interestingly, IGFBP4 expression, which was increased +19.51 fold upon                              
F. nucleatum infection, has been demonstrated to promote apoptosis in the HT29 cells 
(Durai et al., 2007). Microarray data shows that despite IGFBP4 expression being 
significantly increased in F. nucleatum-infected HCT116 cells, it is decreased in 
infected RG/C2 cells by a factor of -2.55 (Figure 5.10). Differential regulation of this 
gene in these cell lines could potentially explain the divergent effect on apoptosis seen 
in F. nucleatum-infected cells presented in Chapter 4. There are conflicting reports 
surrounding the role of SOX10 in EMT, which is thought to inhibit EMT in colorectal 
tumour cells (including HCT116) but promote EMT in other cancers (see Table 5.1). 
Further investigation is therefore required to elucidate the true role of SOX10 in EMT. 
In the study described in Table 5.1, the authors investigated the effect of ectopic 
SOX10 expression in isolation, and it is therefore possible the effect of SOX10 
expression on colorectal tumour EMT is context-dependent (Tong et al., 2014).  
Despite being studied in other cancers, several of these genes identified as 
having expression modified by F. nucleatum infection have not been fully studied in 
CRC, including GSC, MMP3 and WIPF1. The PCR microarrays performed in this 
Chapter 5: Gut bacteria influence tumour cell motility in a tumour stage-dependent manner 
205 
 
study have therefore succeeded in identifying potentially novel pathways which may 
implicate F. nucleatum in the promotion of invasion and metastasis in CRC. Due to 
the high cost of performing these arrays, it was only possible to perform a single 
replicate, meaning that caution must be used when attempting to draw conclusions 
from the data. However, the Qiagen PCR microarrays performed in this study utilise 
internal controls for genomic DNA contamination, PCR reproducibility and reverse 
transcription efficiency, which improve confidence in the dataset. It should also be 
considered that these assays are ultimately measuring changes in mRNA levels 
extracted from treated cells, which do not necessarily correspond to a change in 
translated protein (Liu, Beyer and Aebersold, 2016). To distinctly prove that                         
F. nucleatum expression produces a functional change in protein level, as suggested 
by the alterations in gene expression presented in this study, there are several assays 
which should be performed. Firstly, analysis of protein concentration via Western 
blotting would confirm that any change in mRNA level is translated into a change in 
protein expression. For any proteins whose production is found to be altered by                    
F. nucleatum infection, congenic knock-down cell lines should be produced, and 
migration and invasion assays repeated to definitely show that these genes regulate 
HCT116 motility and invasion in response to bacterial infection.  
In summary, the results presented in this chapter demonstrate that bacteria, 
specifically F. nucleatum, are able to promote migratory and invasive behaviour in 
malignant CRC cells. This aligns with other published studies which have drawn 
similar conclusions, but crucially, this study suggests that the bacteria tested cannot 
directly promote the acquisition of these characteristics in benign tumour cells. When 
considering the adenoma-carcinoma sequence this implicates F. nucleatum, and to a 
lesser extent E. coli, in the progression of late-stage disease. As the overwhelming 
Chapter 5: Gut bacteria influence tumour cell motility in a tumour stage-dependent manner 
206 
 
majority of cancer-related deaths are attributed to metastasis, this supports the growing 
literature which identifies F. nucleatum as a marker of poor prognosis in CRC patients. 
This research could not link the tumour-promoting effects of F. nucleatum infection 
to an increase in CRT, and therefore disagrees with the results published by Rubinstein 
et al. (2013). Although this does not represent a direct contradiction, as differences 
between studies are possible due to strain specific characteristics and differences in 
experimental procedures, it does highlight the need for thorough investigation into the 
interaction of microorganisms and tumours. Finally, this chapter has identified 
numerous cell motility and EMT-related genes which are regulated by F. nucleatum 
and may potentially be responsible for this species’ invasion-promoting effects. 
Although these pathways require further investigation, the apparent synergy between 
these regulated genes, particularly the relationship between SVIL, ACTN and 
MMP2&3, indicates that F. nucleatum may promote invadopodia formation and ECM 
degradation in HCT116 cells. The findings presented in this chapter suggest that not 
only can tumour-associated bacteria be used as prognostic markers in CRC, but that 
they may be associated with lesser-known pathways which may represent novel 
treatment targets for metastatic disease.
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There is an increasing focus on the role of microorganisms in CRC, although studies 
are limited by the inherent difficulties in studying interactions between bacteria and 
tumours over prolonged time periods. There is a need to improve our understanding 
of how this relationship unfolds over the adenoma-carcinoma sequence in order to 
make a positive impact on patient treatment and prognosis. The main aim of this thesis 
was to investigate whether CRC-associated microorganisms influence the behaviour 
of benign and malignant tumour cells and whether they do so differently. The presence 
of specific microorganisms in CRC patients has been extensively investigated, leading 
to several species being proposed as CRC drivers (Feng et al., 2015; Mori et al., 2018; 
Saffarian et al., 2019). Giving the example of Enterotoxigenic strains of B. fragilis, 
which are found in increased abundance in CRC patients, the ‘Alpha-bug’ hypothesis 
proposes that specific bacteria are able to drive CRC development at all stages of its 
progression, beginning with healthy epithelium (Ulger Toprak et al., 2006; Sears and 
Pardoll, 2011). More recently, the Driver-Passenger model was proposed which 
suggests that bacterial drivers, which directly promote CRC development, are 
transiently associated with specific stages of CRC, and are gradually outcompeted by 
passenger species which are better adapted to the tumour microenvironment (Tjalsma 
et al., 2012). Therefore, some species reported as being abundant in CRC patients may 
simply be passengers and possess no pro-tumorigenic effects.  
 Developing our understanding of microbial involvement in CRC is crucial, as 
it remains a leading cause of cancer-related death (Cancer Research UK, 2021). 
Although survival rates in developed countries have improved, increasing incidence 
in developing nations and an earlier onset in Western populations suggests that CRC 
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will remain a global public health challenge (Sung et al., 2021). The Western diet has 
been suggested as a key risk factor for CRC development in high income countries 
(Adlercreutz, 1990). Such dietary patterns alter the composition of the colonic 
microbiota, allowing the colonisation and outgrowth of bacterial species which have 
been linked to CRC development and progression. This project investigated the 
tumour-promoting characteristics of three species commonly associated with CRC: B. 
fragilis (Enterotoxigenic), E. faecalis and F. nucleatum. In addition, the influence of 
E. coli Nissle on tumour behaviour was also investigated, as it is currently 
administered as a probiotic to treat inflammatory bowel disease, which is itself a risk 
factor for CRC development (Lutgens et al., 2008; Kim and Chang, 2014).  
 To investigate how bacteria may influence tumour behaviour at different stages 
of CRC development, the RG/C2 and HCT116 cell lines were selected. RG/C2 cells 
were derived from a tubular adenoma and have retained many of the characteristics 
present in normal colon epithelium, including microvilli and mucin droplet formation 
(Paraskeva et al., 1989). Furthermore, this cell line is non-invasive and non-
tumorigenic in athymic mice. This is in contrast to the HCT116 cell line which was 
isolated from an adenocarcinoma, and is therefore highly tumorigenic and represents 
an advanced stage of CRC (Brattain et al., 1981). In Chapter 3, the gentamicin 
protection assay was used to demonstrate that all four of the species tested readily 
associate with colorectal tumour cells, both attaching to the surface and invading the 
monolayer. This assay revealed the first difference in the interaction of bacteria with 
benign and malignant tumour cells, with levels of bacterial attachment being higher in 
RG/C2 co-cultures, in contrast to bacterial invasion which was higher in HCT116 co-
cultures. Although the levels of attachment and invasion differed between cell lines, 
the total colony forming units isolated from RG/C2 and HCT116 co-cultures were 
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similar, suggesting that bacteria may be blocked from invading benign cells, or that 
malignant cells are more permissive to bacterial entry.  These differing levels of 
bacterial association may be key in regulating the effects of bacteria on CRC 
progression, as many proposed mechanisms for promotion of tumorigenesis by 
bacteria involve microbial binding to cell surface proteins such as E-cadherin, 
expression of which changes during the adenoma-carcinoma sequence (Steck et al., 
2011; Guo et al., 2020).  
 The mechanisms underlying the differences in attachment and invasion may 
be species specific and warrant further investigation. One disadvantage of the 
gentamicin protection assay is that it does not distinguish between active and passive 
entry of bacteria in mammalian cells. This could be elucidated by repeating the assay 
and including heat-killed bacterial cells and testing for their internalisation using 
culture-independent methods e.g. antibody staining. If heat-killed bacteria were not 
internalised, this would indicate that the bacteria are actively invading colorectal 
tumour cells. This would be supported by previous research, which has demonstrated 
that increased numbers of invasive bacteria are present in direct contact with the 
epithelium in CRC patients when compared to healthy controls (Strauss et al., 2011). 
Bacteria have been demonstrated to bind to several epithelial cell surface molecules 
to facilitate their invasion. For example, F. nucleatum was found to attach to the cell 
surface carbohydrate Gal-GalNAC, which is overexpressed in adenocarcinoma and 
specific adenoma subgroups (Abed et al., 2016). The use of the RG/C2 cell line, and 
other adenoma-derived cell lines such as the AA/C1 series also isolated by Paraskeva 
et al. (Paraskeva et al., 1984), could therefore provide a unique opportunity to 
investigate how levels of these surface molecules alter during the adenoma-carcinoma 
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sequence, which coupled with further gentamicin protection assays would provide 
insight into the changing levels of bacteria association.  
 To the author’s knowledge, Chapter 3 also demonstrates for the first time the 
intracellular persistence of the four species in a simple 2D culture of colorectal tumour 
cells under standard conditions (37°C and 5% CO2). This enabled the use of ‘bacteria-
infected’ cells for further downstream assays. Studying the interactions between 
tumour cells and CRC-associated bacteria in vitro has proved challenging as many of 
these species are fastidious, strict anaerobes. This has led to innovation and the 
development of numerous models for gut-microbe simulation including the ‘Simulator 
of Human Intestinal Microbiome’ (SHIME) and Human-oxygen Bacteria-anaerobic 
(HoxBan) systems (Molly et al., 1994; Sadabad et al., 2015). However, such models 
are not suitable for all applications to study mammalian cell behaviour and can be 
associated with high cost and requisite expertise which may preclude their use in 
smaller laboratories. The use of 3D co-culture systems has also proved effective in 
investigating bacteria-tumour interactions. In particular, a recent study by Kasper et 
al. (2020) demonstrated that tumour spheroids of colorectal origin (including 
HCT116-derived spheroids), when grown to a sufficient size are able to provide an 
anaerobic environment in their centre which facilitates the survival and proliferation 
of anaerobic bacteria such as F. nucleatum (Kasper et al., 2020). Finally, 
microfluidics-based approaches have also shown promise in modelling the interface 
between the colonic mucosa and microorganisms. These include the HuMiX system, 
which has the benefit of incorporating immune cells to better mimic the colonic 
microenvironment, as cross-talk between the immune system and multiple cell types 
is a key mechanism in CRC development and progression (Shah et al., 2016). An 
important characteristic of these models is their modularity, allowing the incorporation 
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of multiple cell types to target specific research questions. The results presented in this 
thesis show that simple 2D co-culture systems are appropriate for rapid investigation 
of bacteria-tumour interactions and their effects, which can then be progressed to more 
complex models. In addition, simple modifications such as the addition of mucin to 
the bacterial culture medium were demonstrated to produce phenotypic changes in 
bacterial behaviour, indicating that this model could be further developed to more 
closely represent in vivo conditions. 
 After establishing that the four species of bacteria tested interact with 
colorectal tumour cells in vitro, Chapter 4 and Chapter 5 report the investigation of 
the effects of this interaction on tumour cell behaviour. By monitoring tumour cell 
yield of bacteria-infected cells, it was found that all four species significantly 
promoted cell yield in both RG/C2 and HCT116 cells. This was coupled with a 
decrease in the number of apoptotic cells counted, with the exception of F. nucleatum 
infection of HCT116 cells. This represents a clear means of bacterial contribution to 
tumour progression, with resisting apoptosis being a central hallmark of cancer 
(Hanahan and Weinberg, 2011). Apoptosis resistance facilitates clonal expansion in 
tumour cells, allowing the accumulation of cancer driving mutations; although, 
paradoxically some level of apoptosis within tumours may be beneficial, as it favours 
the outgrowth of more aggressive sub-clones (Labi and Erlacher, 2015). Nevertheless 
increasing tumour cell yield, and subsequent increases in tumour size could represent 
a mechanism through which tumour colonisation by these organisms worsens patient 
prognosis (Kornprat et al., 2011).  
 When investigating the promotion of cell yield in colorectal tumours, it is 
important to consider cellular metabolism as a key moderating factor. To generate 
ATP in vivo, colonocytes primarily metabolise the bacterial fermentation product 
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butyrate, the action of which also influences proliferation, differentiation, motility and 
stemness (Leschelle et al., 2000). Through the Warburg effect, tumours preferentially 
undergo aerobic glycolysis, and the resulting accumulation of butyrate in the cytosol 
allows it to translocate to the nucleus and perform its functions as an HDACi 
(Warburg, Wind and Negelein, 1927; Donohoe et al., 2012). This effect has been 
linked to mutations in APC, and so is thought to be an early event in CRC development 
(Satoh et al., 2017; Cha et al., 2021). The metabolic phenotype assays performed in 
this study confirmed that metabolic differences are present between colorectal 
adenoma and adenocarcinoma cells. Specifically, RG/C2 cells exhibited far higher 
rates of oxygen consumption compared to the three adenocarcinoma cell lines tested, 
confirming that a downregulation of oxidative phosphorylation may occur during the 
transition from adenoma to adenocarcinoma.  
 In addition to differences in the ratio of oxidative phosphorylation to 
glycolysis, cancer formation is associated with changes in numerous other metabolic 
pathways. There is currently a substantial research effort to develop diagnostic tools 
which take advantage of these altered metabolic profiles, with the use of gas sensors 
showing promise in being able to accurately diagnose numerous cancers (Omar et al., 
2016; Bond et al., 2019). In this study, SIFT-MS was used to investigate the volatile 
product ion peaks detected from the headspace above colorectal tumour cells. This 
data demonstrated that benign cells could be differentiated from malignant cells based 
on their volatile profiles, which is supported by the results of the Seahorse metabolic 
assays. A recent study has successfully demonstrated that biomarkers present in urine 
are able to diagnose colorectal adenomas or CRC using GC/MS (Mozdiak et al., 
2019). However, it should be considered that these metabolites are likely to be blood-
borne and may not be reflected in the metabolites detected in the headspace above 
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tumour cell cultures in vitro. Despite this, the results presented in this study highlight 
the suitability of SIFT-MS analysis of RG/C2 and adenocarcinoma cells for 
identifying potential volatile biomarkers, which could then be quantified under 
different conditions (e.g. different nutrient supplements to the medium, hypoxic 
conditions), improving our understanding of the mechanisms which underlie these 
metabolic changes.  
 Having established that metabolic differences are apparent between benign and 
malignant colorectal tumour cells in vitro, Seahorse and SIFT-MS techniques were 
employed to determine if bacterial infection produced a detectable metabolic change. 
SIFT-MS was able to discriminate B. fragilis and F. nucleatum-infected RG/C2 cells 
from those infected with E. coli Nissle or E. faecalis; however, this result was not 
reproduced in HCT116 cells. Other research groups have succeeded in accurately 
discriminating between infectious agents, intracellular bacteria and viruses, in vitro 
(Slade et al., 2017; Traxler et al., 2019). Therefore, identification of specific bacterial 
agents based on the volatile profiles of the infected mammalian cells may be possible 
with altered assay parameters, such as increasing the infection period or using different 
volatile extraction techniques (e.g. solid phase microextraction or solvents).  
 Interestingly, Seahorse metabolic rate assays demonstrated that both B. fragilis 
and F. nucleatum produced a metabolic shift in infected HCT116 cells. Both species 
increased basal levels of glycolysis, with F. nucleatum also increasing the maximum 
glycolytic rate. A Warburg-like metabolism has previously been described in 
mammalian cells upon bacterial infection with species such as Brucella abortus; 
however, it is currently unclear whether this phenomenon is induced by the infecting 
bacteria, or is a response of the human cell to this infection (Czyz, Willett and Crosson, 
2017; Escoll and Buchrieser, 2018). Regardless of the underlying mechanism, a 
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Warburg-like metabolic phenotype induced by B. fragilis and F. nucleatum would 
confer the previously discussed advantages to tumour cells (see Section 1.4.3), which 
include increased growth rate, increased glucose uptake and suppression of immune 
function through lactate secretion. In order to elucidate the contribution of this 
metabolic shift to the observed increases in tumour cell yield, glycolysis could be 
targeted to determine if this effect occurs independent of glucose metabolism. 
Shiratori and colleagues (2019) have found that substituting glucose present in cell 
culture medium for galactose yields no net ATP from glycolysis production, and this 
would represent a suitable model for studying the contribution of bacteria-induced 
glycolysis to tumour cell growth (Shiratori et al., 2019).  
 Ultimately, the results of Chapter 4 implicate infection of colorectal tumours 
by bacteria in the progression of CRC through increasing cell yield, thereby facilitating 
clonal evolution. Chapter 5 focussed specifically on the contribution of these 
microorganisms to tumour invasion and metastasis. Metastasis is the leading cause of 
cancer-related death across all cancerous diseases (Dillekås, Rogers and Straume, 
2019). The tumour microenvironment has been implicated as a key regulator of 
metastatic development, particularly in CRC where this microenvironment also 
includes the microbiota and its associated metabolites. The results presented in 
Chapter 5 demonstrated that two species, E. coli Nissle and F. nucleatum, are able to 
significantly promote HCT116 migration in vivo. The migration-promoting abilities 
of E. coli Nissle could be a by-product of its probiotic activity, and may be beneficial 
to the healing of ulcerative lesions in inflammatory bowel disease (Kruis et al., 2004). 
Crucially, E. coli Nissle did not contribute towards HCT116 invasion, in contrast to 
F. nucleatum which produced a significant increase in invasive behaviour which is 
consistent with the findings of other research groups (Abdulkareem et al., 2018; Ma 
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et al., 2018). This may be a pivotal means through which F. nucleatum colonisation 
of tumour worsens patient prognosis, as metastasis accounts for the overwhelming 
majority of CRC deaths. The lack of impact on tumour cell migration by B. fragilis 
was surprising, as this species has previously been linked to enhanced CRC 
progression through the activation of β-catenin signalling (Wu et al., 2003). However, 
it is important to consider that transwell filter and wound healing assays do not fully 
encompass the range of mechanisms through which bacteria may contribute to tumour 
migration. For example, the increased rate of glycolysis observed in B. fragilis-
infected HCT116 cells (see Chapter 4.4.6) could facilitate tumour migration through 
increased lactate production; as this has been demonstrated to promote tumour cell 
motility through acidification of the tumour microenvironment (Goetze et al., 2011). 
 One of the most substantial findings of this thesis is that despite the significant 
migrating-promoting effects of certain species in the malignant HCT116 cell line, no 
effect on the migration or invasion of benign RG/C2 cells was reported. This would 
suggest that the action of these bacteria (e.g. F. nucleatum and E. coli) is more relevant 
to late-stage CRC patients than those harbouring benign tumours, and implicates these 
species as late drivers of CRC progression (Tjalsma et al., 2012). Recent studies have 
investigated the efficacy of targeted bacterial treatment in patient-derived mouse 
xenograft models, and demonstrated that eradication of F. nucleatum in these tumours 
reduced overall tumour growth (Bullman et al., 2017). The results of this thesis 
indicate that adjuvant antibiotic therapy in CRC patients could improve patient 
prognosis by eliminating the promotion of tumour cell yield and migration/invasion 
by species such as F. nucleatum.  
 Although this thesis progresses our understanding of the temporal association 
between tumour-promoting bacteria and disease stage, further research is required to 
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identify the mechanisms responsible for the observed effects on tumour growth and 
migration. This is particularly important if microorganisms are to be targeted in CRC 
treatment, as any therapy should be highly specific to avoid the negative consequences 
of broad antibiotic use, which can include increased risk of CRC (Cao et al., 2018b). 
Tumour cell yield was increased after infection by all species studied, at relatively low 
MOI. This may suggest that the mechanism is not species-specific and could be due 
to tumour cell interactions with basic bacterial antigens e.g. LPS. The ability of some 
species to promote migration and invasion is likely to be attributable to specific 
virulence factors. For example, the F. nucleatum adhesin protein FadA has been linked 
to promotion of CRC and other cancers, with FadA- mutants possessing less invasive 
capabilities and lower tumorigenic potential (Guo et al., 2020). Therefore, performing 
similar experiments with knockout strains for a number of common virulence factors 
would provide valuable insight into the mechanisms through which bacteria promote 
CRC progression. 
 The difference in response between RG/C2 and HCT116 cells, particularly in 
the migration assays presented in Chapter 5, is an exciting result, and requires further 
research. Interestingly, these changes could not be aligned with changes in catenin-
related transcription of bacteria-infected cells, which has been commonly proposed as 
a mechanism of F. nucleatum-associated tumour promotion (Rubinstein et al., 2013; 
Chen et al., 2017). The PCR microarrays performed using cells infected with F. 
nucleatum in this thesis have highlighted numerous pathways which would be 
beneficial to explore. Of particular interest is the apparent upregulation of SVIL, 
MMP2 and MMP3, which according to the literature may act synergistically with one 
another to promote tumour cell invasion (Clark and Weaver, 2008; Crowley et al., 
2009). Such investigations should begin by determining whether these changes in 
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mRNA levels detected by the PCR microarrays are reflected in the level of transcribed 
protein. Finally, knockout studies using CRISPR/Cas9 or short-interfering RNAs to 
eliminate expression of these genes would determine whether the migration and 
invasion-promoting effects of F. nucleatum infection persists in their absence. This 
would allow us to elucidate the mechanism of bacterially stimulated motility and 
invasion.  
 In summary, this research was performed with the aim of determining whether 
CRC-associated microorganisms, or the probiotic species E. coli Nissle, differentially 
influence the behaviour of benign and malignant tumour cells. It appears that all 
species are capable of indirectly promoting colorectal tumour progression through 
increasing cell yield, whereas F. nucleatum emerged as the one species investigated 
capable of driving the migration and invasion of adenocarcinoma cells. The data 
presented was collected using a simplistic 2D co-culture model under specific micro-
environmental conditions, and therefore further experiments using more 
representative models are required. However, this thesis adds support to the growing 
appreciation of the key role microorganisms play in CRC, particularly in the 
development of migratory and invasive characteristics. The difference in both the 
interaction of benign and malignant cells with bacteria, and the subsequent effect of 
this interaction on their behaviour, suggests that the roles of these microorganisms 
may shift during disease progression. Therefore, integrating our knowledge of the 
involvement of microorganisms in CRC at specific stages is essential to improving 
patient prognosis, and may hold the key to providing novel treatment and diagnostic 
techniques
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Supplementary Figure 1: Survival of bacteria in serum-free DMEM under standard culture conditions. 
Overnight bacterial cultures were adjusted to an optical density of 0.05 in serum-free DMEM (high glucose) in a total 
volume of 10 ml. Bacteria were then incubated under standard cell culture conditions (37°C and 5% CO2 for 4 hours, 
corresponding to the total infection time used for all other assays. At hourly intervals, bacteria were plated onto blood 
agar plates, incubated under anaerobic conditions, and the total colony forming units (cfu) was calculated for each 
time point. The facultative anaerobes E. coli Nissle and E. faecalis were able to proliferate under these conditions. 
Both B. fragilis and F. nucleatum were not able to grow in DMEM under standard culture conditions, but no reduction 
in the total viable cfu was observed, indicating that these conditions did not negatively impact their viability. 





Supplementary Figure 2: Efficacy of gentamicin and metronidazole against target bacterial species. Overnight 
bacterial cultures were adjusted to an optical density of 0.05, before being pelleted by centrifugation and resuspended 
in serum-free DMEM containing 300 μg/ml gentamicin and 200 μg/ml metronidazole (antibiotics). Cultures were 
incubated under standard culture conditions for one hour, reflecting the antibiotic treatment time used in all gentamicin 
protection assays, before being enumerated onto blood agar plates. At this concentration, the antibiotics completely 
eliminated all viable bacteria for all species, with the exception of B. fragilis where a 6 log reduction in viable cfu was 
recorded. As increasing the concentration of antibiotics any further may have caused entry into tumour cells, 
negatively impacting the validity of the gentamicin protection assays, this concentration was deemed suitable for all 
further experiments.  






Supplementary Figure 3: Saponin does not impact bacterial viability. Overnight bacterial cultures were adjusted 
to an optical density of 0.05, before being pelleted by centrifugation and resuspended in serum-free DMEM containing 
1% w/v saponin. Cultures were then incubated for one hour under standard cell culture conditions, before being 
enumerated onto blood agar plates. Incubation with saponin did not alter bacterial viability in any of the four species 
tested (paired T-test). This indicates that this method of tumour cell lysis does not affect the measurement of 
attached/intracellular bacteria.   
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Supplementary Table 1: Complete list of target genes in Qiagen Cell Motility PCR Microarrays (Catalogue number: 
PAHS-128Z) 
Symbol Description Symbol Description 
ACTN1 Actinin, alpha 1 MYH10 Myosin, heavy chain 10, non-muscle 
ACTN3 Actinin, alpha 3 MYH9 Myosin, heavy chain 9, non-muscle 
ACTN4 Actinin, alpha 4 MYL9 Myosin, light chain 9, regulatory 
ACTR2 ARP2 actin-related protein 2 homolog (yeast) MYLK Myosin light chain kinase 
ACTR3 ARP3 actin-related protein 3 homolog (yeast) PAK1 P21 protein (Cdc42/Rac)-activated kinase 1 
AKT1 V-akt murine thymoma viral oncogene homolog 1 PAK4 P21 protein (Cdc42/Rac)-activated kinase 4 
ARF6 ADP-ribosylation factor 6 PFN1 Profilin 1 
ARHGDIA Rho GDP dissociation inhibitor (GDI) alpha PIK3CA Phosphoinositide-3-kinase, catalytic, alpha 
polypeptide 
ARHGEF7 Rho guanine nucleotide exchange factor (GEF) 7 PLAUR Plasminogen activator, urokinase receptor 
BAIAP2 BAI1-associated protein 2 PLCG1 Phospholipase C, gamma 1 
BCAR1 Breast cancer anti-estrogen resistance 1 PLD1 Phospholipase D1, phosphatidylcholine-specific 
CAPN1 Calpain 1, (mu/I) large subunit PRKCA Protein kinase C, alpha 
CAPN2 Calpain 2, (m/II) large subunit PTEN Phosphatase and tensin homolog 
CAV1 Caveolin 1, caveolae protein, 22kDa PTK2 PTK2 protein tyrosine kinase 2 
CDC42 Cell division cycle 42 (GTP binding protein, 25kDa) PTK2B PTK2B protein tyrosine kinase 2 beta 
CFL1 Cofilin 1 (non-muscle) PTPN1 Protein tyrosine phosphatase, non-receptor type 1 
CRK V-crk sarcoma virus CT10 oncogene homolog 
(avian) 
PXN Paxillin 
CSF1 Colony stimulating factor 1 (macrophage) RAC1 Ras-related C3 botulinum toxin substrate 1  
CTTN Cortactin RAC2 Ras-related C3 botulinum toxin substrate 2  
DIAPH1 Diaphanous homolog 1 (Drosophila) RASA1 RAS p21 protein activator 1 
DPP4 Dipeptidyl-peptidase 4 RDX Radixin 
EGF Epidermal growth factor RHO Rhodopsin 
EGFR Epidermal growth factor receptor RHOA Ras homolog gene family, member A 
ENAH Enabled homolog (Drosophila) RHOB Ras homolog gene family, member B 
EZR Ezrin RHOC Ras homolog gene family, member C 
FAP Fibroblast activation protein, alpha RND3 Rho family GTPase 3 
FGF2 Fibroblast growth factor 2 (basic) ROCK1 Rho-associated, coiled-coil containing protein 
kinase 1 
HGF Hepatocyte growth factor  SH3PXD2A SH3 and PX domains 2A 
IGF1 Insulin-like growth factor 1 (somatomedin C) SRC V-src sarcoma (Schmidt-Ruppin A-2) viral 
oncogene homolog (avian) 
IGF1R Insulin-like growth factor 1 receptor STAT3 Signal transducer and activator of transcription 3 
ILK Integrin-linked kinase SVIL Supervillin 
ITGA4 Integrin, alpha 4  TGFB1 Transforming growth factor, beta 1 
ITGB1 Integrin, beta 1  TIMP2 TIMP metallopeptidase inhibitor 2 
ITGB2 Integrin, beta 2  TLN1 Talin 1 
ITGB3 Integrin, beta 3 (platelet glycoprotein IIIa, antigen 
CD61) 
VASP Vasodilator-stimulated phosphoprotein 
LIMK1 LIM domain kinase 1 VCL Vinculin 
MAPK1 Mitogen-activated protein kinase 1 VEGFA Vascular endothelial growth factor A 
MET Met proto-oncogene (hepatocyte growth factor 
receptor) 
VIM Vimentin 
MMP14 Matrix metallopeptidase 14  WASF1 WAS protein family, member 1 
MMP2 Matrix metallopeptidase 2  WASF2 WAS protein family, member 2 
MMP9 Matrix metallopeptidase 9  WASL Wiskott-Aldrich syndrome-like 
MSN Moesin WIPF1 WAS/WASL interacting protein family, member 
1 
 




Supplementary Table 2: Complete list of target genes in Qiagen EMT PCR Microarrays (Catalogue number: PAHS-090Z) 
Symbol Description Symbol Description 
AHNAK AHNAK nucleoprotein MST1R Macrophage stimulating 1 receptor 
AKT1 V-akt murine thymoma viral oncogene 
homolog 1 
NODAL Nodal homolog (mouse) 
BMP1 Bone morphogenetic protein 1 NOTCH1 Notch 1 
BMP2 Bone morphogenetic protein 2 NUDT13 Nudix (nucleoside diphosphate linked moiety X)-
type motif 13 
BMP7 Bone morphogenetic protein 7 OCLN Occludin 
CALD1 Caldesmon 1 PDGFRB Platelet-derived growth factor receptor, beta 
polypeptide 
CAMK2N1 Calcium/calmodulin-dependent protein kinase 
II inhibitor 1 
PLEK2 Pleckstrin 2 
CAV2 Caveolin 2 DESI1 PPPDE peptidase domain containing 2 
CDH1 Cadherin 1, type 1, E-cadherin (epithelial) PTK2 PTK2 protein tyrosine kinase 2 
CDH2 Cadherin 2, type 1, N-cadherin (neuronal) PTP4A1 Protein tyrosine phosphatase type IVA, member 1 
COL1A2 Collagen, type I, alpha 2 RAC1 Ras-related C3 botulinum toxin substrate 1 
COL3A1 Collagen, type III, alpha 1 RGS2 Regulator of G-protein signalling 2, 24kDa 
COL5A2 Collagen, type V, alpha 2 SERPINE1 Serpin peptidase inhibitor, clade E (nexin, 
plasminogen activator inhibitor type 1), member 1 
CTNNB1 Catenin (cadherin-associated protein), beta 1, 
88kDa 
GEMIN2 Survival of motor neuron protein interacting protein 
1 
DSC2 Desmocollin 2 SMAD2 SMAD family member 2 
DSP Desmoplakin SNAI1 Snail homolog 1 (Drosophila) 
EGFR Epidermal growth factor receptor SNAI2 Snail homolog 2 (Drosophila) 
ERBB3 V-erb-b2 erythroblastic leukaemia viral 
oncogene homolog 3 (avian) 
SNAI3 Snail homolog 3 (Drosophila) 
ESR1 Estrogen receptor 1 SOX10 SRY (sex determining region Y)-box 10 
F11R F11 receptor SPARC Secreted protein, acidic, cysteine-rich (osteonectin) 
FGFBP1 Fibroblast growth factor binding protein 1 SPP1 Secreted phosphoprotein 1 
FN1 Fibronectin 1 STAT3 Signal transducer and activator of transcription 3 
FOXC2 Forkhead box C2 STEAP1 Six transmembrane epithelial antigen of the prostate 
1 
FZD7 Frizzled family receptor 7 TCF3 Transcription factor 3 
GNG11 Guanine nucleotide binding protein gamma 11 TCF4 Transcription factor 4 
GSC Goosecoid homeobox TFPI2 Tissue factor pathway inhibitor 2 
GSK3B Glycogen synthase kinase 3 beta TGFB1 Transforming growth factor, beta 1 
IGFBP4 Insulin-like growth factor binding protein 4 TGFB2 Transforming growth factor, beta 2 
IL1RN Interleukin 1 receptor antagonist TGFB3 Transforming growth factor, beta 3 
ILK Integrin-linked kinase TIMP1 TIMP metallopeptidase inhibitor 1 
ITGA5 Integrin, alpha 5 TMEFF1 Transmembrane protein with EGF-like and two 
follistatin-like domains 1 
ITGAV Integrin, alpha V TMEM132A Transmembrane protein 132A 
ITGB1 Integrin, beta 1 TSPAN13 Tetraspanin 13 
JAG1 Jagged 1 TWIST1 Twist homolog 1 (Drosophila) 
KRT14 Keratin 14 VCAN Versican 
KRT19 Keratin 19 VIM Vimentin 
KRT7 Keratin 7 VPS13A Vacuolar protein sorting 13 homolog A 
MAP1B Microtubule-associated protein 1B WNT11 Wingless-type MMTV integration site family, 
member 11 
MMP2 Matrix metallopeptidase 2 WNT5A Wingless-type MMTV integration site family, 
member 5A 
MMP3 Matrix metallopeptidase 3 WNT5B Wingless-type MMTV integration site family, 
member 5B 
MMP9 Matrix metallopeptidase 9 ZEB1 Zinc finger E-box binding homeobox 1 
MSN Moesin ZEB2 Zinc finger E-box binding homeobox 2 
 
 
               
 
          











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































15 3.66 3.60 3.46 3.63 3.59 3.55 3.64 3.58 3.58 3.64 3.57 3.59 
16 4.03 3.99 3.88 4.04 3.98 3.94 4.05 3.96 3.96 4.03 3.98 3.97 
23 1.89 1.83 1.65   1.45 1.87 1.79  1.96 1.58 1.65 
24 2.70 2.68 2.40 2.77 2.63 2.57 2.69 2.59 2.59 2.72 2.60 2.67 
25 3.11 2.98 3.04 3.10 2.99 3.02 3.08 3.01 3.06 3.09 2.95 3.02 
26 2.26 1.88 2.27 2.26 1.72 2.21  2.02 2.22 2.19 2.10 2.09 
27 4.96 4.85 4.91 4.93 4.86 4.88 4.92 4.85 4.89 4.93 4.85 4.91 
28 3.12 3.03 3.09 3.28 3.11 3.17 3.21 3.21 3.28 3.26 3.15 3.24 
32 6.60 6.50 6.49 6.68 6.52 6.60 6.66 6.55 6.61 6.67 6.54 6.61 
33 3.54 3.35 3.36 3.64 3.36 3.54 3.57 3.44 3.59 3.60 3.42 3.58 
34 4.09 3.99 3.98 4.18 4.02 4.11 4.15 4.02 4.14 4.17 4.03 4.15 
40 3.29 3.27 3.10 3.26 3.25 3.17 3.25 3.23 3.15 3.34 3.24 3.22 
41  3.01 3.07 2.96 2.84 3.10  2.82 2.96  2.87 2.96 
42 3.80 3.59 3.90 3.93 3.60 4.02 3.82 3.63 4.04 3.93 3.64 4.08 
44    2.99 3.27 2.81        
46    2.64          
50 5.77 5.65 5.70 5.94 5.66 5.87 5.88 5.72 5.87 5.92 5.70 5.85 
51              
52 3.44 3.27 3.42 3.50 3.24 3.54 3.45 3.34 3.51 3.48 3.33 3.45 
53 2.07  2.17  1.75 2.00 1.81 2.01 1.98 1.81 1.78 2.00 
54 2.81 3.30 2.85 2.79 3.53 2.87 2.79 3.39 2.95 2.87 3.50 2.96 
56 2.81 2.67 2.34       2.73 2.32   
58 2.95 3.01 2.63 2.96 3.00 2.89 2.78 2.77 2.77 2.89 2.90 2.78 
60 3.58 3.40 3.76 3.74 3.45 3.97 3.68 3.46 3.94 3.78 3.52 3.98 
64   2.40   2.59      2.45 
68 2.65 2.64 2.64 2.68 2.67 2.88 2.80 2.81 2.82 2.69 2.68 2.83 
69  2.76 2.88 2.61 2.86 2.93 2.41 2.83 2.99  2.79 2.86 
70 2.46 2.58  2.31  2.16 2.07 1.88 2.22 2.30 2.11 2.14 
72     2.36   2.43 2.07  2.28   
76  1.93  2.10  2.20 1.82 2.06 2.14 2.13  2.11 
78 2.27 2.14 2.32 2.31  2.36   2.29 2.39  2.29 
80 2.70 2.62 2.54 2.80  2.78        
82 2.24 2.17  2.00 1.94  2.23  2.02 2.23 1.56   
84    2.22 1.92 2.17     1.99 1.96 
86 2.46 2.72 2.25 2.31 2.27  2.13 2.23 2.26 2.07  1.93 
88  2.29 2.34 2.07  2.21 2.10 2.31 2.15 2.12 2.25 2.24 
90   1.85       1.70 1.47   
92 2.03 1.90 2.05    2.02 1.72 1.90 1.86    
Supplementary Table 3: Product ion array for colorectal tumour cell cultures. The headspace 
above tumour cell cultures was analysed via SIFT-MS. Tables shows the product ions detected 
from each cell line (n=3) with mean intensity log(cps) for each product ion included in analysis 
after background subtraction using uninoculated cell culture medium as a control. Table is 
continued on the following page.  
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94      2.70        
96  2.20 2.00 1.96 1.94  2.09   2.17 2.10 2.08 
97  2.37 2.46 1.96 1.98 2.20 1.94  2.29     
98  1.77    1.75   2.11 2.24  2.05 
100 2.82 2.87 2.73 3.07 3.06 3.02 3.11 3.07 3.11 3.14 3.02 3.09 
104    2.01 2.08 1.99 1.88 1.80 1.74   1.97 
110   2.14 2.00  2.00 2.24 1.97 1.98   1.98 
112 2.07 2.30 2.06 2.31 1.89 2.36  2.12 2.30  2.04 2.02 
116 2.92 3.14 3.16 2.76 3.09 3.10 2.89 3.04 3.11 2.90 2.96 3.06 
118 1.75 1.98 2.08 1.75 1.85 1.88   1.80     
120 1.77   2.03  2.10        
122 2.85 2.77 2.60 2.76 2.51 2.93 2.84 2.37 2.62 2.89 2.59 2.43 
124 2.10 1.94 1.94   2.05  1.94 2.13 2.11 1.98   
126 1.72 1.85 1.96           
130       1.46       
132    1.79 1.70    1.65     
134 2.46 2.57 2.75 2.55 2.71 2.77 2.43 2.51 2.72 2.70 2.52 2.68 
136 2.66 2.49 2.56 2.58 2.71 2.82 2.64 2.48 2.60 2.56 2.49 2.48 
137 1.95 2.20 2.40 2.28 2.42   2.21 2.35  2.08 2.26 
138 2.41 2.33 2.16 2.23 2.10 2.38 2.24 1.98 2.17 2.41 2.18 2.26 
140 2.03 1.87    1.94        
144 1.66 1.52            
146       1.64 1.70   1.37   
148 1.71  1.53           
150 2.62 2.53  2.62  2.64 2.34   2.61 2.30   
152 2.10 1.85  2.10  2.18 2.10    2.07   
154  1.92  1.89  1.96    1.85 1.92   
156          1.65    
158 1.74 2.05 2.19    1.68       
160 1.76             
162   1.87 2.26 1.81  1.77    1.65 1.51 
164 3.05 2.85 2.69 2.94 2.54 2.95 2.98 2.64 2.84  2.73 2.73 
165 1.95   2.21      2.32    
166 2.38 1.91  2.40 2.15 2.40 2.35 2.02 2.20 2.44 2.43 2.42 
168 2.16      2.07       
172     1.79 2.11  1.85  1.79 2.10   
176 1.90 2.05            
178 2.54 2.42   2.61 2.77  2.45 2.43  2.48 2.67 
180          2.40    
182      1.62  1.70 1.79     
188     2.12    2.23 1.66    
190 2.11  1.81 1.92          
192 2.54 2.80 2.42 2.69 2.66 2.79 2.64  2.50  2.63 2.45 
194                   2.34     
              
     Key 1 2 3 4 5 6 7  
  




  B. fragilis E. coli Nissle E. faecalis F. nucleatum 
m/z 
15 3.67 3.61 3.51           
16 4.06 3.99 3.88           
23  1.68            
24 2.74 2.60 2.57           
25 3.13 3.03 2.97           
26 2.34 1.92 1.92           
27 4.96 4.86 4.91           
28 3.11 3.03 3.16           
32 6.59 6.49 6.52           
33 3.43 3.29 3.39 2.24 2.44 2.56        
34 4.07 3.95 4.02           
35          1.16 1.13 1.18 
40 3.17 3.14 3.00      1.18  1.41   
41 2.97 3.01 2.99           
42 3.73 3.53 3.84           
49            2.16 
50 5.72 5.57 5.72           
52 3.29 3.22 3.45           
54 2.83 3.22 2.81           
56 2.41 2.60            
58 2.73 2.87 2.56           
60 3.53 3.37 3.76           
64 2.13             
66 2.56 2.58 2.77           
67   2.30           
68 2.48 2.59 2.63           
69 2.79 2.93 3.02           
70 2.09 2.41 2.15           
72  2.17            
74      2.76        
76   1.97           
78 1.93 1.95 2.27           
80 2.60 2.51 2.89           
82 2.09 1.97 1.86           
85          2.71 2.63 2.59 
86  2.39            
88 2.12 2.00 2.09           
89       2.43 2.40 2.33     
92 1.91  2.02           
Supplementary Table 4: Product ion array for bacteria-infected RG/C2 cells. The headspace 
above infected RG/C2 cultures was analysed via SIFT-MS after a 4-hour bacterial co-culture. 
Tables shows the product ions detected from each cell line (n=3) with mean intensity log(cps) for 
each product ion included in analysis after background subtraction using non-infected RG/C2 cells 
as a control. Table is continued on the following page.  
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94 2.57 2.50 2.82           
96 1.95 1.89 1.99           
97   2.05           
98 2.00         1.31 1.49 1.32 
99          2.39 2.17 2.08 
100 2.81 2.92 2.71           
104 1.80 2.03 0.00           
106 0.00 1.99 2.27     1.84      
108 2.54 2.60 2.76           
110 2.14  2.10           
111          2.03    
112 1.97             
113          2.73 2.75 2.50 
116 2.90 3.11 3.00           
120 0.00 2.02 2.10           
122 2.56 2.61 2.84           
124 2.23  1.96           
125          1.55 1.87 1.96 
132   1.63           
134 2.44 2.64 2.81           
136 2.37 2.63 2.73           
137  2.36 2.24           
138 2.23 2.41 2.15           
140 1.93             
146  1.64            
150 2.25 2.33 2.63           
154  2.02 2.07     1.31      
158  1.75 2.17           
161          1.97    
162 2.01 2.01            
164 2.67 2.69 2.96           
166 2.33       1.42      
168          1.65    
170          1.97    
175            2.00 
178 2.46 2.39 2.63           
180 1.85  1.92           
183            2.57 
186  1.97            
188 2.15  1.99           
192 2.43 2.42 2.89           
193      2.41        
194  2.13 2.07           
197       2.70   2.76    
198             2.09 1.64 1.82       
              
    Key 1 2 3 4 5 6 7   








15 3.62 3.56 3.57 3.67 3.60 3.57 3.64 3.61 3.60 3.64 3.59 3.61 
16 4.07 3.98 3.95 4.07 4.00 3.96 4.05 4.01 3.98 4.05 4.00 3.98 
23 1.67 1.67   1.73     1.73 1.60   
24 2.77 2.56 2.59 2.81 2.67 2.63 2.75 2.70 2.53 2.76 2.65 2.63 
25 3.10 3.02 3.07 3.07 2.92 3.06 3.07 2.96 3.06 3.06 3.02 3.04 
26 2.22 2.08 2.27 2.24 1.87 2.04 2.21 2.20 2.19 2.17 2.20 2.01 
27 4.93 4.87 4.92 4.95 4.87 4.92 4.96 4.88 4.92 4.96 4.87 4.92 
28 3.17 3.09 3.20 3.07 3.00 3.15 3.08 3.07 3.15 3.15 3.01 3.20 
32 6.64 6.49 6.56 6.59 6.47 6.53 6.57 6.46 6.53 6.57 6.46 6.53 
33 3.51 3.25 3.47 3.39 3.23 3.39 3.33 3.12 3.41 3.40 3.15 3.42 
34 4.12 3.94 4.10 4.08 3.91 4.04 4.04 3.94 4.04 4.06 3.94 4.04 
35  1.31         1.11   
40 3.23 3.12 3.11 3.69 3.24 3.22 3.31 3.29 3.29 3.25 3.19 3.17 
41 2.86 2.86 3.02 2.90 2.76 2.96 2.87 2.92 2.98 2.81 2.93 2.89 
42 3.78 3.58 4.02 4.14 3.72 4.01 3.67 3.58 3.93 3.68 3.56 3.96 
44 2.93 3.23   3.25 2.71 2.50 3.31 2.63 3.97 3.80 3.81 
50 5.84 5.60 5.75 5.72 5.53 5.68 5.68 5.51 5.66 5.69 5.50 5.66 
52 3.43 3.23 3.47 3.36 3.21 3.37 3.34 3.30 3.37 3.31 3.20 3.44 
53 0.00 1.87 1.88 2.12  1.93 1.93   2.17  1.88 
54 2.66 3.35 2.88 2.78 3.33 2.87 2.68 3.32 2.90 2.70 3.37 2.78 
58 2.81 2.86 2.53 3.19 2.85 2.79 2.91 2.94 2.73 3.26 3.19 3.17 
60 3.56 3.35 3.90 3.94 3.48 3.85 3.44 3.29 3.76 3.45 3.35 3.78 
62           1.96 2.12 
64  2.09 2.50   2.58  2.04 2.48   2.45 
66 2.90 2.63 2.87 2.91 2.68 2.70 2.83 3.03 2.58 2.79 2.62 2.67 
67  1.92 2.16 2.15  2.15 2.21 1.96 2.17     
68 2.78 2.56 2.69 2.56 2.53 2.54 2.59 2.48 2.44 2.57 2.49 2.71 
69 2.69 2.83 3.05 2.76 2.98 3.00 2.76 2.79 2.93 2.84 2.98 3.10 
70 2.35 2.34 2.36 2.45 2.13 2.20 2.46 2.35 2.30 2.42 2.31 2.25 
72  2.25      2.24      
76 2.07 1.94 2.00 2.12  2.03 1.80 1.92 1.78 2.09  2.00 
78 2.28 1.96 2.44 2.37 1.85 2.33 2.22 2.36 2.38 2.23 2.07 2.21 
80 2.86 2.66 2.95 2.97 2.58 2.82 2.80  2.62 2.72 2.66 2.66 
82  1.82 2.05   2.01 2.08  2.00 2.08  2.06 
84 2.23  2.03  1.74 1.77 2.83 3.23 2.60 1.96  1.96 
86 0.00 2.01  2.24  2.09  2.40  2.53 2.35 2.25 
88 2.16 2.02 2.08 2.36  2.14   2.25 2.30    
90   1.78 1.81  1.72      1.91 
92 2.24  2.07    2.23 2.09 1.81 1.93 1.91   
94 2.74 2.55 2.80 2.90 2.58  2.88 2.82 2.65 2.76 2.58 2.70 
96 2.20 2.08 2.21 2.23 2.07   2.01 2.29 2.22 1.89 2.32 
97     2.10      1.96 2.10 
98         2.01     
Supplementary Table 5: Product ion array for bacteria infected HCT116 cells. The headspace 
above infected HCT116 cultures was analysed via SIFT-MS after a 4-hour bacterial co-culture. 
Tables shows the product ions detected from each cell line (n=3) with mean intensity log(cps) for 
each product ion included in analysis after background subtraction using non-infected HCT116 
cells as a control. Table is continued on the following page.  
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100 2.94 2.99 2.73 2.82 2.93 2.96 2.70 2.95 2.86 2.79 2.95 2.96 
102 2.27             
104 1.89  1.73 1.81 2.02   1.99  1.94    
108 2.87 2.50 2.88 2.91 2.69 2.78 2.81 2.88 2.59 2.73 2.65 2.70 
110 1.97  1.80 2.07  2.08 2.15  2.06 2.39  1.86 
112 2.08    2.10 1.97 2.06 2.05 2.19  1.98 2.26 
114   1.87           
116 2.70 3.01 3.08 2.81 3.09 3.06 2.85 3.10 3.04 2.88 3.01 3.04 
118 1.71 1.78 1.83 2.08 1.88 1.91 1.85  1.81   1.93 
120 2.34  2.12  1.72  2.06  1.82  1.76   
122 2.98 2.58 2.91 2.96 2.65  2.77 3.06 2.51 2.86 2.74 2.59 
123    1.67          
124 2.13 1.84 1.96 2.10 1.97 1.58  1.99 2.07 2.03 1.78 1.89 
128       1.86       
130  1.79         1.37   
132 1.74 1.80   1.70  1.70    1.57   
134 2.63 2.73 2.70 2.56  2.68 2.50 2.70 2.72 2.64 2.62 2.69 
136 2.74 2.52 2.60 2.79 2.46 2.65 2.71 2.73 2.35 2.62 2.46 2.56 
137 2.28   2.07   2.25  2.29 1.92 2.12 2.31 
138 2.36 2.27    2.18 2.39 2.23 2.09 2.44  2.00 
144        1.60      
146    2.04     1.36  1.49   
148 1.91 1.50  1.63 1.84  1.99   1.50 1.84   
150 2.75 2.45 2.59 2.74 2.51 2.56 2.67 2.73 2.20 2.66 2.29 2.35 
151   1.86           
152 2.26  2.12 2.17 2.19 1.91 2.25  1.74 2.18    
154 1.89 2.10   1.73   2.10  2.17 1.85 1.90 
160   1.67  1.42         
162 2.19  1.96 2.12  2.22      2.05 
164 3.04 2.53 2.97 3.09 2.68 2.84 3.07  2.52 2.92 2.73 2.74 
165 2.23          1.94 2.02 
166 2.42 2.22 2.36  2.20 2.08 2.54 2.35 2.13 2.41 2.31 2.22 
168 2.20   2.12   1.75    2.26   
172      1.97   1.71     
176 2.04             
178 2.76 2.49 2.59 2.70 2.61  2.71 2.84  2.46 2.31 2.45 
179    1.96          
180 2.37  2.00 2.15  2.11   1.72 2.35 1.94   
181              
182  1.75   1.75      2.23   
186 2.07   2.02      1.85    
188            2.20 
190   1.94    2.27       
192 3.01 2.62 2.74 2.93 2.58 2.68 2.92 2.98 2.49 2.94 2.59 2.78 
194       1.97 1.91 2.03       1.83     
              
   Key  1 2 3 4 5 6 7    
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